Fabrication and characterisation of 3-D porous bioactive glass-ceramic/polymer composite scaffolds for tissue engineering by Mohamad Yunos, Darmawati & Mohamad Yunos, Darmawati
 1 
 
 
 
 
Fabrication and characterisation of 3D porous 
bioactive glass-ceramic/polymer composite scaffolds 
for tissue engineering. 
 
 
 
 
 
 
 
 
 
 
Darmawati Mohamad Yunos 
 
 
 
 
 
Department of Materials, Imperial College London (UK) 
 
 
 
 
 
A thesis presented for the degree of Doctor of Philosophy (PhD)  
 
Imperial College London 
 
 
 
 
 
April 2010 
 
 
 
 
 
 
 
 
 
 2 
 
 
 
Declaration 
 
This thesis is a presentation of my original research work. Wherever contributions of 
others are involved, every effort is made to indicate this clearly, with due reference to 
the literature, and acknowledgement of collaborative research and discussions. 
 
 
 
 
 
 
                                                                               Darmawati Mohamad Yunos 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Abstract 
 
Designing tissue engineering scaffolds with the required mechanical properties and 
favourable microstructure to promote cell attachment, growth and new tissue 
formation is one of the key challenges in the tissue engineering field.  An important 
class of scaffolds for bone tissue engineering is based on bioceramics and bioactive 
glasses. The primary disadvantage of these materials is their low fracture resistance 
under load and their high brittleness. These drawbacks are exacerbated by the fact that 
optimal scaffolds must be highly porous (>90% porosity). As a main focus of this 
thesis, a novel approach was investigated to enhance the structural integrity, fracture 
strength and toughness of partially sintered 45S5 Bioglass
®
 based glass-ceramic 
scaffolds by polymer infiltration and to develop an understanding of the interaction of 
these two phases in the final composite structure. Commercially available synthetic 
poly(D,L-Lactic acid) (PDLLA) was incorporated as a coating onto the partially 
sintered Bioglass
®
 based scaffolds by dipping technique. Two natural polymers 
synthesised from bacteria, which exhibit different properties to those of PDLLA, were 
also investigated: i.e. poly(3-hydroxybutryate) (P(3HB)) and poly(3-
hydroxyoctanoate) (P(3HO)). The work of fracture of partially sintered 45S5 
Bioglass
®
 scaffolds was significantly improved by forming interpenetrating polymer-
bioceramic microstructures which mimic the composite structure of bone. It was 
demonstrated that coating with polymers such as PDLLA, P(3HB) and P(3HO) does 
not impede the bioactivity of the scaffolds but the extent of bioactivity, given by the 
kinetic of HA formation, was seen to depend on polymer type and on scaffold 
sintering conditions. Polymer coated 45S5 Bioglass
®
 pellets sintered at the same 
condition as the scaffolds and immersed in SBF were investigated to better evaluate 
the bioactivity mechanism and interfacial properties of the materials. It was 
demonstrated that polymer coated 45S5 Bioglass
® 
based glass-ceramic scaffolds can 
have higher bioactivity and improved fracture toughness when the basic scaffold 
structure is sintered at relative lower sintering temperatures leaving residual open 
porosity which can be efficiently infiltrated by the polymer.  
 
A bilayered scaffold structure was also designed and fabricated to develop for the first 
time a porous bioactive glass-ceramic scaffold coated with PDLLA nanofibers. 
Electrospinning was used to deposit a PDLLA fibrous layer on top of the bioactive 
 4 
glass scaffold. These scaffolds were developed for osteochondral tissue engineering 
applications. SBF studies showed that the extent of mineralisation of the PDLLA 
fibres depended on the fibrous mesh thickness. PDLLA fibres deposited for 2 hours 
did not mineralise when immersed for 7, 14 and 28 days in SBF making the structure 
suitable for osteochondral defect applications. Initial in vitro cell response studies 
showed that the bilayered scaffolds were non toxic and chondrocyte cells were able to 
proliferate on the PDLLA fibre layers, demonstrating the potential of the novel 
scaffolds for osteochondral tissue engineering. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5 
 
 
Acknowledgements 
 
 
First of all I would like to thank Malaysian Government and Sirim Berhad for the 
financial support during these three years. I would also like to thank Professor Aldo 
R. Boccaccini, for his supervision, guidance and support as my supervisor during my 
PhD years. I am also very grateful to my collaborators during the course of my PhD 
research; including Dr. Ipsita Roy and Miss Ranjana Rai from Westminster University 
for the assistance in production of natural biodegradable polymers, Dr. Zeeshan 
Ahmad at University College London for introducing electrospinning technologies 
into my project and Dr. Vehid Salih from Eastman Dental Institute, University 
College London, for his support in carrying out the in vitro investigation on the 
materials of this project. Dr. A. Petrie from Eastman Dental Institute, University 
College London is acknowledges for the statistical assistance of the in vitro 
investigation. Among the technical supporting staff in the Department of Materials of 
Imperial College London I would like to extend my special thanks to Mr Richard 
Sweeney, Mr Richard Carter and Dr. Mahmoud Ardakani for the technical assistance 
and Miss Norma Hikel for the administrative assistance. 
 
I would like to thank my group mates for their support and friendship despite my 
serious character. Special thanks must go to Dr.Oana Bretcanu and Dr.Qizhi Chen for 
their help during my initial research work. Dr.Judith Roether, Dr.Lutz Gerhardt, 
Dr.Xanthippi Chatzistavrou and Dr.Melek Erol are acknowledged for their 
encouragement. Special thanks to Mikey, Pippa, Bo, Tayyab, Fatemah, Deborah, 
Ilaria and Superb for always being supportive and helpful. Also thanks to Jingjing, 
Panpailin and Air, friends from other groups, who were always there when I needed 
most. 
 
Last but not least, I would like to thank my family for their support, patience and love, 
in particular both my parents who have supported me emotionally.  
 
 
 
 
 6 
Table of Content 
 
 
Chapter One ...........................................................................................................20 
1. Introduction ...............................................................................................20 
Chapter Two...........................................................................................................22 
2. Literature Review ......................................................................................22 
2.1 Tissue engineering: definition and principles .............................................22 
2.2 Rational for bone tissue engineering ..........................................................23 
2.3 The bone tissue engineering approach........................................................24 
2.4 Challenges in tissue engineering and ideal scaffolds for bone tissue 
engineering................................................................................................25 
2.5 Osteochondral tissue engineering...............................................................27 
2.6 Materials for bone tissue engineering scaffolds ..........................................28 
2.6.1 Bioactive glasses............................................................................29 
2.6.2 Calcium phosphate ceramics (CPC) ...............................................32 
2.6.3 Apatite-wollastonite (A/W) glass-ceramics.....................................33 
2.6.4 Ceravital
®
 bioactive glass-ceramic .................................................34 
2.6.5 Bioverit
®
bioactive glass-ceramic....................................................35 
2.6.6 Natural biopolymers.......................................................................35 
2.6.7 Synthetic polymers.........................................................................36 
2.6.8 Synthetic composite materials ........................................................37 
2.7 Technologies for bioactive glass processing...............................................38 
2.7.1 Melt casting ...................................................................................39 
2.7.2 Firing of compacted powders (sintering) ........................................40 
2.7.3 Sol-Gel processing .........................................................................41 
2.8 Methods to produce macroporous ceramic scaffolds ..................................42 
2.8.1 Replica technique...........................................................................42 
2.8.2 Sacrificial template method ............................................................44 
2.8.3 Direct foaming methods .................................................................45 
2.9 Bioceramic porous scaffolds coated with polymer layers ...........................45 
2.9.1 Calcium phosphate-based scaffolds ................................................45 
2.9.2 Bioactive glass and calcium silicate-based scaffolds.......................49 
2.9.3 Polymer-coated scaffolds based on alumina and titania ..................51 
2.10 Nanostructured 3D scaffolds with added functionality ...............................52 
2.10.1 Nanostructured scaffolds by particle processing .............................53 
2.10.2 Nanofibrous scaffolds by electrospinning.......................................54 
2.10.3 Nanofibrous scaffolds by self-assembly..........................................55 
2.11 Bone and cartilage physiology. .....................................................................56 
2.11.1 Bone ..................................................................................................56 
2.11.2 Cartilage. ...........................................................................................58 
2.11 Summary of the literature review...............................................................60 
Chapter Three ........................................................................................................61 
3. Objectives and Aims of the project ............................................................61 
3.1 Experimental Approach .............................................................................62 
3.1.1 Bioactive-glass/polymer composite scaffolds .................................62 
3.1.2 Bilayered scaffolds for osteochondral tissue engineering................63 
Chapter Four..........................................................................................................66 
4. Materials and methods ...............................................................................66 
4.1 Materials....................................................................................................66 
 7 
4.2 Fabrication of 45S5 Bioglass
®
 based scaffolds...........................................68 
4.2.1 Preparation of 45S5 Bioglass
®
 powder slurry .......................................68 
4.2.2 Preparation of green bodies..................................................................68 
4.2.3 Heat treatment of the green bodies .......................................................69 
4.2.4 Selection of binders..............................................................................70 
4.2.5 Functionalisation of 45S5 Bioglass
®
 scaffolds with ALP enzyme.........70 
4.2.5.1 Cleaning of the scaffolds ................................................................70 
4.2.5.2   Silanisation of the scaffolds.............................................................70 
4.2.5.3 Preparation of enzyme (ALP) solutions ..........................................71 
4.3 Synthesis of P(3HB) polymers using bacterial fermentation............................71 
4.3.1 Growing bacteria in nutrient broth (inoculum) .....................................71 
4.3.2 Growing bacteria in nitrogen limiting medium (production medium) ...71 
4.3.3 Isolation/harvesting the bacteria ...........................................................72 
4.3.4 Extraction of polymer ..........................................................................72 
4.4 Synthesis of P(3HO) using bacterial fermentation...........................................73 
4.4.1 Growing bacteria in nutrient broth and production media ...............73 
4.4.2 Extraction of polymer.....................................................................73 
4.4.2.1 Removal of bacterial components...................................................74 
4.5 Coating of 45S5 Bioglass
®
 scaffolds with PDLLA.....................................74 
4.6 Coating of 45S5 Bioglass
®
 based scaffolds with P(3HB) and P(3HO)........75 
4.7 45S5 Bioglass
®
 pellets with PDLLA polymer coating................................75 
4.8 45S5 Bioglass
®
 pellets with P(3HB) and P(3HO) polymer coatings ...........76 
4.9 Preparation of PDLLA fibres on 45S5 Bioglass
®
pellets and scaffolds by 
electrospinning method..............................................................................76 
4.10 Materials Characterisation .........................................................................78 
4.10.1 Physical characteristics of Bioglass
®
 scaffolds ...............................78 
4.10.2 Microstructural characteristics........................................................79 
4.10.3 Mechanical properties ....................................................................80 
4.10.4 SBF treatment of polymer coated 45S5 Bioglass
®
 pellets and 
scaffolds.........................................................................................80 
4.10.5 Polymer/Bioglass
®
 bonding strength in composite scaffolds...........81 
4.10.6 White light interferometry (Zygo
®
) ................................................82 
4.10.7 Permeability study..........................................................................83 
4.10.8 Capillary test using calf-serum .......................................................85 
4.10.9 Characterisation of P(3HB) and P(3HO) polymers .........................86 
4.10.9.1 Structural characterisation ..............................................................86 
i) Gas Chromatography-Mass Spectrometry, GC-MS.....................86 
4.10.9.2 Physical characterization................................................................87 
i) Crystallinity ................................................................................87 
ii) Contact angle study....................................................................87 
iii) Molecular weight analysis ........................................................87 
iv) Thermal properties....................................................................87 
4.10.10 In-vitro Assessment-Cell culture ....................................................88 
4.10.10.1 Preparation of chondrocytes cells line (ATDC) .............................88 
4.10.10.2 Sterilisation of samples .................................................................89 
4.10.10.3 Cell proliferation of ATDCs in porous (3D) scaffolds and   pellets 89 
i) Cell seeding on substrates ...........................................................89 
ii) Assessment of proliferation of ATDC ........................................90 
4.10.10.4 Preparation of SEM samples .........................................................90 
4.10.10.5 Statistics........................................................................................90 
 8 
i) Individual Components on 2D surfaces (pellets) .........................90 
ii) Cell proliferation on 3D surfaces (bilayered scaffolds)...............91 
Chapter five ............................................................................................................92 
5 Optimisation of scaffolds by developing composite structures ...................92 
5.1 Introduction ...............................................................................................92 
5.2 Results.......................................................................................................93 
5.2.1 Characterisation of the porous structure of 45S5 Bioglass
®
 based 
scaffold (As-sintered).....................................................................93 
5.2.1.1 Capillary test ..................................................................................96 
5.2.1.2 Permeability test.............................................................................97 
5.2.1.3 Surface functionalisation of 45S5 Bioglass
®
 scaffolds ....................99 
5.2.1.4 Optimisation of the binder (i.e. poly-vinyl-alcohol (PVA)) for 
scaffold fabrication using the foam replica method.......................100 
5.2.1.5 Effects of concentration of the PDLLA coating solution and of 
immersion time ............................................................................103 
5.2.2 Characterisation of 45S5 Bioglass
®
 based scaffolds coated with 
PDLLA film.................................................................................105 
5.2.2.1 Physical properties of scaffolds of the 900-1100 Series ................105 
5.2.2.2 Mechanical property - microstructure correlation of the 900-1000 
series scaffolds .............................................................................110 
5.2.2.3 Physical analysis of the 1000 series scaffolds ...............................115 
5.2.2.4 Mechanical property-microstructure correlation in 1000 series 
scaffolds.......................................................................................118 
5.2.2.5 Mechanical properties of PDLLA coated 45S5 Bioglass
®
 scaffolds
 122 
5.2.3 Characterisation of 45S5 Bioglass
®
 sintered pellets coated with 
PDLLA film.................................................................................125 
5.2.3.1 Interface properties.......................................................................125 
5.2.3.2 Bioactivity assessment of coated 45S5 Bioglass
®
 pellets and 
scaffolds.......................................................................................127 
i ) Bioactivity analysis in SBF (45S5 Bioglass
®
 pellets)..............................127 
ii) Bioactivity analysis in 1.5 SBF (PDLLA coated 45S5 Bioglass
®
 pellets)130 
iii) Bioactivity analysis of 45S5 Bioglass
®
 composite scaffolds in SBF ......135 
5.2.4 Characterisation of 45S5 Bioglass
®
 scaffolds coated with P(3HB) 
films.............................................................................................141 
5.2.4.1 Characterisation of synthesised P(3HB) from bacteria fermentation
 ……………………………………………………………………141 
5.2.4.2 Physical analysis of scaffolds of the 900-1100 Series ...................143 
5.2.4.3 Mechanical property- Microstructure correlation in 900-1100 series 
scaffolds.......................................................................................147 
5.2.4.4 Physical analysis of the 1000 series scaffolds ...............................150 
5.2.4.5 Mechanical property- microstructure correlation in 1000 series 
scaffolds.......................................................................................152 
5.2.4.6 Characterisation of 45S5 Bioglass
®
 pellets coated with P(3HB) film
 ……………………………………………………………………156 
i) Interface properties..................................................................................156 
ii) Bioactivity analysis of the P(3HB) coated 45S5 Bioglass
®
 pellets ..........157 
iii) Bioactivity analysis of the P(3HB) coated 45S5 Bioglass
®
 scaffolds. ....161 
iv) Compressive strength after SBF immersion ...........................................165 
 9 
5.2.5 Characterisation of 45S5 Bioglass
®
 scaffolds coated with P(3HO) 
films.............................................................................................166 
5.2.5.1 Characterisation of poly-3-hydroxyoctanoate P(3HO). .................166 
5.2.5.2 Characterisation of 45S5 Bioglass
®
 pellets coated with P(3HO) film
 ……………………………………………………………………167 
               i) Bioactivity analysis of P(3HO) coated 45S5 Bioglass
®
 pellets ..167 
5.2.5.3 Mechanical property -microstructure correlation in 1000 series 
scaffolds coated with P(3HO).......................................................171 
5.2.5.4 Bioactivity analysis in SBF ..........................................................176 
5.3 Discussion ...............................................................................................179 
5.3.1 Comparison of the compressive strength of 45S5 Bioglass
®
/Polymer 
composite scaffolds with spongy bone and with previous 
investigations ...............................................................................179 
5.3.2 Proposed toughening mechanisms................................................181 
5.3.3 Comparison of 45S5 Bioglass
®
/polymer composites: assessment in 
simulated body fluid.....................................................................183 
5.4 Conclusions .............................................................................................185 
Chapter Six...........................................................................................................187 
6 Design of bilayered scaffolds: Electrospun PDLLA nanofiber coated 45S5 
Bioglass
®
substrates ................................................................................................187 
6.1 Introduction .............................................................................................187 
6.2 Results.....................................................................................................188 
6.2.1 PDLLA fibre deposition on 45S5 Bioglass
®
 sintered pellets .........188 
6.2.1.1 Processing....................................................................................188 
6.2.1.2 Microstructure analysis ................................................................190 
6.2.1.3 Surface topography measurement using white light interferometer
 ……………………………………………………………………194 
6.2.1.4 SBF bioactivity studies.................................................................195 
6.2.2 PDLLA fibre deposition on 45S5 Bioglass
®
 scaffolds ..................201 
6.2.2.1 Motivation ...................................................................................201 
6.2.2.2 Microstructure analysis of PDLLA fibres on 45S5 Bioglass
® 
scaffolds by SEM. ........................................................................202 
6.2.2.3 SBF bioactivity studies.................................................................206 
i) Microstructure and EDS analysis. .............................................206 
                      ii) Final development of osteochondral scaffolds. ..........................211 
6.2.3 Cell culture assessment of the bilayered osteochondral scaffolds ...............212 
6.2.3.1 Cell proliferation on 2D surfaces (pellets). ......................................213 
6.2.3.3 Cell proliferation on 3D surfaces (Bilayered scaffolds) ...................215 
6.3 Discussion ...............................................................................................219 
6.4 Conclusions. ............................................................................................223 
Chapter Seven ......................................................................................................224 
7 Conclusions and Further Work.................................................................224 
7.1 General remarks.......................................................................................224 
7.2 Optimisation of scaffolds microstructure by developing composites. .......225 
7.3 PDLLA nanofiber coatings on the 45S5 Bioglass
® 
pellets and scaffolds: 
bilayered scaffold development................................................................226 
7.4 Suggested Further Work ..........................................................................227 
7.4.1 Composite scaffolds .....................................................................227 
7.4.2 Bilayered scaffolds.......................................................................230 
Conference papers and publications. ..................................................................252 
 10 
APPENDIXES ......................................................................................................253 
 
 
List of Figures 
 
Figure 2.1 The Tissue Engineering triad. .................................................................25 
Figure 2.2 Schematic diagram of the mechanism of apatite formation on the surface 
of CaO, SiO2-based glasses and glass-ceramics in the body [42]. .............................30 
Figure 2.3 General molecular structure of polyhdroxyalkanoates. m=1,2,3, yet m=1 is 
most common, n can range from 100 to several thousands. R is variable. When m=1, 
R=CH3, the monomer structure is 3-hydroxybutyrate, while m=1 and R=C3H7, it is a 
3-hydroxyhexanoate monomer. ................................................................................36 
Figure 2.4 Basic flow chart for the production of A) glasses and B) glass-ceramic by 
melt casting..............................................................................................................39 
Figure 2.5 Basic flow chart for the production of polycrystalline ceramics by 
sintering of consolidated powders. ...........................................................................40 
Figure  2.6 Basic flow charts for sol-gel processing of ceramics and glasses............41 
Figure 2.7 Schematic diagram of the replica technique for fabrication of porous 
ceramics [84]. ..........................................................................................................42 
Figure 2.8 Schematic diagram showing the sacrificial template method to produce 
porous ceramics. [84] ...............................................................................................44 
Figure  2.9 Schematic diagram showing the direct foaming methods to produce a 
porous ceramic. [84].................................................................................................45 
Figure 2.10 SEM micrographs showing the microstructure of PLGA/HA composite 
scaffolds fabricated by Huang and Miao [126]: (A) PLGA phase (dark) filling open 
micropores in a HA strut (bright) and (B) PLGA phase filling the large defect in the 
centre of a strut. .......................................................................................................47 
Figure 2.11 SEM image showing the microstructure of a Bioglass
®
 scaffold coated by 
P(3HB) [135]. ..........................................................................................................50 
Figure 2.12 SEM image of the fracture surface of a PCL/alumina composite scaffold 
obtained by infiltrating alumina foams with a PCL solution [83]. The polymer phase 
is seen to coat the strut and to penetrate cracks in the alumina microstructure...........51 
Figure 2.13 Structure of bone: (A) cortical (or compact) bone; (B) trabecular bone 
[168]. .......................................................................................................................58 
Figure 2.14 Normal articular cartilage, illustrating the variability in density and 
orientation of the chondrocytes and collagen network. [168] ....................................59 
Figure 3.1 Schematic diagram showing the designed interpenetrating microstructure 
of partially sintered scaffold struts infiltrated by biodegradable polymer. .................63 
Figure 3.2 Schematic diagram of the bilayered scaffold structure developed in this 
project for osteochondral tissue engineering. ............................................................64 
Figure 3.3 Schematic diagram showing the research methodology used in this project.
................................................................................................................................65 
Figure 4.1 Particle size distribution of  45S5 Bioglass
®
 powder. ..............................67 
Figure 4.2 The macroporous structure of 45 ppi polyurethane sponge use to fabricate 
scaffolds by the replica technique. (Recticel, England) .............................................67 
Figure 4.3 Heat treatment program designed for burning-out polyurethane templates 
and sintering of 45S5 Bioglass
®
 scaffolds. ...............................................................69 
Figure 4.4 Schematic diagram showing the setting-up of the electro-spinning 
apparatus. (Mech.Eng Department, UCL).................................................................78 
 11 
Figure 4.5 A schematic diagram showing the crack propagation from a Vickers 
indentation on a sintered Bioglass
®
 pellet (developed using the microhardness tester).
................................................................................................................................82 
Figure 4.6 Schematic diagram showing the permeability assay rig used to obtain 
Darcy’s permeability. [176]......................................................................................85 
Figure 4.7 Photograph showing the experimental set-up for the capillary test. .........86 
Figure 5.1 Graph showing the porosities of 45S5 Bioglass
®
 based scaffolds at 
different sintering conditions (900-1100 series). .......................................................94 
Figure 5.2 Graph showing the porosities of 45S5 Bioglass
®
 based scaffolds at 
different sintering conditions (1000 series). ..............................................................94 
Figure 5.3 SEM images showing the pore structure of 45S5 Bioglass
®
 based scaffolds 
sintered at 1000
o
C for A) 0.5 hours, B) 1 hour and C) 2 hours. The magnification for 
all images is the same (X 50)....................................................................................96 
Figure 5.4 Photographs showing the 45S5 Bioglass
®
 derived scaffolds (sintered at 
1000
o
C for 2 hours) before capillary test: A) whole scaffolds and B) internal section 
of scaffolds. Bioglass
® 
derived scaffolds after capillary test (2 seconds immersion in 
bovine calf serum): C) whole scaffolds and D) internal section of scaffolds. ............97 
Figure 5.5 Relationship ∆p[Pa] – Q for two Bioglass
®
 scaffold specimens (sintered at 
1100
o
C for 2 hours) tested  in deionised water (N= two samples tested). ..................98 
Figure 5.6 ALP specific enzymatic activity on silanised 45S5 Bioglass
®
 scaffolds 
(BG-SIL-37-1) as compared to non-silanised scaffolds (BG 37) at 37
o
C.  Values are 
presented by mean ± standard deviation (s.d) for N = 3 samples . .............................99 
Figure 5.7 Photograph showing the yellowish functionalised scaffold (above) as 
compared to the non-functionalised scaffold (below)..............................................100 
Figure 5.8 Typical pore structure of 45S5 Bioglass
®
 scaffold sintered at 1100
o
C for 2 
hours using a 10 wt/v% PVA binder in the starting Bioglass
®
 slurry.......................101 
Figure 5.9 Graph showing the porosities of 45S5 Bioglass
®
 scaffolds sintered at 
different sintering temperature for 2 hours using 10 wt/v% PVA as binder. ............101 
Figure 5.10 Graphs showing the compressive strength (MPa) of the 45S5 Bioglass
®
 
scaffolds sintered at different sintering conditions (temperature-time) using a 10 wt% 
PVA suspension as binder. Values are presented as mean ± standard deviation (s.d) 
where N = 5 samples for as-sintered and N = 5 samples for PDLLA coated samples.
..............................................................................................................................102 
Figure 5.11 SEM images showing the microstructure of strut cross-section of 45S5 
Bioglass
®
 scaffolds fabricated using 10 wt% PVA suspension as a binder sintered at 
1000
o
C for 2 hours; A) before coating and B) after coating with 5 wt% PDLLA. ...103 
Figure 5.12. SEM images of the 45S5 Bioglass
® 
scaffolds sintered at 1000
o
C for 2 
hours and immersed in PDLLA solution with different concentration; A) 2.5wt% B) 
5wt%......................................................................................................................104 
Figure 5.13. SEM images of the 45S5 Bioglass
® 
scaffolds sintered at 1000
o
C for 2 
hours and immersed in the 5wt% PDLLA solution at different times; A) 2hours and 
B) 24hours .............................................................................................................105 
Figure 5.14 Graphs showing compressive strength values (MPa) against porosity of 
PDLLA coated 45S5 Bioglass
®
 based scaffolds of the 900-1100 series. .................108 
Figure 5.15  Typical microstructures of 45S5 Bioglass
®
 scaffolds sintered at 1100
o
C 
for 2 hours: A) before coating, B) after coating, C) strut surface before coating and D) 
strut surface after coating with 5wt% PDLLA. The inhomogenous coating due to 
strut’s roughness is indicated in (D)........................................................................109 
Figure 5.16 Graph showing the compressive strength values (MPa) of PDLLA coated 
Bioglass
®
 scaffolds of the 900-1100 series compared with the values of as-sintered 
 12 
samples. All values are presented as mean ± standard deviations (s.d) where N = at 
least 10 samples (coated samples); N = at least 5 samples (as-sintered samples). ....110 
Figure 5.17 SEM images showing the microstructure of Bioglass
®
based scaffold 
struts cross sections before and after coating with 5wt% PDLLA for the following 
sintering conditions: before coating: A) 900
o
C, B) 930
o
C C) 950
o
C, D) 970
o
C, E) 
1000
o
C,  F) 1050
o
C and G) 1100
o
C, sintered for 2 hours ; after coating: A1) 900
o
C 
B1) 930
o
C, C1) 950
o
C, D1) 970
o
C, E1) 1000
o
C, F1) 1050
o
C and G1) 1100
o
C, sintered 
for 2 hours..............................................................................................................113 
Figure 5.18 Graphs showing the relationship between compressive strength values 
and porosity of PDLLA coated scaffolds at different sintering conditions: A) 1000
o
C-
0.5 hrs, B) 1000
o
C-1hrs and C) 1000
o
C-2hrs. .........................................................117 
Figure 5.19 Graph showing compressive strength values of scaffolds of the 1000 
series before and after PDLLA coating. All values are presented as mean ± standard 
deviations (s.d) where N = 10 samples (Coated samples); N = 5 samples (As-sintered 
samples). ................................................................................................................118 
Figure 5.20 SEM images showing the microstructure of scaffold strut cross sections 
before and after coating with PDLLA at different sintering conditions of scaffolds of 
the 1000 series. Before coating: A) 0.5 hr, B) 1 hrs and C) 2 hrs; after coating: A1) 0.5 
hr, B1) 1 hr and C1) 2 hrs.......................................................................................120 
Figure 5.21 SEM images showing the surface morphology of the 45S5 Bioglass
® 
scaffold struts sintered at different sintering times before and after coating with 5wt% 
PDLLA. Before coating: A) 0.5 hr, B) 1 hr and C) 2 hrs; after coating: A1) 0.5 hr, B1) 
1 hr and C1) 2 hrs. The arrow indicates infiltration of PDLLA into the micropores of 
the partially sintered scaffold..................................................................................121 
Figure 5.22  Schematic diagram showing different stages (regimes) of the stress-
strain curve for polymer coated scaffolds. ..............................................................122 
Figure 5.23 Typical compressive stress-strain curves of A) an as-sintered Bioglass
®
 
scaffold and B) a poly(D,L-Lactic acid) coated scaffold. Series 1000 scaffolds 
sintered at 2 hours. .................................................................................................122 
Figure 5.24 Photographs of scaffolds after compressive strength test (failure): A) as-
sintered and B) PDLLA coated scaffolds sintered at 1000
o
C for 2 hours.................123 
Figure 5.25 SEM images of the PDLLA coated 45S5 Bioglass
®
 based scaffolds after 
fracture: (A) polymer bridging between the crack surfaces, (B) collagen fabrils 
bridging crack in bone [179] ,(C) polymer fibres pulled out at the fracture surface (D) 
partially magnified image of (C).............................................................................125 
Figure 5.26 Optical image of PDLLA coating on a 45S5 Bioglass
®
 pellet sintered at 
1000
o
C for 2 hours. ................................................................................................126 
Figure 5.27 SEM image showing crack propagation at the interface between the 
PDLLA coating and the Bioglass
® 
substrate. The crack was formed by 
microindentation at a load of 200g applied at a 50µm distance from the interface, on 
the sintered Bioglass
®
 substrate. .............................................................................126 
Figure 5.28 SEM images of surfaces of PDLLA coated pellets sintered at 1000
o
C for 
2 hours and immersed in SBF for: A) 7, B) 14 and C, D) 28 days, showing formation 
of hydroxyapatite (HA) layers on the surface of the pellets at different magnifications.
..............................................................................................................................128 
Figure 5.29 EDS spectra of 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
(PDLLA-coated) after immersion in SBF for A) 7, B) 14 and C) 28 days compared to 
a non-coated samples (D) and an as-sintered sample (E).........................................129 
Figure 5.30 XRD spectra of PDLLA coated 45S5 Bioglass
®
 pellets sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days, compared to the 
 13 
spectrum of commercial crystalline HA. The major peaks of Na2Ca2Si3O9 phase and 
hydroxyapatite are marked by (∆) and (●) respectively...........................................130 
Figure 5.31 SEM images of the surface of 45S5 Bioglass
®
 pellets coated with 
PDLLA sintered at 1000
o
C for 2 hours  after immersion in 1.5 SBF at A) 7, B) 14 and 
C, D ) 28 days, showing the different morphologies on the surfaces. ......................131 
Figure  5.32 EDS spectra of 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
(PDLLA-coated) after immersion in 1.5SBF for A) 7, B) 14 and C) 28 days compared 
to a non-coated sample (D) and to an as-sintered sample (E). .................................132 
Figure 5.33 X-ray diffraction spectra of PDLLA coated 45S5 Bioglass
®
 pellets 
sintered at 1000
o
C for 1, 0.5 and 0 hrs after immersion for 14 and 28 days in 1.5 SBF. 
The major peaks of Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●) 
respectively. ...........................................................................................................133 
Figure 5.34 X-ray diffraction spectra of PDLLA coated 45S5 Bioglass
®
 pellets 
sintered at 1000
o
C for 0 hrs after immersion in 1.5 SBF for 0, 7, 14, 28 and 60 days as 
compared to the spectrum for commercial HA. The major peaks of Na2Ca2Si3O9 phase 
and hydroxyapatite are marked by (∆) and (●) respectively. ...................................134 
Figure 5.35 SEM images of PDLLA coated scaffolds sintered at 1000
o
C for 2 hours 
after immersion in SBF at A), A1) 7 days, B), B1) 14 days and C), C1) 28 days, at 
different magnifications showing formation of HA.................................................136 
Figure 5.36 SEM-EDS results for PDLLA coated scaffolds sintered at 1000
o
C for 2 
hours and immersed in SBF:  A, A-1) 7 days,  B, B-1) 14 days and C, C-1) 28 days, 
showing formation of hydroxyapatite layers on the surface of the scaffolds............137 
Figure 5.37 XRD spectra of the PDLLA coated 45S5 Bioglass
®
 scaffolds sintered at 
1000
o
C for 2 hours and immersed in SBF for 7, 14 and 28 days. The peaks of 
hydroxyapatite phase are marked (●) (The peaks of Na2Ca2Si3O9 are not visible)...138 
Figure 5.38  XRD spectra of the as-sintered 45S5 Bioglass
®
 scaffolds sintered at 
1000
o
C for 2 hours and immersed in SBF for 7, 14 and 28 days. The major peaks of 
Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), respectively.....138 
Figure 5.39 XRD spectra of the PDLLA coated 45S5 Bioglass
®
 scaffolds sintered at 
1100
o
C for 2 hours and immersed in SBF for  7, 14 and 28 days. The major peaks of 
Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), respectively.....139 
Figure 5.40 XRD spectra of the as-sintered 45S5 Bioglass
®
 scaffolds sintered at 
1100
o
C for 2 hours and immersed in SBF for 7, 14 and 28 days. The major peaks of 
Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), respectively.....139 
Figure 5.41 Chromatogram of the methanolysed P(3HB) produced in this 
investigation showing the peaks of each component separated at different retention 
times. .....................................................................................................................142 
Figure 5.42  MS spectra of the methanolysed P(3HB) with a retention time of 6.81 
min.........................................................................................................................142 
Figure 5.43 Graphs showing the relationship between the compressive strength 
values and porosity for the 900-1100 series of P(3HB) coated scaffolds. ................145 
Figure 5.44 SEM images showing 45S5 Bioglass
® 
scaffolds after coatings with 
P(3HB): A)  scaffold pore structure, B) high magnification image showing P(3HB) 
polymer coating of a pore wall, C) strut surface and D) high magnification of strut 
surface. The arrow in (D) indicates Bioglass
®
 particles can protrude from the P(3HB) 
coatings, leading to direct contact of the bioactive material and the local environment.
..............................................................................................................................146 
Figure 5.45 Graph showing the compressive strength values (MPa) of  P(3HB) coated 
Bioglass
®
 scaffolds of  the 900-1100 series compared with the values of  as-sintered 
 14 
samples. All values are presented as mean ± standard deviation (s.d) where N = 5 
samples (Coated samples); N = 5 samples (As-sintered samples)............................147 
Figure 5.46 SEM images showing the microstructure of Bioglass
®
based scaffold 
struts (cross sections) after coating with  5wt% P(3HB) for the following sintering 
conditions: A) 930
o
C, B) 950
o
C, C) 970
o
C, D) 1000
o
C, E) 1050
o
C and  F) 1100
o
C, 
sintered for 2 hours.................................................................................................149 
Figure 5.47 Graphs showing the relationship between the compressive strength 
values and porosity for the 1000 series of P(3HB) coated scaffolds. .......................151 
Figure 5.48 Graph showing the compressive strength values of scaffolds of the 1000 
series before and after P(3HB) coating. All values are presented as mean ± standard 
deviations (s.d) where N = 5 samples (Coated samples); N = 5 samples (As-sintered 
samples). ................................................................................................................152 
Figure 5.49 SEM images showing the microstructure of scaffold struts cross-section 
before and after coating with  5wt% P(3HB) for the following sintering conditions: A) 
0.5 hrs, B) 1 hrs and C) 2 hours sintered  at 1000
o
C................................................153 
Figure 5.50 Typical compressive stress-strain curves of A) an as-sintered Bioglass
®
 
scaffold and B) a P(3HB) coated scaffold. Series 1000 scaffolds sintered for 2 hours.
..............................................................................................................................154 
Figure 5.51 Photograph of the scaffolds after compressive strength test: A) as-
sintered and B) P(3HB) coated scaffolds sintered at 1000
o
C for 2 hours. ................154 
Figure 5.52 SEM image of the fracture surface of a P(3HB) coated Bioglass
®
 
scaffolds after compressive strength testing, showing P(3HB) polymer fibrils formed 
due to P(3HB) infiltration into micropores. ............................................................155 
Figure 5.53 SEM image of a P(3HB) coated 45S5 Bioglass
®
 pellet sintered at 1000
o
C 
for 2 hours..............................................................................................................156 
Figure 5.54 SEM image showing the crack propagation at the interface between 
P(3HB) layer and 45S5 Bioglass
®
 substrate. The crack was formed using 
microindentation applying a load of 200g at a distance of 50µm from the interface.
..............................................................................................................................157 
Figure 5.55 SEM images of the surfaces of P(3HB) coated pellets sintered at 1000
o
C 
for 2 hours and immersed in SBF for A) 7, B) 14 and C,D) 28 days, showing the 
change of surface morphology and formation of hydroxyapatite (HA)....................158 
Figure 5.56 EDS spectra of 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
(P(3HB)-coated) after immersion in SBF for A) 7, B) 14 and C) 28 days compared to 
a non-coated sample (D).........................................................................................160 
Figure 5.57 XRD spectra of P(3HB) coated 45S5 Bioglass
®
 pellets sintered at 1000
o
C 
for 2 hours and immersed in SBF for 0, 7, 14 and 28 days, as compared to the pattern 
of commercial HA. The major peaks of Na2Ca2Si3O9 phase and hydroxyapatite are 
marked by (∆) and (●) respectively. .......................................................................161 
Figure 5.58 SEM images showing the formation of HA on the 5wt% P(3HB) coated  
45S5 Bioglass
®
 scaffolds sintered at 1000
o
C for 2 hours after immersion in SBF for 
A) 7 days , B) 14 days and C) 28 days. ...................................................................162 
Figure 5.59 SEM images and EDS spectra of the surface of P(3HB) coated scaffolds 
sintered at 1000
o
C for 2 hours and immersed in SBF for A, A1) 7, B, B1) 14 and 
C,C1) 28 days, showing formation of hydroxyapatite on the surface of the scaffolds.
..............................................................................................................................163 
Figure 5.60 XRD spectra of P(3HB) coated 45S5 Bioglass
® 
scaffolds sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days. The major peaks of 
Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), respectively.....164 
 15 
Figure 5.61 Compressive strength values of PDLLA and P3HB coatead scaffolds 
compared to non-coated scaffolds after SBF immersion. All values are presented as 
mean ± standard deviations (s.d) where N = 7 samples for PDLLA and P(3HB) coated 
samples and N = 7 samples for AS (as-sintered) samples........................................165 
Figure 5.62 A) The gas chromatogram for the methanolysis product of PHA 
produced from P. mendocina when grown in octanoate. (B) Mass spectra showing 
molecular ion related mass fragments of octanoic acid 3 hydroxymethyl ester........166 
Figure 5.63 SEM images of the surfaces of P(3HO) coated pellets sintered at 1000
o
C 
for 2 hours and immersed in SBF for A) 0, B) 7 and C)14 and D) 28 days, showing 
formation of hydroxyapatite (HA). .........................................................................167 
Figure 5.64 EDS spectra of 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
(P(3HO) -coated) after immersion in SBF for A) 0, B) 7 , C) 14 and D) 28 days ....169 
Figure 5.65  XRD spectra of P(3HO) coated 45S5 Bioglass
®
 pellets sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days, as compared to the 
pattern of commercial HA. The major peaks of Na2Ca2Si3O9 phase and 
hydroxyapatite are marked by (∆) and (●), respectively..........................................170 
Figure 5.66  SEM images showing the 45S5 Bioglass
® 
scaffolds after coating with 
P(3HO) at different magnifications. The presence of a non-homogenous coating is 
indicated by the arrow in (B). .................................................................................172 
Figure 5.67  SEM images showing the microstructure of Bioglass
® 
based scaffold 
strut cross sections before and after coating with 5wt% P(3HO) for the following 
sintering conditions: A) 2 hrs and B) 1 hr sintered  at 1000
o
C.................................173 
Figure 5.68 Typical compressive stress-strain curves of A) as-sintered Bioglass
®
 
scaffold and B) a P(3HO) coated scaffold. Series 1000 scaffolds sintered at 2 hours.
..............................................................................................................................174 
Figure 5.69 Photographs of the scaffolds after compressive strength test: A) as-
sintered and B) P(3HO) coated scaffolds sintered at 1000
o
C for 2 hours.................174 
Figure 5.70 SEM image of the fracture surface of a P(3HO) coated Bioglass
®
 scaffold 
after compressive strength testing, showing P(3HO) polymer fibrils formed due to 
efficient P(3HO) infiltration into micropores (arrows). ...........................................176 
Figure 5.71 SEM images and EDS spectra of the surface of P(3HO) coated scaffolds 
sintered at 1000
o
C for 2 hours and immersed in SBF at A, A1) 7, B, B1) 14 and C, 
C1) 28 days showing formation of hydroxyapatite layers on the surface of the 
scaffolds.................................................................................................................177 
Figure 5.72 XRD spectra of P(3HO) coated 45S5 Bioglass
®
 scaffolds sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days. The major peaks of 
Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), respectively.....178 
Figure 5.73 Schematic diagram showing the infiltration behaviour for 1) P(3HB), 2) 
PDLLA and 3) P(3HO) coating of partially sintered 45S5 Bioglass
®
 scaffolds. ......182 
Figure 6.1 SEM images of PDLLA deposition on glass slides using a suspension of 
2.5wt% PDLLA in DMC at different electrospinning parameters A = Flow rate 
(10µl/min), Voltage (8-10kV), B = Flow rate (5µl/min), Voltage (8-10kV) and C = 
Flow rate (2µl/min), Voltage (10-12kV), deposited for 1 minute. (See Table.6.1)...192 
Figure 6.2 SEM images of PDLLA deposition on glass slides using a suspension of 
5wt% PDLLA in DMC at different electrospinning parameters A = Flow rate 
(10µl/min), Voltage (8-10kV); B = Flow rate (3µl/min), Voltage (10-12kV); C = Flow 
rate (2µl/min), Voltage (10-12kV); D = Flow rate (2µl/min), Voltage (12-14kV) 
deposited for 1 minute. (See Table.6.2) ..................................................................193 
Figure 6.3 SEM images of PDLLA fibres deposited on 45S5 Bioglass
®
 at optimum 
electrospinning parameters of Flow rate = 5µl/min and Voltage = 15kV:  (A) Partially 
 16 
aligned fibres (5 minutes deposition time) and (B) Random fibres, using a suspension 
of 5wt% PDLLA in DMC (10 minutes deposition time). (See Table 6.3) ...............193 
Figure 6.4  3-D plot and scales in colour of the 45S5 Bioglass
®
 surface coated with 
PDLLA fibers, deposited for 30 minutes obtained by white light interferometry 
(Zygo
®
). .................................................................................................................194 
Figure 6.5  Scheme showing (A) surface profile and scales in colour and (B) 3D 
representation of the polished 45S5 Bioglass
®
 surface, obtained by white light 
interferometry. .......................................................................................................195 
Figure 6.6  SEM images of PDLLA fibres deposited on 45S5 Bioglass
®
 sintered discs 
after immersion in SBF: A, A1)7 days, B, B1) 14 days and C, C1) 28 days at different 
magnifications, showing formation of HA indicated by the needle-like nanostructure.
..............................................................................................................................196 
Figure 6.7 SEM images showing the homogenous growth of HA on PDLLA fibres 
which are not in direct contact with the 45S5 Bioglass
®
 substrate, as shown by the 
arrow......................................................................................................................197 
Figure 6.8 XRD spectra showing the peaks corresponding to PDLLA fibre coated 
45S5 Bioglass
®
 specimens before and after immersion in SBF.  The major peaks of 
Na2Ca2Si3O9 phase and hydroxyapatite (HA) are marked by (∆) and (○), respectively.
..............................................................................................................................198 
Figure 6.9  XRD spectra of PDLLA films: A) as fabricated and B) after immersion in 
SBF for 2 weeks. The PDLLA film after immersion in SBF shows no HA formation 
on the surface. ........................................................................................................198 
Figure 6.10 EDS analysis of the surface of a Bioglass
®
 pellet coated with PDLLA 
fibers after 28 days in SBF, showing the presence of P and Ca, indicating the presence 
of a HA layer. ........................................................................................................199 
Figure 6.11 Schematic diagram showing A) bilayered structure scaffold covered with 
a thin fibrous mesh of PDLLA fibres obtained by electrospinning and B) the 
applications of the bilayered scaffolds in the osteochondral defect. (Diagram in (B) 
has been adapted from [212]) .................................................................................201 
Figure 6.12 SEM images showing the PDLLA fibrous deposition on 45S5 Bioglass
®
 
scaffolds (uncoated) at different deposition times:  A) 10 mins, B) 30 mins , C) 
2hours, and A1) 10 mins, B1) 30 mins and C1) 2 hours at higher magnification of the 
area’s showed by the circles. ..................................................................................203 
Figure 6.13 SEM images showing different fibre orientations at different positions of 
the PDLLA fibres on the surface of 45S5 Bioglass
®
 scaffolds deposited for 2 hours 
showed by the cicles...............................................................................................204 
Figure 6.14 SEM images showing the microstructure of a PDLLA/45S5 Bioglass
®
 
bilayered scaffold (coated):  A) interface of the 45S5 Bioglass
®
 scaffold coated with 
PDLLA fibre for 2 hours, B) layer of PDLLA fibres observed at higher magnification 
of the circled area in  A). ........................................................................................205 
Figure 6.15 SEM images showing the cross-section of the PDLLA/45S5 Bioglass
® 
composites bilayered scaffolds. (The PDLLA fibre layer was deposited for 30 
minutes) .................................................................................................................205 
Figure 6.16 SEM images of PDLLA fibres on 45S5 Bioglass
®
 based scaffolds 
(coated) deposited for 10 mins after immersion in SBF for A) 7, B) 14 and C) 28 
days. ......................................................................................................................207 
Figure 6.17 EDS analysis on PDLLA fibres deposited on 45S5 Bioglass
®
 scaffolds 
(coated) electrospun for 10 minutes and immersed in SBF for 14 days.  The spectra 
correspond to the positions indicated on the SEM image. .......................................208 
 17 
Figure 6.18 SEM images of PDLLA fibres on 45S5 Bioglass
®
 (coated) scaffolds 
deposited for 30 mins after immersion in SBF for A) 7, B) 14 and C) 28 days. .......209 
Figure 6.19 SEM and EDS results on PDLLA fibres deposited on 45S5 Bioglass
®
 
scaffolds (coated with 5 wt% PDLLA ) deposited for 2 hours after immersion in SBF 
for A) 7, B) 14 and C) 28days and EDS spectra after immersion in SBF for A1) 7, B1) 
14 and C1) 28 days ................................................................................................210 
Figure 6.20 Schematic diagram showing the development of the interface of a 
bilayered scaffold A) as fabricated, B) after immersion in SBF for 14 days. ...........211 
Figure 6.21 Cell proliferation data up to 7 days on the different materials 
investigated. (Values are presented by mean ± standard deviation (s.d) where N = 6 
samples).................................................................................................................214 
Figure 6.22 SEM images of the ATDC-5 cell adherence and spreading on PDLLA 
fibres: A) on glass slide and B) on sintered 45S5 Bioglass
®
 pellets (cells are indicated 
by arrows). .............................................................................................................214 
Figure 6.23 Cell proliferation data up to 10 days for 45S5 Bioglass
®
/PDLLA 
composites with and without PDLLA fibres deposited on the scaffolds. (Values are 
presented by mean ± standard deviation (s.d) where N = 6 samples).......................215 
Figure 6.24 SEM images showing of the ATDC5-cell adherence and proliferation on 
PDLLA mesh of bilayered scaffolds at different magnifications at day 1: A) 100 µm, 
B) 30 µm scale. (Cells are indicated by arrows)......................................................217 
Figure 6.25 SEM images showing of the ATDC5-cell proliferation and spreading on 
PDLLA mesh of the bilayered scaffolds at different magnification at day 7: A) 
300µm, B) 60 µm scale. (Cells are indicated by arrows).........................................218 
Figure 6.26 SEM images showing the ADTC5-cells migrate through the pore and 
grew within layers of fibrous network at day 14. ....................................................219 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
 
 
 
 
 
List of Tables 
 
Table 2.1 Criteria for an ideal scaffold for bone tissue engineering [15-17]..............26 
Table 2.2 Physical properties of synthetic, biocompatible and biodegradable polymers 
investigated as scaffold materials [82]. .....................................................................37 
Table 4.1 Physical properties of the biodegradable polymers used in this project. ....68 
Table 4.2 Amounts of reagents used for preparation of 1.0 SBF and 1.5 SBF [173] .81 
Table 5.1  Processing Condition for 45S5 Bioglass
®
 based glass-ceramic Scaffolds.93 
Table 5.2 Compressive strength values (MPa) and porosity (%) of PDLLA coated 
45S5
 
Bioglass
®
 based scaffolds of the 900-1100 series. ..........................................105 
Table 5.3 Compressive strength values (MPa) and porosity (%) of as-sintered 
(uncoated) samples of the 900-1100 series. ............................................................106 
Table 5.4 Compression strength values (MPa) and porosity (%) of PDLLA coated 
45S5
 
Bioglass
®
 based scaffolds of the 1000 series. .................................................116 
Table 5.5 Compressive strength values (MPa) and porosity of as-sintered samples of 
the 1000 series .......................................................................................................116 
Table 5.6 Compounds in P(3HB) identified for each retention time (GC-MS 
measurement).........................................................................................................143 
Table 5.7 Compression strength values (MPa) and porosity (%) of P(3HB) coated 
45S5
 
Bioglass
®
 based scaffolds of the 900-1100 series. ..........................................143 
Table 5.8 Compressive strength values (MPa) and porosity (%) of as-sintered 
(uncoated) samples of the 900-1100 series. ............................................................144 
Table 5.9 Compressive strength values (MPa) and porosity of P(3HB) coated 45S5
 
Bioglass
®
 based scaffolds of the 1000 series...........................................................150 
Table 5.10 Compressive strength values (MPa) and porosity (%) of as-sintered 
(uncoated) samples of the 1000 series.....................................................................150 
Table 5.11 Compressive strength values (MPa) and porosity of P(3HO) coated 45S5
 
Bioglass
®
 based scaffolds of the 1000 series...........................................................171 
Table 6.1  Electrospinning parameters for deposition of PDLLA fibres on glass slide 
substrate using 2.5 wt% PDLLA solution in DMC. ................................................189 
Table 6.2  Electrospinning parameters for deposition of PDLLA fibres on glass slide 
substrate using 5wt% PDLLA solution in DMC. ....................................................189 
Table 6.3 Optimum conditions for the electrospinning parameters of PDLLA fibers 
on Bioglass
®
pellets using 5wt% PDLLA solution in DMC.....................................190 
 
 
 
 
 
 
 
 
 
 
 
 19 
 
 
 
 
List of Equations 
 
 
 
1
1
1 1
V
W
P
BGρ
−=                                                          (4.1)………………………….78 
 
2
121
2 1 V
WWW
P PDLLABG






−
+
−=
ρρ
                                     (4.2)………………………….78     
 
Rms = √ y1
2
+ y2
2
 +…..+ yn
2
/n…                          (4.3)…………………………..83 
 
 
 
Ra = y1+y2+…+yn/n…                      (4.4)………………………….83 
 
  k =  µt Q/ A ∆p                                        (4.5)………………………….83 
 
∆pTotal = ∆p + ∆psec                                          (4.6)………………………….84 
 
∆psec = 2Q2p/π [1/d1
2
 – 1/d2
2 
]
                                           
(4.7)………………………….84 
 
 
O
P
N
O
O
OO
N
O
O
+
O..
+ HPO3 =+ HH20
+
+ +
ALP
     
p-nitrophenylphosphatase                                   p-nitrophenol 
 
                                                                              (5.1)…………………………..100 
 
 
 
 
 
 
 
 
 
 
 20 
 
Chapter One 
1. Introduction 
 
Highly porous scaffolds with 3-dimensional (3D) open pore structure are required for 
most bone tissue engineering applications. Current synthetic scaffolds are usually 
made from bioceramics or polymers, but a better combination of mechanical and 
biological properties may be achieved with a composite or hybrid material. 
Bioceramic-polymer composites will mimic better the extracellular matrix (ECM) of 
the host bone tissue, considering the complex composite structure of bone. Likewise, 
for osteochondral tissue engineering, one should consider the need of simultaneous 
regeneration of both cartilage and subchondral bone when designing novel 
osteochondral constructs. In this case, again composite materials may represent a 
better alternative to monolithic ceramics or single phase polymers. In the present 
research project, based on previous results obtained by Chen and Boccaccini [1], the 
addition of a well-known biodegradable polymer, i.e. poly(DL-lactide) (PDLLA), to a 
3D 45S5 Bioglass
®
 based scaffold has been investigated. The scaffolds were 
fabricated by the foam replica technique [1] and polymer coating and infiltration were 
obtained by a simple immersion procedure developed in this study. The 
characterisation of scaffolds includes microstructural analysis, bioactivity in 
simulated body fluid (SBF) and mechanical property determination. The use of 
poly(3-hydroxybutyrate) (P(3HB)) as a highly biocompatible, natural biodegradable 
polymer in combination with 3D 45S5 Bioglass
®
 based scaffolds is also of great 
interest to fabricate composite bioactive scaffolds which were also developed in this 
project. A different type of natural biodegradable polymer, in this case, poly(3-
hydroxyoctanoate) (P(3HO)), an elastomeric polymer, has also been investigated. 
P(3HB) and P(3HO) biodegradable polymers were synthesised in collaboration with 
researchers at University of Westminster (UK).  Scaffolds coated and infiltrated with 
PDLLA, P(3HB) and P(3HO) were compared, in terms of mechanical properties, 
degradation behaviour and bioactivity. The composite scaffolds produced serve as 
robust 3D systems to study relevant properties, such as the mechanical properties 
(compressive strength and work of fracture) and bioactivity, as well as to establish the 
mechanism of reinforcement imparted by the polymer by characterisation of the 
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fracture behaviour of the polymer/Bioglass
®
 interface. The development of an 
optimised PDLLA nanofiber coating on the 45S5 Bioglass
®
-based scaffolds, utilising 
electrospinning, was also investigated. In addition, the development of a new 
bilayered construct based on PDLLA fibrous layer, obtained by electrospinning, on 
the surface of a PDLLA coated Bioglass
®
 scaffolds was investigated. This novel 
construct represents a suitable matrix for osteochondral tissue engineering 
applications, and a preliminary cell culture study utilising chondrocyte cells (ADTC5) 
was carried out. 
 
This thesis is organised as follows. Chapter 2 provides a comprehensive literature 
review, aiming at covering the state-of the art of the research areas of relevance for 
this project in order to rationalise the materials, techniques and strategies adopted in 
the project. Chapter 3 presents the aims and objectives of the project and the 
experimental strategies followed to realise these aims and objectives. Chapter 4 
describes the experimental procedure and analytical techniques used, while Chapter 5 
focuses on the fabrication and characterisation of the PDLLA, P(3HB) and P(3HO) 
coated 3D 45S5 Bioglass
®
-based scaffolds, describing the results obtained which are 
comprehensively discussed. Chapter 6 focuses on the development of PDLLA nano 
fibre coatings on 45S5 Bioglass
®
 sintered pellets and 45S5 Bioglass
®
 3D scaffolds, 
based on electrospinnning technique. In Chapter 6 the complete characterisation of the 
layered scaffolds is presented including a preliminary cell culture study on the novel 
constructs. Chapter 7 concludes the thesis summarising the results and drawing 
conclusions as well as presenting suggestions for further work. 
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Chapter Two 
2. Literature Review 
 
2.1 Tissue engineering: definition and principles 
 
Tissue engineering (TE), a scientific field which started in 1987 in USA [2], has made 
important contributions to the progress of medical research. In this innovative 
biomedical approach, the fundamental principle that the body is able to heal itself is 
conveniently applied [3]. The organs of the body are known to have an ability to 
repair or recover when they are diseased or injured. Regenerative medicine is a more 
recent term that came into use during the 1990s, and to some it is synonymous with 
stem cell technology or cell therapy [4]. Thus, these two areas; tissue engineering and 
regenerative medicine, are very much complementary and many researchers use the 
two terms interchangeably. 
 
Fundamentally, biological tissues consist of the cells, the extracellular matrix and the 
signalling systems. A common tissue engineering strategy involves the use of 
scaffolds, made from biomaterials, which serve primarily to support and delivery of 
cells. Scaffolds can be enriched with signalling molecules which can be bound to 
them or infused into them [5]. Then the designed scaffold, which is cultured with 
sufficient cells in vitro, is implanted and surgeons manipulate the local environment 
in order for the scaffold to integrate in the host body. Under these ideal conditions, the 
body is capable of healing itself. 
 
In summary, tissue engineering requires a designed, engineered scaffold that is 
populated with cells and signalling molecules to induce the regeneration ability of the 
host body, aiming at regenerating functional tissues. Tissue engineering is thus an 
alternative to conventional organ transplantation and tissue reconstruction.  
 
Tissue engineering has been also defined as the application of principles and methods 
of engineering and life sciences to obtain a fundamental understanding of the 
structure-function relationship in normal and pathological mammalian tissue and the 
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development of biological substitutes to restore, maintain or improve tissue function 
[6]. Similarly, Galletti, Hellman and Nerem [7] in 1995 defined TE as the basic 
science and development of biological substitutes for implantation into the body or 
the fostering of tissue remodelling for the purpose of replacing, repeating, 
regenerating, reconstructing, or enhancing biological function. 
 
Tissue engineering principles have been applied to a large number of tissues, 
including bone, cartilage, skin, liver, etc., and the field continues to grow with the 
contribution of cellular biology, materials science and medicine, as core disciplines. 
 
2.2 Rational for bone tissue engineering  
 
Bone tissue engineering is being developed as an alternative therapeutic treatment to 
tackle the shortcomings of conventional clinical treatment of bone fracture and 
disease, i.e. transplantation and implantation [8]. For example, one of the 
shortcomings in the application of bone graft is the size of the defect and the viability 
of the host body. In an autograph procedure, there could be significant donor site 
morbidity and therefore the need for multiple surgeries. In allografting, however, 
there are problems with donor tissue scarcity and the risk of tissue rejection due to 
diseased or infectious donor tissue. In addition, the survivability of an orthopaedic 
prostheses for a reasonable period of 15 years is 75% to 85% and requirements for 
longer than 30 years durable prostheses is increasing due to the enlargement of  the 
aging population [9;10]. 
 
Therefore, tissue engineering is expected to have a significant impact in the 
improvement of human health and the life of patients in the future. It can be 
anticipated that the tissue engineering approach has the potential to solve the 
transplantation crisis caused by donor shortage, immune rejection, pathogen transfer 
and multiple surgeries [11]. 
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2.3 The bone tissue engineering approach 
 
Tissue engineering of hard tissue has the purpose of filling of a wound site where 
bone has been lost through trauma or disease with a scaffold, as mentioned above, to 
regenerate bone tissue and to restore the mechanical function of bone. Biological 
substitutes such as cells and biomolecules are used, in addition to the biomaterials 
scaffolds, to maximise the regeneration capacity and to allow for greater success in 
developing therapeutic strategies for replacement, repair, maintenance and 
enhancement of bone tissue function [2].  
 
As indicated above, natural tissues consist of three components: cells, extracellular 
matrix (ECM), and signalling systems (e.g. growth factors) [12]. Thus, the bone tissue 
engineering approach is concerned with the design of suitable 3D scaffolds made 
from engineering materials which will act as an extracellular matrix (ECM) and will 
be the substrate for bone cells to attach to and proliferate in vitro to facilitate tissue 
regeneration in vivo. The use of signalling molecules has a potential to markedly 
increase scaffold effectiveness [5]. Fig. 2.1 illustrates the tissue engineering triad. 
 
Living cells can either migrate into the scaffolds after implantation (acellular 
approach) or can be introduced into the scaffolds in cell culture before implantation 
(cellular approach). In the acellular approach, guided regeneration of tissues can be 
achieved by using scaffolds as templates for ingrowth of host cells and bone tissue in 
vivo. In the cellular approach, however, cells are cultured within a scaffold in vitro 
before being implanted as part of an engineered device. The success of the cellular 
approach for tissue engineering of bone is critically dependent on the development of 
the scaffold which must resemble the ECM of the host tissue. 
  
Cells can be isolated as fully differentiated cells of the tissue intended to be 
engineered, or they can be manipulated to produce the desired function when isolated 
from other tissues or a stem cell source. In both approaches, the engineered scaffold 
should induce the specific cell type attachment and proliferation either in vitro or in 
vivo being thus one of the most important components in the regeneration of new 
functional bone tissue. 
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Figure 2.1 The Tissue Engineering triad. 
 
2.4 Challenges in tissue engineering and ideal scaffolds for 
bone tissue engineering 
 
As mentioned above, tissue engineering requires a multi disciplinary approach, 
including cell and molecular biology, biochemistry, materials science and 
engineering. Materials scientists and engineers encounter a variety of challenges when 
designing an ideal scaffold. Tissue engineering advancement depends on the progress 
of the science and technology in these areas. The main challenges can be grouped into 
three categories, namely understanding cells and their mass transfer requirements, the 
fabrication of materials to provide scaffolds and templates and the interaction between 
materials and cells.  
 
One major requirement for successful tissue regeneration is acquiring a sufficient 
amount of relevant cells. Stem cell biology involving embryonic stem cells shows 
promise for tissue engineering [13]. As first step, tissue is harvested as allograph, 
autograph or xenograph to yield the required cells. The cells are then transferred to 
the scaffolds where further remodelling can occur. Large masses of cells for tissue 
engineering need to be kept alive, not only in vitro but also in vivo. To achieve this, 
systems including in vitro flow bioreactors and in vivo strategies to maintain healthy, 
functional cell populations are being considered [14]. 
 
Tissue Engineering Construct 
3-D Scaffolds 
Cells Signalling Molecules 
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The challenges for material scientists are linked to developing optimal chemical and 
physical configuration of new biomaterials for scaffolds and to understand the 
interaction of scaffolds with cells to produce engineered organs. Scaffolds are usually 
made of biodegradable materials. They can be naturally occurring materials, synthetic 
materials and hybrid materials, which need to be compatible with living systems and 
with cells in vitro and in vivo. The interface between cells and scaffolds must be 
clearly understood so that biomaterial surface chemistry and topography can be 
optimised. Design of scaffold/cell interfaces is one of the major challenges in the 
field, and should be considered at molecular, nanostructural and microstructural level. 
 
The design of biomaterials for tissue engineering scaffolds can also incorporate 
biological signalling to induce tissue growth and regeneration, for example the release 
of growth and differentiation factors, design of specific receptors and anchorage sites 
as well as 3D site specificity using computer assisted design and manufacturing 
techniques are being considered. 
 
As mentioned above, the scaffold should ideally mimic the ECM of the tissue that 
needs to be regenerated. The criteria for an ideal scaffold for bone TE are summarised 
in Table 2.1. 
 
Table 2.1 Criteria for an ideal scaffold for bone tissue engineering [15-17].  
 
 
1. The scaffold materials should be biocompatible and non toxic to the body. 
2. The scaffolds should act as a 3D template for the in-vivo and in-vitro bone 
growth, i.e. the structure of the scaffolds should be similar to the structure of 
trabecular bone. 
3.  Interconnected pores of porosity > 90% with macropores of size between 300 
and 500 microns are required for cell penetration, tissue ingrowth, 
vascularisation and nutrient delivery. 
4. The scaffolds material should promote osteoconduction and osteoinduction 
with the host bone. 
5. Scaffold surfaces should exhibit texture and topography that can promote cell 
adhesion and adsorption of biological metabolites. 
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6. The scaffolds should influence the genes in bone generating cells to enable 
efficient cell differentiation and proliferation. 
7. The mechanical properties of the scaffolds should match those of the host 
tissue and scaffolds should bond to host tissue (bioactivity). 
8. Ideally, the scaffold degradation kinetics should be matched to the rate of new 
tissue regeneration. 
9. The manufacturing technique should enable the production of scaffolds of 
irregular or complex shapes depending on the site of application. 
 
2.5 Osteochondral tissue engineering 
 
Articular cartilage injuries occur frequently as a result of trauma, tumour or 
osteoarthritis [18]. Articular cartilage is normally made of hyaline cartilage which is 
composed of a complex organization of type II collagen and other minor collagens in 
combination with hyaluronic acid and cartilage-specific proteoglycan termed 
aggrecan. Osteochondral defect is a term used to indicate joint damage of the articular 
cartilage and the underlying bone (subcondral bone) which requires a unique repair 
response to that of chondral defects [19].  
 
However, the repair response typically leads to formation of fibrocartilage in the 
defect void [20] which will often be observed after long-term follow-up using 
conventional surgical procedures such as abrasion arthroplasty, microfracture and 
subcondral bone drilling [21-23]. Several studies have shown that tissue engineering 
strategies have potential for regeneration of cartilage [24-27].  
 
For osteochondral tissue engineering combinations of both bone and cartilage tissue 
engineering principles can potentially be met by using engineered osteochondral 
(bone-cartilage) composite scaffolds of predefined size and shape generated in vitro 
using autologous cells. The bone region of the engineered osteochondral composite 
may further help anchor the graft within the defects, since a bone-to-bone interface 
integrates better and faster than cartilage-to-cartilage interfaces [28].  
 
Many strategies dealing with tissue engineering scaffolds for osteochondral repair 
employ the design of bilayered scaffolds that could regenerate both cartilage and 
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subchondral bone involving different combinations of materials, morphologies and 
properties in both parts of the scaffolds. Common approaches involve: 1) seeding 
autologous chondrocytes at the top of the 3D scaffolds to create a cell-scaffold 
construct for in vivo implantation [29-32], 2) two different cartilage and bone 
scaffolds that have been joined (or assembled) together either before or during 
surgical implantation [33;34] and 3) an integrated bilayered structure that allows for a 
complete transition between the bone and the cartilage layers without requiring a 
joining mechanism [35-37]. For these strategies, also several bioreactors have been 
described, as reviewed in refs [38;39] and proposed  by several authors [40]. 
Moreover, several strategies with single-layer materials can be followed, as recently 
reviewed by Mano and Reis [18]. Nevertheless, it is widely accepted that a bilayered 
structure would be more challenging to produce but more suitable for regenerating an 
osteochondral defect. Such bilayered scaffold should be able to incorporate/induce 
different types of cells in a favourable environment requiring different chemical 
surroundings and mechanical requirements, leading to the growth of the two different 
tissues with different biological requirements. Essentially, this means that the 
bilayered scaffolds can be designed to better mimic the native ECM for each tissue 
type independently, rather that trying to fabricate a construct that attempts to 
compensate for the functional requirements of both cartilage and bone in a single 
structure.  
 
A characteristic interfacial region present in bilayered scaffolds would provide 
segregation of the consequential up growth of osseous tissues into the cartilage region 
as well as allowing for a straightforward cell seeding process for in vitro cell culture. 
Unlike traditional scaffolds, these bilayered structures incorporate various inclusions 
and coatings to form unique composite layered morphologies. 
 .  
2.6  Materials for bone tissue engineering scaffolds 
 
In developing successful scaffolds for bone tissue engineering, the goal is to produce 
a bone-matrix-like material. Natural bone matrix is a composite composed of 
biological ceramic (a natural apatite) and biological polymer. The inorganic part of 
the bone; Ca10(PO4)(OH)2 (carbonated hydroxyapatite), provides the relatively high 
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compressive strength of bone.  The biological polymer; collagen fibres, are tough and 
flexible, and thus tolerate stretching, twisting, and bending. It is hence not surprising 
that ceramics, polymers and their composites have been chosen for developing 
scaffolds for bone tissue engineering applications which are reviewed in this section. 
2.6.1 Bioactive glasses 
 
As early as in 1969, Hench and colleagues discovered that certain silicate glass 
compositions had excellent biocompatibility as well as the ability of bone bonding 
[41]. A common characteristic of bioactive glasses and glass-ceramics is the 
formation of a biological hydroxyl carbonate apatite (HCA) layer, in relevant 
biological conditions, that bonds to bone [41].  
 
Rapid formation of a HCA layer on the surface of bioactive glasses occurs in five 
stages. A high level of bioactivity means that these stages occur fast, e.g. in a matter 
of hours. The surface reactions (stages 1-5) on a bioactive glass in a relevant aqueous 
solution, e.g. simulated body fluid, are summarized below [41]:  
 
Stage (1). Rapid exchange of  Na
+
 or  K
+ 
with H
+
 or  H3O
+
 from solution: 
Si-O-Na
+ 
 +  H
+
  +  OH
-
                    Si-OH  +  Na
+ 
(solution) +  OH
- 
 
Stage (2). Loss of soluble silica in the form of Si(OH)4 to the solution resulting 
from breakage of Si-O-Si bonds and formation of Si-OH (Silanols) at the glass 
solution interface: 
Si-O-Si +  H2O                  Si-OH + OH-Si. 
  
Stage (3). Condensation and repolymerisation of a SiO2 rich layer on the 
surface that is depleted in alkalis and alkaline earth cations: 
2(Si-OH)  +  2(OH-Si)                 -Si-O-Si-O-Si-O-Si-O- 
 
Stage (4). Migration of Ca
2+
 and PO4
3-
 groups to the surface through the SiO2 
rich layer forming a CaO-P2O5-rich film on top of the SiO2-rich layer, 
followed by growth of an amorphous CaO-P2O5-rich film by incorporation of 
soluble calcium and phosphate from the solution. 
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Stage (5). Crystallisation of the amorphous CaO-P2O5 film by incorporation of 
OH, CO3
2-
, (or F anions) from the solution to form a mixed HCA layer (or 
hydroxyl fluroapatite, HCFA layer). 
 
Figure 2.2 shows schematically that calcium ions dissolved from bioactive glasses and 
glass-ceramics increase the ion activity in the surrounding body fluid, and the 
hydrated silica on the surface of glasses and glass-ceramics provides favourable sites 
for apatite growth. 
 
Figure 2.2 Schematic diagram of the mechanism of apatite formation on the 
surface of CaO, SiO2-based glasses and glass-ceramics in the body [42]. 
 
According to Hench [9], bioactive materials are classified into two classes: Class A 
and Class B materials. Class A bioactive materials are both osteoconductive and 
osteoproductive [9], as consequence of rapid reactions involving critical concentration 
of soluble Si, Ca, P and Na ions that give rise to both an intracellular and an 
extracellular response on the material surfaces and the physiological environment. 
Class B materials are osteoconductive, i.e. they induce bone migration along an 
interface, due to slower surface reactions, minimal ionic release and only extracellular 
responses occur at the interface [9]. Class A bioactive materials elicit bone and soft 
tissue bonding while class B bioactive materials only show bone bonding. Silicate 
bioactive glasses, the materials of interest in this investigation, are Class A bioactive 
materials, while hydroxyapatite is a Class B bioactive material [9].  
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As mentioned above, bioactive glass was discovered more than 30 years ago [43] and 
provided for the first time an alternative material showing strong interfacial bonding 
of an implant with host bone tissue. A typical melt-derived bioactive glass 
composition known as 45S5 Bioglass
®
 contains SiO2(45wt%), Na2O(24.5wt%), 
CaO(24.4wt%) and P2O5(6wt%). The composition was selected to provide a large 
amount of CaO with P2O5 in a Na2O-SiO2 matrix. The composition is very close to a 
ternary eutectic, and it is easy to melt. Commercial Bioglass
®
 based products are 
being marketed under the names Perioglass
®
 and Novabone
®
. Based on the success of 
Bioglass
®
, “third-generation” bioactive materials, composites, hybrid materials and 
macroporous foams are being designed for bone tissue engineering applications. It has 
been shown that bioactive glass activates genes that stimulate regeneration of bone by 
the direct affect of ion dissolution products of bioactive glasses. [44] 
 
The 45S5 Bioglass
®
 composition is able to develop a hydroxyapatite (HA) surface 
layer in contact with simulated body fluid in vitro. These HA crystals can bond to 
layers of collagen fibrils produced at the bone/Bioglass
®
 interface by osteoblast cells 
in vivo. The chemical bonding of the HA layers to collagen creates strongly bonded 
interfaces [45]. A quantitative evaluation of the interfacial shear strength in rat and 
monkey models has shown that the strength of the interfacial bond between Bioglass
®
 
and cortical bone was equal to or greater than the strength of the host bone [46]. 
 
Bioactive glass bonding to tissues takes place by a series of ion-exchange and film-
forming reactions as described in Figure 2.2. The bioactive glass bonding to soft 
tissue is composition dependent and only glass compositions with rapid reaction rates 
form a soft tissue bond [47].
 
Confirmation of Bioglass
®
 bone bonding was 
demonstrated in 1976 when Bioglass
®
 coated alumina implants were tested as load 
bearing prostheses in sheep [48]. The results showed bone bonding [49].
 
Small 
additions of K2O and MgO to the basic Bioglass
®
 composition has led to the bioactive 
glass called “Ceravital
®
”. This glass was implanted in animal models by Gross et al. 
[50] who found that the material bonded to bone with a mechanically strong interface.  
 
The first five reaction stages that occur on bioactive glass surfaces in contact with 
physiological fluid lead to a rapid release of soluble ionic species and formation of a 
high surface area hydrated silica and a polycrystalline hydroxyl carbonate apatite 
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(HCA) bilayer on the glass surface (as discussed above). The reaction layers can 
enhance adsorption and desorption of growth factors and will influence the length of 
time required for macrophages to prepare the implant site for tissue repair and 
attachment, synchronised proliferation and differentiation of osteoblasts. 
Mineralization of the matrix follows soon thereafter and mature osteocytes, encased in 
a collagen-HCA matrix, are the final product after 12-16 days in vitro and in vivo. 
 
Thus, the primary advantage that makes bioactive glasses promising scaffold 
materials is their rapid rate of surface reactions which lead to fast tissue bonding. 
However, it has been reported that crystallisation of bioactive glasses decreases the 
level of bioactivity [51] and it can even turn a bioactive glass into an inert material 
[52]. Recently results obtained at Imperial College London (UK) demonstrated that if 
sintering conditions during scaffold fabrication are well controlled, bioactive glass-
ceramic scaffolds still show high degree of bioactivity [53]. These aspects of the 
development of partially crystallised Bioglass
®
 based scaffolds will be investigated in 
detail in the present project. 
 
The primary disadvantage of bioactive glass is its mechanical weakness and low 
fracture toughness. Its low tensile strength (in the range of 40-60MPa for dense 
components) makes it unsuitable for load-bearing applications. Thus, combining the 
mechanical properties of polymers with bioactive glass to produce optimised 
bioactive composites for bone repair is being highly investigated [54] and this topic 
will constitute a significant part of the present investigation. 
 
 
2.6.2 Calcium phosphate ceramics (CPC) 
 
Jarcho et al. in the USA [55] ,
 
DeGroot et al. [56], and Denissen [57] in Europe and 
Akao et al. in Japan [58] have shown that ceramics made of calcium phosphate can be 
successfully used for replacing and augmenting bone tissue. The most widely used 
calcium phosphate based bioceramics are hydroxyapatite (HA) and β-tricalcium 
phosphate (β-TCP) [46]. Hydroxyapatite has the chemical formula Ca10(PO4)6(OH)2, 
a Ca/P ratio of 1.67 and it possesses a hexagonal structure. It is the most stable phase 
of various calcium phosphates. It is stable in body fluids and in dry or moist air up to 
1200
o
C and does not decompose. HA has been shown to be bioactive [55].  
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The two main ways to prepare HA are wet chemical methods and solid-state 
reactions. Wet chemical methods involve the acid-base titration or co-precipitation 
from aqueous solutions that contain calcium nitrate and di-ammonium hydrogen 
phosphate; direct precipitation reaction between orthophosphoric acid solution and 
calcium hydroxide dispersed in water. In solid-state reactions, the mixed calcium 
compound is compressed and sintered above 950
o
C. There are also other options for 
preparation of HA powders such as sol-gel based methods and electro-crystallisation, 
spray pyrolysis, freeze-drying, microwave irradiation, mechanochemical methods as 
well as emulsion processing [59]. 
 
The rate of addition of reactants, pH and sintering temperature influence the 
stoichiometry (Ca/P ratio) and thus the nature of HA. Dried HA powder is amorphous 
while sintering at 900
o
C produces crystalline HA. Both Ca
2+
 and PO4
3-
 ions, as well as 
the OH
- 
group in HA, can be replaced by other ions, several of them present in 
physiological surroundings. For biomedical purposes, carbonated apatite and 
fluorapatite are the materials of interest because of their similarity with bony apatite 
and decreased solubility in aqueous solution, respectively [60]. 
 
β-tricalcium phosphate (β-TCP) is represented by the chemical formula Ca3(PO4)2, the 
Ca/P ratio being 1.5. β-TCP shows an X ray diffraction (XRD) pattern of pure 
hexagonal crystal structure, and it is highly soluble in body fluid. Many studies 
indicate that the dissolution of HA in the human body after implantation is too low to 
achieve the optimal results in tissue engineering applications. On the other hand, the 
dissolution rate of β-TCP is too fast for bone bonding. Thus studies have focused on 
development of biodegradable scaffolds based on biphasic calcium phosphate 
composed of HA and β-TCP [61]. 
 
2.6.3 Apatite-wollastonite (A/W) glass-ceramics 
 
In A/W glass-ceramics, the parent glass is the pseudoternary system 3CaO.P2O5-
CaO.SiO2-MgO.CaO.2SiO2. When the glass in bulk form is heated up to 1050
o
C at a 
rate of 5
o
C/min, fine grains of hydroxyapatite and fibrous β-wollastonite precipitate 
before complete densification and microcracking occur. β-wollastonite (CaO.SiO2) 
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consisting of a silicate chain structure acts as the reinforcing phase [62]. To avoid 
crack formation, a small amount of CaF2 is added to the parent glass, forming the 
composition MgO(4.6wt%), CaO(44.7wt%), SiO2(34.0wt%), P2O5(6.2wt%) and 
CaF2(0.5wt%) which is subjected to the same heat treatment. As a result, the glass 
powder can be fully densified at about 830
o
C, and oxyfloroapatite (Ca10(PO4)6(F2O)) 
and wollastonite precipitate successively at 870
o
C and 900
o
C, respectively, to give a 
crack- and pore-free, dense and homogenous glass-ceramic [63]. 
 
A/W glass-ceramics can be easily machined into various shapes such as artificial 
vertebrae, intervertebral spacers, spinous process spacers and iliac spacers. The 
bending strength of A/W glass ceramics (215MPa) is twice that of dense sintered HA 
(112 MPa), which is due to the reinforcement effect of β-wollastonite as well as 
apatite. It has a relatively high fracture toughness of 2MPa.m
1/2 
and high fracture 
surface energy of 15.9 Jm
-2
.  
 
The A/W glass-ceramic is capable of binding to living bone within a few weeks after 
implantation, and the implant does not deteriorate in vivo [64]. However, and 
surprisingly, there are no studies reported in the literature on the development of 
highly porous scaffolds made of A/W glass-ceramics for application in bone tissue 
engineering. 
 
2.6.4 Ceravital® bioactive glass-ceramic 
 
Ceravital
®
, is the trade name describing a number of different compositions of glasses 
and glass-ceramics. Their basic network components include SiO2, Ca(PO2)2, CaO, 
Na2O, MgO and K2O with ceramic additions being Al2O3, Ta2O5, TiO2, B2O3, 
Al(PO3)3, SrO, LA2O3, or Gd2O3. The only field in which glass-ceramic “Ceravital
®
” 
implants are clinically applied is in the replacement of the ossicular chain in the 
middle ear where the loads are minimal and the mechanical properties of the materials 
are sufficient [65].
  
 
However, in-vitro experiments showed that the solubility condition of these materials 
could be adjusted from high to low solubility, by addition of metal oxides to the melt. 
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This degradability property is attractive for tissue engineering, however no studies 
about the fabrication of highly porous scaffolds based on Ceravital
® 
have been 
reported in the open literature. 
 
2.6.5 Bioverit®bioactive glass-ceramic 
 
Bioverit
®
 is a mica-apatite glass-ceramic with chemical composition in the SiO2-
Al2O3-MgO-Na2O-K2O-F-CaO-P2O5 base glass system with special fluorophlogopite 
mica crystal (Na/KMg3(AlSi3O10)F2). The formation of these crystals is possible by 
heating the base glass composition at temperatures between 610
o
C and 1050
o
C. Mica 
crystals give the materials good machinability, and apatite crystals ensure the 
bioactivity of the implants.  
 
Bioverit
®
 has been used as implants especially as spacers in orthopaedic surgery, 
middle ear implants and dental tooth fillers. The in vitro reaction of the Bioverit
®
 
surface in Ringer’s solution and tris-buffer-solution indicates ion-exchange between 
the glass-ceramic and simulated body fluid. In vivo experiments with Bioverit 
®
 have 
shown good bioactive behaviour of the implants. The proven performance of the 
material in vivo is an attractive attribute for bone tissue engineering, however the 
author is not aware of any research work on the production of scaffolds from this 
material. 
 
2.6.6 Natural biopolymers 
 
Special interest has been paid to naturally occurring polymer materials for tissue 
engineering scaffolds due to their high biocompatibility and potential similarity to 
extracellular matrix (ECM) components. Among them collagen [66] and chitosan [67] 
are mostly investigated for bone tissue engineering. These polymers should not cause 
any inflammatory response when in contact with human tissue.  
 
Other biopolymers of high biocompatibility are those developed from microbial 
sources. For example, polyhydroxyalkanoates (PHA) are a group of biodegradable 
and biocompatible polyesters produced by micro-organisms under unbalanced growth 
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condition [68]. So far, only few PHA, including poly 3-hydroxybutyrate P(3HB), 
copolymers of 3-hydroxybutyrate and 3-hydroxyvalerate, P(HBV), poly 4-
hydroxybutyrate, P(4HB), copolymers of 3-hydroxybutyrate and 3-hydroxyhexanoate, 
P(HBHHX), and poly 3-hydroxyoctanoate P(HO) are available in sufficient quantity 
for applications in laboratory research [69]. Figure 2.3 shows the general chemical 
structure of PHAs. Poly 3-hydroxybutyrate, P(3HB), and poly 3-hydroxyhexanoate, 
P(HHX), structures can be obtained by replacing the R group with methyl or propyl 
group, respectively. 
H CH
 
C OC
 OR
2 m
n
 
Figure 2.3 General molecular structure of polyhdroxyalkanoates. m=1,2,3, yet 
m=1 is most common, n can range from 100 to several thousands. R is variable. 
When m=1, R=CH3, the monomer structure is 3-hydroxybutyrate, while m=1 
and R=C3H7, it is a 3-hydroxyhexanoate monomer. 
  
P(3HB) is the most common member of the PHA family. It was discovered by 
Lemoige in 1926 [70]. The P(3HB) crystal is a relatively stiff, rigid material and has 
tensile strengths comparable to polypropylene. Doyle et al. [71] demonstrated that 
materials based on P(3HB) produce a consistent favourable bone tissue adaptation 
response with no evidence of an undesirable chronic inflammatory response after 
implantation periods of up to 12 months. Bone is rapidly formed close to the 
materials and 80% of the implant surface was seen to be in direct apposition to new 
bone. When porous composites of P(HBV) and sol-gel-bioactive glass (SGBG) are 
exposed to SBF for 12 hours (for bone tissue engineering scaffolds), results indicated 
that hydroxyl carbonate apatite (HCA) had formed on the surface of P(HVB)/SGBG 
scaffolds [72]. PHA have also been combined with HA [73] and bioactive glasses 
[74] in novel composites for tissue engineering scaffolds. 
2.6.7 Synthetic polymers 
 
The number of synthetic polymers that hold promise for bone tissue engineering is 
limited. Polymers, in particular the biodegradable ones, have a Young’s modulus 
much lower than bone and cannot be used directly in load bearing applications. Table 
2.2 shows a summary of common synthetic polymers used in tissue engineering and 
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their relevant properties. There is also concern over the acidic degradation products of 
some polymers where hydrolysis occurs at the ester group giving an acidic by-product 
(e.g. PLA degrading to lactic acid). The synthetic polymers that are widely used for 
tissue engineering scaffolds include polyglycolic acid (PGA) and poly-(L)-lactic acid 
(PLLA), or their copolymer (PLGA) [75]. Poly(D,L)-Lactic acid (PDLLA) has been 
extensively investigated as well, for example as a biomedical coating of orthopaedic 
materials because of its excellent features with respect to implant performance [76]. 
PDLLA also shows excellent biocompatibility in vivo and a good osteoconductive 
potential [77]. In cartilage tissue engineering, PGA [78], PDLLA [79], and PGA-
PLLA copolymers [80] have been studied for their efficacy as chondrocyte-delivering 
scaffolds in vitro and in vivo. Several investigators have also found that some non-
biodegradable polymer substances, such as polytetrafluroethylene [81],
 
polymethylmethacrylates [77], and composites of hydroxyapatite-Dacron
®
 also 
facilitate restoration of articular surface.  
 
Table 2.2 Physical properties of synthetic, biocompatible and biodegradable 
polymers investigated as scaffold materials [82]. 
_____________________________________________________________________ 
Polymers               Melting             Glass           Degradation time              Modulus      
                               Point, Tm         Transition              Month                      (GPa) 
                                (
o
C)                   Tg,(
o
C) 
PDLLA                amorphous           55-60                    12-16                   1.9-2.4 (film) 
PLLA                   173-178               60-65                    > 24                     1.2-3.0 (film) 
PGA                     225-230               35-40                    6-12                     7-14 (fibre) 
PLGA                  amorphous           45-55                   adjustable              1.4-2.8 
 
 
2.6.8 Synthetic composite materials 
 
The development of composite materials for tissue engineering combining 
biopolymers and bioactive ceramic phases serves the purpose of enhancing the 
mechanical behaviour of the polymer, while maintaining its excellent biocompatibility 
and imparting bioactivity. Thus a better combination of mechanical and biological 
properties is usually achieved with a composite or hybrid structure.  
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Calcium phosphate ceramics (i.e. hydroxyapatite and tricalcium phosphate) and 
bioactive glasses (silica glasses containing calcium and phosphorus), are the most 
popular bioactive materials. They have demonstrated good biological properties and 
clinical successes. However, calcium phosphates and bioactive glasses are brittle; 
hence they cannot be used in load-bearing applications. In addition, their handling by 
the surgeon is difficult. 
 
As mentioned above, many polymers have been proposed for applications in tissue 
engineering, either natural polymers (e.g. collagen, alginate, glycosaminoglycan, 
starch, chitin, poly(hydroxybutyrate) and chitosan) or synthetic ( e.g. poly(lactic acid), 
poly(glycolic acid) and co-polymers of poly(lactic acid) and poly(glycolic acid). 
However, polymers usually exhibit low modulus and creep resistance compared to 
bone (whose Young’s modulus ranges between 0.5 and 20 GPa depending on bone 
type) [83]. This is a major drawback of biopolymers which limits their clinical 
applications as tissue engineering scaffolds, particularly in load bearing applications. 
 
Using composites comprising biopolymers and an inorganic phase takes advantage of 
both polymer and ceramic properties, ideally to achieve materials with the required 
stiffness (close to the stiffness of bone), fracture strength and high toughness. Such 
composites can be based either on a polymer or a ceramic matrix and should be highly 
porous to enable cell penetration, tissue ingrowth, vascularisation and nutrient 
delivery, as outlined in Table 2.1 [1]. 
 
 
2.7 Technologies for bioactive glass processing 
 
The most widely used methods for the fabrication of dense bioactive glasses are: 1) 
melt casting and 2) firing of compacted powder. The latter route involves the 
production of the desired body from a powder compact by viscous flow sintering. 
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2.7.1 Melt casting 
 
Figure 2.4 Basic flow chart for the production of A) glasses and B) glass-ceramic 
by melt casting. 
  
The simplest form of melt casting involves melting a batch of powdered raw 
materials, followed by cooling and forming to produce a solid finished body (Fig. 
2.4). For glasses that crystallise very easily, the solidification of the melt is 
accompanied by rapid nucleation and growth of crystals (i.e. grains). Uncontrolled 
grain growth generally leads to critical problems due to uncontrolled microstructure 
and low mechanical properties (e.g. low fracture strength). The melt casting method is 
limited to the fabrication of glasses and, by a controlled nucleation and crystal growth 
heat treatment, glass-ceramics. 
 
One important variation of the melt casting method is the glass-ceramic process.
 
This 
process involves heating a glass in controlled manner in a two-step process, firstly to 
nucleate and then to grow the crystals throughout the glass (Fig. 2.4). Glass-ceramics 
are by definition ≥ 50% crystalline by volume, and most are >90% crystalline. Since 
the process depends initially on the formation of a parent glass, it is limited to 
chemical compositions that can form glasses and in which crystallisation can be 
controlled by suitable heat treatments. 
Powder Mixture 
Melt 
A) Solid Glass Product 
Solid Glass 
B) Glass-Ceramic 
Product 
Heating 
Cooling and 
forming 
Nucleation and 
crystal growth 
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2.7.2 Firing of compacted powders (sintering) 
 
In principle, the sintering of compacted powders can be used for the production of 
both glasses and polycrystalline ceramics. It is by far the most widely used method for 
the production of polycrystalline ceramics. The processing steps are shown in Fig. 
2.5.   
 
Figure 2.5 Basic flow chart for the production of polycrystalline ceramics by 
sintering of consolidated powders. 
  
In its simplest form, this method involves the consolidation of a powder to form a 
porous, shaped powder compact (green body), which is then sintered at high 
temperature to produce a dense product. 
 
 
 
 
 
 
 
 
Powder 
Shaped Powder Form 
Dense Polycrystalline 
Product 
Mixing             (e.g, with binder or additives) 
Sintering 
Consolidation      (e.g., die pressing, slurry casting, plastic      
                                     forming, or injection moulding) 
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2.7.3 Sol-Gel processing 
 
 
Figure  2.6 Basic flow charts for sol-gel processing of ceramics and glasses. 
 
Sol-gel processing is a chemically based method for producing ceramics, glasses, 
glass-ceramics and composites at much lower temperatures than the traditional 
processing methods. The process involves fine particles (1-100nm in diameter) being 
dispersed in either liquid or gases called colloids. When a colloid is sufficiently fluid 
and stable for a long period of time, the colloid is called a sol. The rigid solid formed 
by the evaporation of a solvent from a sol is called gel. By manipulating the sol-gel 
transformation behaviour, it is possible to form a variety of shapes quickly. The gel 
network can also be formed from hydrolysis and condensation of liquid metal-
alkoxide precursors. An example of a metal-alkoxide precursor used to provide –Si-
O-Si- network of bioactive gel-glasses is Si(OR)4, where R is CH3, C2H5, or C3H7. 
Other metal ions can also be used in addition to Si, such as, Ca, P, Ti, etc. Figure 2.6 
shows the generic processing steps for sol-gel process to obtain ceramics and glasses. 
 
Solution 
(of metal alkoxides) 
Sol 
(Solution of polymers) 
‘Polymeric gel’ 
Dried Gel 
Dense Product (Ceramic or glass) 
Hydrolysis and condensation 
Gelation 
Drying 
Firing 
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A gel is dried when the physically adsorbed water is completely eliminated from the 
pores and this requires heating at controlled rate to temperatures of 120-180
o
C. 
Chemical stabilization of the dried gel is necessary to control the environmental 
stability of the material. Thermal treatment in the range of 500-900
o
C desorbs surface 
silanol (Si-OH) and eliminates a 3D network of silica rings from the gel. The surface 
chemistry is important to control the rate of HCA formation on the gel-glasses and 
their bioactivity. Stabilization also increases the density, strength and hardness of the 
gel and converts the network into a glass with network properties similar to melt-
derived glasses. Densification of alkoxide-derived gel-glasses is completed in the 
range of 900-1150
o
C depending upon composition. Hydroxyls and adsorbed water 
must be removed from the gels prior to closure of pores or inhomogeneous 
microstructure will result. An important advantage of the sol-gel process is the ability 
to control the surface chemistry of the material by these thermal treatments. 
 
2.8 Methods to produce macroporous ceramic scaffolds 
 
An ideal scaffold is the one that mimics the extracellular matrix (ECM) of the tissue 
that is to be replaced so that it can act as a template in three dimensions onto which 
cells attach, multiply, migrate and function. In this section, several methods proposed 
in the literature for the fabrication of macroporous ceramic scaffolds are described.   
 
2.8.1 Replica technique 
 
Figure 2.7 Schematic diagram of the replica technique for fabrication of porous 
ceramics [84]. 
 
The earliest production of macroporous ceramics by the foam replica method dates 
back to the early 1960s, when Schwartzwalder and Somer [85] started using 
polymeric sponges as templates to prepare ceramic cellular structures of various pore 
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sizes, porosities and chemical compositions. In the polymer replica approach, 
synthetic e.g. polymer foams, typically polyurethane, (PU) [53] and natural (e.g. 
coral, wood [86]) templates of desired macrostructures can be used to fabricate 
macroporous ceramics. Figure 2.7 shows the schematic diagram of the replica 
technique for the fabrication of macroporous ceramics. The template is initially 
soaked into a ceramic suspension until the struts are homogeneously coated with the 
ceramic material. At this stage, the coatings should be viscous enough to avoid 
dripping by thixotropic effects. Thickening additives such as clays, colloidal silica, 
carboxymethyl cellulose and polyethylene oxide in combination with conventional 
dispersants can be used [86-89]. Moreover, binders and plasticizers are added to the 
initial suspension in order to prevent cracking of the struts during the subsequent heat-
treatment process. The ceramic-coated polymeric template is subsequently dried and 
the polymer template is burnt out through careful heating between 300
o
C and 800
o
C 
and finally densified by sintering in an appropriate atmosphere at temperatures 
between 1,000 and 1,500
o
C, depending on the material.  
 
Highly porous ceramics can be produced reaching open and interconnected porosity 
levels in the range 40%-95% with pores sizes between 200 micron and 3 mm. One 
possible disadvantage of the method is the tendency to produce a hole in the centre of 
each strut resulting from the removal of the polymer skeleton on heating. The 
presence of this hole can negatively affect the mechanical properties of the foams 
[53]. However, the approach of filling the hole with a polymer, as discussed below, 
leads to improved mechanical behaviour exploiting the interaction between the 
polymer and ceramic phases.  
 
Alumina [90-92], titania [93], zirconia [94-96] and Bioglass
® 
[53;97] foams are 
examples of scaffolds produced by the replica method using polymer sponges as the 
synthetic templates. A great variety of hydroxyapatite and calcium phosphate 
scaffolds have been also produced using both synthetic polymers templates as well as 
coral as natural templates [98-103]. The polymeric sponge method has also been 
proposed to manufacture macroporous calcium phosphate glass scaffolds of 
composition CaO-CaF2-P2O5-MgO-ZnO [104] and glass-reinforced HA foams [105]. 
Several approaches are being investigated to improve the mechanical properties of 
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foams produced by the replica techniques, which may lead to HA cellular structures 
of improved fracture strength [100]. 
 
2.8.2 Sacrificial template method 
 
This method leads to porous materials having a negative replica of the original 
sacrificial template, as opposed to the (positive) replica obtained with the method 
described above. The technique involves the preparation of a biphasic composite 
comprising a homogenously dispersed sacrificial phase in a continuous matrix of 
ceramic or glass particles [106]. The sacrificial phase is then extracted from the 
partially consolidated matrix to generate pores within the microstructure. The removal 
of the sacrificial phase does not usually lead to flaws in the struts as is the case in 
positive replica methods. Therefore, the mechanical strength of the structures made by 
the sacrificial template method is usually higher than that of scaffolds fabricated by 
the replica method; however, porosity and pore interconnectivity are substantially 
lower [106;107]. Hydroxyapatite porous bodies produced from PMMA particles, PVB 
beads, wax and starch particles, as well as naphatane and sucrose [108-112] as 
sacrificial materials have been made by this method. Figure 2.8 shows the schematic 
diagram of the sacrificial template processes to produce porous ceramics.  
 
 
 
Figure 2.8 Schematic diagram showing the sacrificial template method to 
produce porous ceramics. [84] 
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2.8.3 Direct foaming methods 
 
 
Figure  2.9 Schematic diagram showing the direct foaming methods to produce a 
porous ceramic. [84] 
 
In the direct foaming method, air is incorporated into a ceramic suspension which is 
then set in order to create a structure containing air bubbles [113;114]. In most cases, 
the consolidated foams are subsequently sintered at high temperatures to produce a 
high-strength porous ceramic. Stabilisation of air bubbles in the initial suspension is 
the most critical process. The stability of the air bubbles can be achieved by various 
surfactants and particle stabilisers. The foam structure prior to solidification is 
important because it influences the total porosity, pore size, wall thickness and 
microstructure of the final products. The porosity of foams produced from the direct 
foaming technique are hydroxyapatite and calcium phosphate scaffolds [115;116] 
obtained by gel-casting setting process as well as sol-gel derived bioactive glass 
scaffolds [113;117]. Figure 2.9 show the schematic process of direct forming methods 
to produce porous ceramics. 
   
2.9 Bioceramic porous scaffolds coated with polymer layers 
 
2.9.1 Calcium phosphate-based scaffolds 
 
As mentioned above, calcium phosphates including HA, tricalcium phosphate (TCP) 
and calcium phosphate cements (CPC) play an important role in the development of 
scaffolds for bone tissue engineering. Miao et al. [118] have produced porous calcium 
phosphate ceramics with interconnected macroporous ( > 200µm) and microporosity 
(~ 5µm) as well as high porosities (~ 80%) by firing polyurethane (PU) foams coated 
with calcium phosphate cement at 1200
o
C. The open micropores of the struts were 
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infiltrated with poly(lactic-co-glycolic acid) (PLGA) to achieve an interpenetrating 
bioactive ceramic/biodegradable polymer composite structure. This work followed on 
from earlier study by the authors [119], where PLGA-coated porous CPC scaffolds 
were developed exhibiting compressive strength values of up to 4 MPa. In their most 
recent investigation Miao et al. [118] have also developed highly porous HA/TCP 
composite scaffolds (87% porosity) infiltrated with PLGA to form ceramic-polymer 
interpenetrating microstructures. In these composites the addition of PLGA led to a 
significant improvement on the compressive strength [120]. The mechanism based on 
crack bridging, previously investigated by Pezzotti et al. [121], was proposed to 
explain the strengthening and toughening achieved in the composites, evident by the 
presence of polymer ligaments that were stretched upon crack opening along the wake 
of the crack [120]. 
 
Li et al. [122] have produced macroporous HA ceramics with nanoporous struts. 
Subsequently, a commercially available biopolymer, Polyactive™, was incorporated 
into the struts by vacuum infiltration. As a result, the mechanical properties of the 
porous composites with interpenetrating organic/inorganic phases were found to 
improve significantly. Similar results were achieved in earlier investigations by 
Tencer et al. [123;124], who found that coating the internal surfaces of porous HA 
with biodegradable polymer (PDLLA) improved the compressive strength 
significantly but the coated material was shown to lack bioactivity. 
 
Since bioactive silicate glasses exhibit higher bioactivity [125] or have faster rates of 
apatite formation compared to crystalline HA, bioactive glasses have been combined 
with HA scaffolds in bioactive composite coatings. Huang and Miao [126], for 
example, have used tetracalcium phoshates (Ca4(PO4)2O; TTCP) and dicalcium 
phosphate anhydrous (CaHPO4; DCPA) macroporous ceramics and PLGA/Bioglass
®
 
composites to coat HA scaffolds. The bioactive glass addition to the polymer coating 
increased the bioactivity of the scaffolds, as expected [125]. The replication technique 
was combined with H2O2 (hydrogen peroxide) pore forming method to produce the 
macroporous HA scaffolds which resulted in an increase in porosity but smaller pores 
sizes [126]. The HA scaffolds were first coated with 40wt% PLGA and further coated 
with bioactive glass/PLGA to increase the bioactivity as well as the compressive 
strength (5.8 MPa). Figure 2.10 A) shows a SEM micrograph of the microstructure of 
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Huang and Miao’s composites [126] showing that the PLGA phase fills the open 
micropores in the struts of the hydroxyapatite foam. It was observed that PLGA also 
filled the large defects (central hole) in the struts, as shown in Fig. 2.10 B). 
 
 
 
Figure 2.10 SEM micrographs showing the microstructure of PLGA/HA 
composite scaffolds fabricated by Huang and Miao [126]: (A) PLGA phase 
(dark) filling open micropores in a HA strut (bright) and (B) PLGA phase filling 
the large defect in the centre of a strut. 
 
Nakahira et al. [127] investigated hybrid hydroxyapatite/polymer composites by the 
infiltration of nylon into porous hydroxyapatite prepared from whisker-like powder at 
sintering temperatures between 800 and 1000
o
C. These HA/nylon composites 
exhibited a fracture toughness (KIC) of 1.65MPam
1/2
, and also showed good 
bioactivity according to results of SBF immersion tests. 
 
A related study was published by Pezzotti et al. [128] who produced HA composites 
with relative porosity of 32% by cold-isostatic pressing followed by sintering. The 
HA structures containing percolated submicron porosity channels were infiltrated 
A 
B 
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with 6-nylon to produce composites with improved fracture properties. The results of 
this investigation also demonstrated the effect of different types of polymers with 
different mechanical properties on the overall fracture behaviour of the composites. 
 
Miao et al. [129] have studied a composite consisting of three interpenetrating 
networks; tricalcium phosphate (TCP), HA and PLGA, which was produced in 3 
steps. Firstly, the porous TCP network was produced by coating a PU foam with 
hydrolysable α-TCP slurry. Then, a HA network was derived from calcium phosphate 
cement (CPC) filled with the porous TCP network. Finally, the remaining open pore 
network in the HA/TCP composites was infiltrated with PLGA. These composites 
feature three phases with different degradation behaviour. It was postulated that bone 
would grow on the fastest degrading network (PLGA), while the remaining phases 
would remain intact thus maintaining their geometry and load bearing capability. The 
achieved compression strength of the PLGA coated material was remarkable at 
30MPa; however the final porosity of the coated foams was not reported in the 
original study [129]. 
 
In other developments targeted to improve bone ingrowth and osseo integration, HA 
scaffolds have been coated with HA particles and polycaprolactone (PCL). The PCL 
matrix also acted as carrier for the antibiotic drug tetracycline hydrochloride which 
was entrapped within the coating scaffold layer [130;131]. HA scaffolds have also 
been coated with PLLA and compressive strength values of ~ 3MPa were achieved, 
however for a volume fraction of 70%, which is lower than the ideal value for bone 
tissue scaffolds [132]. With the PCL/HA composite coating, on the other hand, the 
mechanical properties such as compressive and elastic modulus were improved by 
several orders [130;131]. The release rate of the drug sustained for prolonged periods 
was found to be dependent on the degree of coating dissolution. In parallel study by 
the same group [133], HA porous scaffolds were coated with polymer (PCL)-HA 
hybrids for use as would healing and tissue regeneration substrates. The antibiotic 
vancomycin was incorporated in the PCL matrix at different concentrations and the 
drug release profile was determined. The encapsulated drug within the coated 
scaffolds was released in a highly sustained manner as compared to the rapid release 
of drugs directly adsorbed on the pure HA scaffolds [133]. These studies were the 
first to show the enhanced function of a scaffold achieved by applying a polymer 
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coating. Not only are the mechanical properties improved but the scaffold also 
becomes a vehicle for targeted drug delivery. A complete review on the use of tissue 
scaffolds as drug delivery platforms has been published recently [134] showing that 
polymer coated calcium phosphate scaffolds are highly attractive for this application. 
 
2.9.2 Bioactive glass and calcium silicate-based scaffolds 
 
Chen et al. [1] have investigated the mechanical properties and bioactivity of 
Bioglass
®
-based scaffolds, before and after applying a PDLLA coating on the foam 
struts. They found that the bioactivity of scaffolds upon immersion in simulated body 
fluid (SBF) was maintained in the PDLLA-coated foams, while the transformation of 
the crystalline phase (Na2Ca2Si3O9) to amorphous calcium phosphate [53], which is a 
typical feature in Bioglass
®
 derived glass-ceramic scaffolds, was delayed by the 
PDLLA coating. PDLLA was the first biodegradable polymer considered to coat 
Bioglass
®
 scaffolds [1]; however, more recently, a new polymer based on 
polyhydroxyalkanoate has been investigated as an alternative coating material [135]. 
The polymer chosen, poly(3 hydroxybutyrate), P(3HB), is a natural thermoplastic 
polymer produced by many types of micro-organisms, which can be extracted as a 
stereoregular, optically active, isotactic polyester with purity and without any 
inclusion of catalyst residues [136]. In addition to its biocompatibility and 
biodegradability P(3HB) has been reported to have piezoelectric properties, which can 
stimulate bone growth and aid in healing of damaged or diseased tissue. 
 
In the present project, also polymers of the PHA family, including P(3HB) and 
P(3HO) will be investigated, as discussed below. Bretcanu et al. [135] used for the 
first time bacteria-derived P(3HB) to infiltrate 45S5 Bioglass
®
 scaffolds. These 
scaffolds are intended for the applications in cancellous bone substitution after trauma 
incidents. The pore morphology and macrostructure of the scaffolds before and after 
coating with P(3HB) as well as the coating homogeneity were investigated. It was 
found that polymer coating did not affect the interconnectivity of the pore structure; 
however, the coating was not fully homogenous as shown in Fig. 2.11.  In terms of 
compressive strength of the coated and uncoated scaffolds, the polymer coated 
samples exhibited considerably increased compressive strength compared to uncoated 
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scaffolds. The formation of HA crystals on the surface of the scaffolds was 
investigated confirming the high bioactive character of the scaffolds. After two weeks 
of immersion in SBF a uniform layer of HA crystal was formed.  
 
Figure 2.11 SEM image showing the microstructure of a Bioglass
®
 scaffold 
coated by P(3HB) [135]. 
 
In separate developments, Wu et al. [137] have produced a highly porous 
interconnected (~ 99.9%) calcium silicate scaffold coated with PDLLA by the sponge 
replica technique. They reported compressive strength values of up to 1.45 MPa in air 
and 1.10MPa in PBS. The PDLLA modification was found to decrease the dissolution 
ratio of the calcium silicate scaffolds, while maintaining their apatite forming ability 
in SBF. In addition, the studies showed that PDLLA-modified scaffolds had a more 
uniform and continuous network of inner connectivity compared to non-modified 
scaffolds, in agreement with other investigation using Bioglass
®
 [1] or HA [132], 
while also increasing the spreading and viability of human bone cells. The analysis of 
the literature on bioactive glass and glass-ceramic scaffolds has revealed the need for 
further optimisation work to improve the mechanical and biological performance of 
these novel scaffolds, this being one of the aspects to be covered in the present 
project. 
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2.9.3 Polymer-coated scaffolds based on alumina and titania 
 
The concept of polymer coating and formation of interpenetrating polymer-ceramic 
microstructures has also been applied to scaffolds made from “bioinert” ceramics, 
such as alumina and titania. Peroglio et al. [83] have recently investigated alumina 
scaffolds coated with PCL. The coating was obtained by infiltrating the scaffolds with 
either a PCL solution or PCL nanodispersion. A typical fracture surface of a scaffold 
strut is shown in Fig. 2.12, which exhibits the presence of the polymer phase on the 
surface and penetrating into cracks in the alumina micro-structure. It was found that 
the elastic behaviour was primarily controlled by the ceramic scaffold, while the 
fracture energy mainly depends on the polymer phase. PCL additions of 10-20% to 
alumina scaffolds led to a 7- to 13-fold increase of the apparent fracture energy, in 
agreement with the results of Chen et al. for PDLLA-coated Bioglass
®
 scaffolds [1]. 
The toughening mechanisms leading to this result was attributed to crack bridging by 
polymer fibrils [83]. The authors also showed that infiltrating PCL by nanodispersion 
did not result in a significant improvement of the mechanical behaviour of the 
scaffolds. 
 
Figure 2.12 SEM image of the fracture surface of a PCL/alumina composite 
scaffold obtained by infiltrating alumina foams with a PCL solution [83]. The 
polymer phase is seen to coat the strut and to penetrate cracks in the alumina 
microstructure. 
 
TiO2 foam-like scaffolds with pore size ~ 300µm and >95% porosity were fabricated 
by the foam replication method by Novak et al. [138] in order to improve the 
structural integrity of the as-sintered foams, which exhibited low compression 
strength (< 0.045MPa), PDLLA or PDLLA/Bioglass
®
 coatings were developed. The 
 52 
PDLLA coating of a few microns in thickness was shown to improve the mechanical 
properties of the scaffolds: the compressive strength was increased by a factor of ~7 
(0.3MPa). Moreover the composite coating containing Bioglass
®
 particles was shown 
to impart the rutile TiO2 scaffolds with the necessary bioactivity for the intended 
applications in bone tissue engineering. A dense hydroxyapatite layer was shown to 
form on the surface of the foams upon immersion in SBF for one week [138]. 
2.10 Nanostructured 3D scaffolds with added functionality 
 
As mentioned above, scaffolds should act as an artificial extracellular matrix (ECM) 
and play a fundamental role in accommodating cell growth and proliferation. Since 
tissue-engineering scaffolds are intended as temporary artificial ECM to 
accommodate cells and to guide 3D tissue formation, materials that most closely 
resemble the critical features of the natural ECM are the most promising candidates. 
Structural protein fibres in a typical connective tissue, such as collagen and elastin 
fibres, have dimensions in the range from ten to several hundreds nanometers. Cells 
respond to the ECM through plasma membrane receptors that bond the matrix to the 
cell cytoskeleton. Because of a close connection between the cytoskeleton and the 
ECM through cell-surface receptors, cells sense and respond to the mechanical 
properties of their environment by converting mechanical signals into chemical 
signals. Therefore, the biophysical properties of the ECM influence various cells 
functions, including adhesion and migration. Structural fibrils and pores are often of a 
size compatible with cellular processes involved in migration, which may influence 
the mechanism by which cells migrate through the ECM [139]. As a result, cells can 
respond not only to micrometer-scale topography, but also to nanometre-scale 
topography [140].  
 
Studies on 2D surfaces with various types of nanotopographies have been used to 
elucidate the mechanism by which cells respond to nano-scale features.
 
Dalby et al. 
[141]
 
investigated fibroblast responses to 2D nano-islands produced by polymer de-
mixing. The results showed that the cells respond to the islands by broad gene up-
regulation; with the topography affecting notably cell signalling, proliferation, 
cytoskeleton and production of ECM proteins. It has been suggested that topography 
alone can be used to elicit different responses from the same cell phenotype. With the 
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advance of nanotechnology, critical knowledge on the nano-scale organization of 
ECM components and how they interact with one another to organize a functional 
ECM is being generated. Atomic force microscopy (AFM) has become particularly 
important for the study of biological systems. Its major advantage is that it can 
produce high-resolution topographic images in aqueous and physiologically relevant 
conditions without the need to stain the specimen. More importantly, when operated 
in the force mode, AFM can reveal molecular information that is critical for the 
complete functioning of the native tissue [142]. 
  
In the present section several techniques developed for production of nanostructured 
3D scaffolds will be briefly reviewed. 
2.10.1 Nanostructured scaffolds by particle processing 
 
Although advances have been made in the application of nanotechnology for other 
research fields including mechanical, electrical, catalytic and optical, relatively few 
advances have been made for biological applications (specifically, those involving 
bone regeneration), despite their promise to mimic the surface roughness that cells 
experience in vivo. 
 
Studies by Webster et al. [143;144] have shown that bioactivity of biomolecules 
(protein such as fibronectin and vitronectin) is enhanced in terms of mediating 
osteoblast adhesion on nano-phase materials. Thapa et al. [144] have developed nano-
structured PLGA and poly(ether urethane) (PU) formulations with surface feature 
dimensions ranging between 50 and 100 nm and tested their in vitro cytocompatibility 
properties with bladder smooth muscle cells. 
  
Another recent study has shown that titania nano-size particles embedded in PLGA 
promoted osteoblast adhesion compared with conventional sized titania (> 100nm) in 
PLGA, since nano-particles of titania were more hydrophilic than those of 
conventional titania [145]. Similarly, Boccaccini et al. [146] have shown that 
bioactivity of PDLLA/TiO2 composite film increased with increasing amount of TiO2 
nanoparticles incorporated in the films. Their studies also showed that TiO2 
nanoparticles alone have no significant effect on MG-63 cell viability. 
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As mentioned above, surface roughness is a crucial property influencing cell 
responses. Price and co workers [147] have demonstrated the importance of 
nanometer roughness based on the polymer casts of consolidated carbon nanofibre-
based materials. Their study has indicated an increase in osteoblast adhesion on 
polymer casts of nanophase carbon fibres compared to conventional carbon fibres. 
Polymer casts of composites of polycarbonate urethane/carbon nanotubes also 
promoted osteoblast functions compared to conventional carbon tubes [148].
  
 
In conclusion, all the reviewed studies imply that cell response might be more 
sensitive to changes in surface roughness in the nanometer range (<100 nm) 
compared with conventional size (>100nm) and the sensitivity may vary with cell 
type.  
2.10.2 Nanofibrous scaffolds by electrospinning 
 
Electrospinning of fibres can be used to produce scaffold (ECM-like) structures 
similar to that of the fibrous proteins in native ECM albeit with different chemical 
compositions. The principle of electrospinning is to use an electric field to draw a 
polymer solution from an orifice to a collector, producing a submicron polymer fibre 
mesh with fibre diameter of several hundred nanometres. High voltages, usually 10-
20 kV, are applied to generate a sufficient surface charge to overcome the surface 
tension in a pendant drop of the polymer fluid, resulting in a 2D membrane [149]. 
 
Due to the simplicity of this method, electrospinning has been widely used by a 
variety of research groups to prepare nanofibrillar matrices. Many studies have been 
carried out in the application of polymer nanofibers in the tissue engineering of bone 
[150], blood vessels [151], cartilage [79], cardiac tissue [152],
 
peripheral nerve system 
[153], ligaments [154], liver [155], and skin [156]. In most of these studies, 
biodegradable polymer materials such as PCL, PLA, PGA and PLGA were used. In 
addition, naturally occurring macromolecules, such as collagen [157], silk protein 
[158], fibrinogen [159], elastin mimetic polypeptides [160], chitosan [161], dextran 
[162] and hyaluronic acid [163], have been fabricated into nanofibers by 
electrospinning. Nanofibers produced are expected to possess high axial strength 
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combined with extreme flexibility. The high surface area, high porosity and high 
spatial interconnectivity maximise the cell-nanofibres-scaffold interaction and 
promote tissue regeneration. As mentioned above, porosity plays a significant role in 
the transport of nutrients and cell migration during tissue regeneration.  
 
In general, electrospun nanofibrous matrices are found to support cell adhesion and 
proliferation and cells tend to maintain their phenotype shape and guided growth 
according to the fiber orientation. Xu et al. [164] studied the potential of non-woven 
and aligned nanofiber matrices made from PLA-PCL and PLLA-PCL/Collagen as a 
scaffold for blood-vessel regeneration. A favourable interaction between the scaffold 
and human coronary artery smooth muscle cells (SMC’s) was demonstrated in the 
study. Attachment and migration of SMC’s along the axis of aligned nanofibers was 
significantly better than that on the polymer films. Challenges exist in utilising this 
technique to fabricate complex 3D scaffolds. Cells cultured on the fibrous membrane 
can penetrate into scaffolds only after the scaffolds have been degraded to a large 
extent. It is however difficult to produce nanofibers with diameters smaller than 50 
nm using electro-spinning. 
 
2.10.3 Nanofibrous scaffolds by self-assembly 
 
Molecular self-assembly has recently emerged as a new approach to engineering 
artificial scaffolds that emulate the ECM both structurally and functionally. Unlike 
electrospinning, this technology not only incorporates specific biological components 
of the ECM, but also mimics the process of ECM assembly in a bottom-up manner 
[165]. Self assembly involves concerted action of weak and non-covalent interactions 
that result in hierarchical structures [166]. Stupp and co-workers [167] designed self-
assembling molecules with a hydrophobic alkyl tail and hydrophilic oligopeptide 
head. The amphiphilicity of these molecules creates cylindrical nanofibres with well-
defined diameters, which subsequently induce a liquid-to-gel transformation.  
 
In one demonstration, the designed peptide amphiphile contains five key structural 
features which are conducive to in-situ directed self-assembly, reversible cross-
linking, mineralization and cell adhesion. Upon acidification of the peptide solution 
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below pH4, cylindrical micelles form, in which the alkyl tails pack on the inside of 
the fibre and the peptide segments are displayed on the fibre surface [167]. Upon 
cross-linking of the cysteine residues on adjacent molecules, the stable nanofibers are 
able to direct the mineralization of hydroxyapatite. The resultant mineral is aligned 
with the direction of the self-assembled fibrils. These mineralised nanofibres resemble 
the lowest level of hierarchical organization of bone; their mechanical properties 
however are likely to be inferior to those of native bone. Probably is for this reason 
that no further study regarding the potential of this material as bone tissue engineering 
scaffold can be found in the specialised literature.  
 
2.11 Bone and cartilage physiology. 
 
2.11.1 Bone 
 
There are two types of bone: a) compact (or cortical) bone and b) trabecular (or 
cancellous) bone. Cortical bone is found in the shaft (diaphyses) of long bone. It is 
consists of a number of irregularly spaced overlapping units termed Haversion 
systems (Fig 2.13 (A)) [168]. Each consists of a central Haversion canal-surrounded 
by concentric lamellae of bony tissue. Trabecular bone is found principally at the ends 
of long bones, and in vertebral bodies and flat bones. It is composed of a meshwork of 
trabeculae within which are intercommunicating spaces (Fig 2.13 (B)) [168]. The 
skeleton consists of approximately 80% cortical bone, largely in peripheral bones, and 
20% trabecular bone, mainly in the axial skeleton. These amounts vary according to 
site and relate to the need for mechanical support. While trabecular bone accounts for 
the minority of total skeletal tissue, it is the site of greater bone turnover because its 
total surface area is greater than that of cortical bone.  
 
Bones are generally richly supplied with blood, via periosteal vessels, vessels that 
enter close to the articular surfaces and nutrients passing obliquely through the cortex 
before dividing into longitudinally directed branches. Loss of the arterial supply to 
parts of a bone results in death of bone tissue, a process called avascular necrosis or 
osteonecrosis. In addition to its role as a support structure, the other primary function 
of bone is calcium homeostasis. More than 99.9% of the total body calcium resides in 
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the skeleton. The maintenance of normal serum calcium (1% of total body calcium) 
depends on the interplay of interstinal calcium absorption, renal excretion and skeletal 
mobilisation or uptake of calcium which is extremely important for maintenance of 
normal cellular functions. 
 
The structural components of bone consist of extracellular matrix (largely 
mineralised), collagen and cells. The collagen fibres are of type I, comprise 90% of 
the total protein in bone and are oriented in a preferential direction giving lamellar 
bone its structure. Hydroxyapatite crystals are found within the collagen fibres and in 
the ground substance. The ground substance is primarily composed of glycoproteins 
and proteoglycans which have high ion-binding capacity and are thought to play an 
important role in the calcification process. The principle cells in bone are the 
osteoclasts and osteoblasts (including bone-lining cells and osteocytes). Osteoclasts, 
the cells responsible for resorption of bone, are derived from haematopoietic stem 
cells. Osteoblasts are derived from local mesenchymal cells. They are the pivotal bone 
cells, responsible directly for bone formation and indirectly, via paracrine factors, for 
regulating osteoclastic bone resorption. 
 
 
 
 
 
 
 
 
 
 
 
(A) 
 
 58 
 
                                                                  (B) 
 
Figure 2.13 Structure of bone: (A) cortical (or compact) bone; (B) trabecular 
bone [168]. 
 
2.11.2 Cartilage. 
 
Articular cartilage is a specialised form of connective tissue that covers and protects 
the end of the bones in synovial joints. For the knee joint this includes the smooth 
surfaces covering the femoral and tibial condyles and the under surface of the patella. 
The surface is smooth and slippery with an extraordinarily low coefficient of friction, 
while the deeper layer merges with a calcified layer (the tidemark) that interlocks with 
the subchondral bone (Fig. 2.14) [168]. Cartilage is an elastic, resilient structure that 
acts as a shock absorber to protect the underlying bone. The properties of articular 
cartilage depend on the composition and structure of the extracellular matrix, and the 
synthesis and maintenance of this matrix is dependent on the chondrocytes. The 
functional integrity of the articular cartilage in a healthy joint depends on the 
chondrocytes synthesising the many different matrix components in the appropriate 
amounts and in the right sequence. During skeletal development, the articular 
cartilage forms very densely packed mesenchymal cells that differentiate into 
chondrocytes, which proliferates rapidly and synthesise the large amounts of 
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extracellular matrix. The extracellular matrix is made up predominantly of water (up 
to 80%), collagen and proteoglycans, which are produced and maintained by the 
relatively sparse cells, the chondrocytes. Type II collagen is the predominant fibrous 
component making up 90-95% of the primary collagen and 40-70% of the total dry 
weight of articular cartilage. Proteoglycans trapped in the collagen fibrils make up 15-
40% of the dry weight of articular cartilage. Proteoglycans play a crucial role in the 
ability to absorb loading forces in a reversible way.  
 
 
 
Figure 2.14 Normal articular cartilage, illustrating the variability in density and 
orientation of the chondrocytes and collagen network. [168] 
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2.11 Summary of the literature review 
 
The requirement for production of scaffolds for bone tissue engineering exhibiting 3D 
open porous structures with pore size of ~ 400 micron and porosity above 90% can be 
achieved by the foam replication technique. It has also been recognised that 
biocomposites made from Bioglass
®
 foams and poly(DL-Lactide) or P(3HB) coatings 
are promising materials for bone tissue scaffolds in terms of their pore structure and 
bioactivity. For improvement of mechanical properties of ceramic 3D scaffolds, the 
limited literature available shows that this can be achieved through infiltration of 
polymers into the porous structure to achieve polymer-ceramic composite struts. This 
constitutes a broad, new and relatively unexplored field of research. Moreover, to 
obtain nanoscale features on the scaffold’s surface, which is also a requirement in the 
optimisation of the design of 3D scaffolds for bone tissue engineering, most work in 
the literature regarding nanostructured scaffolds has been on electrospinning of 
nanofibers. The development of biopolymer coatings of 3D-scaffold, where the 
polymer layer could also incorporate nanoparticles has been investigated. However, 
the combination of electrospinning methods and conventional 3D scaffold 
manufacturing techniques, e.g. foam replica method, has not been explored in the 
literature. This combination could offer the possibility of manufacturing layered 
scaffolds with adequate 3D geometry and surface topography. This technology 
approach will be investigated as part of the present project. 
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Chapter Three 
 
 
 
3. Objectives and Aims of the project 
 
The main aim of this PhD research project is the development of improved bioactive 
glass-based scaffolds for bone and osteochrondral tissue engineering. The objective is 
to fabricate highly porous scaffolds from melt-derived 45S5 Bioglass
®
 powder using 
the sponge replication technique, aiming at enhancing the structural integrity 
(compressive strength, fracture toughness) of 45S5 Bioglass
®
 based scaffolds by 
polymer infiltration and to gain understanding of the interaction of these two phases 
in the composite structure which mimics the composite structure of natural bone. A 
commercially available synthetic polymer, poly(D,L-Lactic acid) (PDLLA), should be 
incorporated as a coating onto the partially sintered Bioglass
®
-based scaffolds by a 
solution dipping technique. Natural polymers synthesised from bacteria which have 
different properties from PDLLA are investigated as well, in this case poly(3-
hydroxybutryate) (P(3HB)) and poly(3-hydroxyoctanoate) (P(3HO)) have been 
selected. Mechanical properties, in term of compressive strength and work of fracture, 
and bioactivity of these scaffolds coated with the different polymers were evaluated 
and compared. Coated 45S5 Bioglass
®
 pellets sintered at the same condition as the 
scaffolds and immersed in SBF and 1.5 SBF were investigated to better evaluate the 
bioactivity mechanism and interfacial properties. It is emphasised that this is the first 
comprehensive investigation on the development and optimisation of Bioglass
®
-based 
3D scaffolds combined with biodegradable polymers with intrinsic different 
properties, i.e. (PDLLA), P(3HB) and P(3HO). Another objective of this research 
work is to design and fabricate a bilayered scaffold structure in order to develop the 
first bioactive glass-ceramic scaffold coated with PDLLA nanofibers by combining 
the electrospinning method and the foam replica fabrication technique. An initial in 
vitro cell culture investigation on the bilayered scaffolds was carried out to assess the 
ability of this novel bilayered composite structure to support and foster cell 
proliferation on the PDLLA fibres layer (cartilage side). The final goal is to achieve 
an ideal bilayered scaffold for osteochodral tissue engineering that can provide 
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adequate mechanical support temporarily and degrade subsequently at a suitable rate 
in relation to the rate of new tissue formation. 
 
3.1  Experimental Approach 
 
A series of experiments was designed to achieve the several objectives of this project 
as summarised in the next paragraphs. 
3.1.1  Bioactive-glass/polymer composite scaffolds 
 
In order to exploit the effect of interpenetrating network microstructures in the 
scaffold optimisation process, this research work investigated the infiltration of 
biodegradable polymer phases (i.e. PDLLA, P(3HB) and P(3HO)) into partially 
sintered Bioglass
®
 glass-ceramic scaffolds prepared by the foam replica technique. 
With the objective of developing partially sintered, e.g. relative porous, strut 
structures, in different series of experiments sintering was stopped at a temperature of 
1000
o
C, which is lower than the temperature normally used for complete densification 
of the structure [1], or sintering time was reduced. The partially sintered scaffolds 
were then dipped into the different polymer solutions in order to achieve polymer 
coatings on the 3D scaffold structure. The coated scaffolds were characterised in 
terms of their mechanical property, microstructure and bioactivity in SBF and 
compared with the behaviour of the dense scaffolds. In order to better evaluate the 
bioactivity mechanism and interfacial properties of the coated samples for different 
types of biodegradable polymer, polymer coated 45S5 Bioglass
®
 pellets sintered at 
the same sintering condition were evaluated and characterised by XRD, SEM and 
EDS. The experimental details will be presented in Chapter 4. The schematic diagram 
of the scaffolds structures to be developed in this project is shown in Figure 3.1. 
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A) Partially sintered scaffold struts.                      B) Interpenetrating network of    
                                                                                     the polymer phase. 
 
Figure 3.1 Schematic diagram showing the designed interpenetrating 
microstructure of partially sintered scaffold struts infiltrated by biodegradable 
polymer. 
 
3.1.2  Bilayered scaffolds for osteochondral tissue engineering 
 
In order to develop bilayered constructs/scaffolds for osteochondral tissue engineering 
applications, this research project investigated the electrospinning technique to 
deposit a PDLLA fibrous layer on the surface of the 3D porous bioactive glass-
ceramic/PDLLA composite scaffolds. PDLLA was chosen due to its suitable 
properties and because it is a polymer approved by the US FDA for clinical use. It 
was anticipated that the use of PDLLA as coating of the scaffold would enhance the 
bonding at the interface between the coated scaffold and the electrospun PDLLA 
fibrous layer, which is a requisite to obtain adequate structural integrity and 
functionality of osteochondral bilayered constructs. The schematic diagram of the 
bilayered scaffolds designed in this project is presented in Figure 3.2. The PDLLA 
fibrous structure deposited by electrospinning technique was investigated in SBF to 
confirm that this layer is not bioactive and that no mineralisation occurs on the fibre 
surfaces in contact with simulated body fluid. Electrospinning technique was also 
used to deposit PDLLA fibrous structures on the flat surface of sintered 45S5 
Bioglass
®
 discs in order to introduce basic nanostructured topography for better bone 
cell attachment. In order to present an overview of the different tasks of the project 
Polymer phase 
filling the 
micropores 
Pores 
Immersion in 
PDLLA, P(3HB)  or 
P(3HO) polymer 
solution 
Pores 
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and facilitate comprehension of the future chapters, the research methodology used is 
schematically shown in Figure 3.3. 
 
 
 
 
 
 
 
Figure 3.2 Schematic diagram of the bilayered scaffold structure developed in 
this project for osteochondral tissue engineering. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bioglass
®
 derived glass-
ceramic/PDLLA 
composite structure. 
Bone side 
Cartilage side PDLLA fibers deposited by 
electrospinning 
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Figure 3.3 Schematic diagram showing the research methodology used in this 
project. 
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Chapter Four 
 
4.  Materials and methods 
 
4.1  Materials 
 
The bioactive glass used in this project was a melt-derived 45S5 Bioglass
® 
powder of 
composition (wt%): SiO2(45%), Na2O(24.5%), CaO(24.4%) and P2O5(6%). This 
powder was purchased from Novamin.Inc, Florida, USA. The particle size of the glass 
powder used in this experiment was in the range between 0.73µm to 17.59µm with 
the typical particle size (medium) being 8.66µm, determined using the Malvern 
Particle Size Analyser, as shown in Fig. 4.1. Poly( D,L- lactic acid) (PDLLA) that 
was used as a binder and coating material in this project, was purchased from Purac, 
(Purasorb PDLLA, Biochem, the Netherlands) with inherent viscosity of 2.15dL/g 
(chloroform as the solvent). Using the Mark-Houwink relations for PDLLA, ([η] = 
1.33 x 10
-4
 Mv
0.79 
), where Mv = viscosity average molecular weight, given by Van de 
Witte et al. [169] for poly-lactides in chloroform, the molecular weight of PDLLA 
used here is 200,000 g/mol. Purasorb (Purac, Biochem, the Netherlands) PDLLA was 
used without further purification. Dimethyl carbonate (DMC) of purity > 99% was 
used as a solvent. It was purchased from Sigma-Aldrich, UK. A different type of 
binder used was polyvinyl alcohol (PVA), 98-99% hydrolysed with molecular weight 
in the range of 85,000 to 146,000. PVA was purchased from Sigma-Aldrich, UK. A 
reticulated polyester-based polyurethane foam with 45ppi (pores per inch) was 
purchased from Recticel, England, and it was used as the template for the replica 
method developed to prepare Bioglass
®
 scaffolds. A SEM image of the foam is shown 
in Figure 4.2. Deionised water was used in all the experimental preparations in this 
project. In a separate part of the project, P(3HB) and P(3HO) were produced from 
bacteria fermentation (as reported in detail below; section 4.3 and section 4.4). All 
chemicals used were purchased from Sigma-Aldrich, UK, except if stated otherwise. 
Table 4.1 summarises the physical properties of the biodegradable polymers used in 
this project. 
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Figure 4.1 Particle size distribution of  45S5 Bioglass
®
 powder. 
 
 
 
 
Figure 4.2 The macroporous structure of 45 ppi polyurethane sponge use to 
fabricate scaffolds by the replica technique. (Recticel, England) 
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Table 4.1 Physical properties of the biodegradable polymers used in this project. 
 P(DLLA)[169] P(3HB)[170] P(3HO)
1
 
Mw (g/mol) 200,000 885,000 225,000 
Contact Angle (
o
) 80.04 87.9 64.5 
Tg (
o
C) 55 2.7 -35.5 
Xc (%) amorphous 64.1 37.2 
Where; Mw= molecular weight 
             Tg = glass transition temperature  
             Xc = percentage crystallinity 
 
4.2  Fabrication of 45S5 Bioglass® based scaffolds 
 
4.2.1 Preparation of 45S5 Bioglass® powder slurry 
 
The preparation of the 45S5 Bioglass
® 
powder slurry was carried out according to a 
previously developed method [53] with slight modifications. 3 grams of PDLLA were 
dissolved in 100 ml DMC to give a polymer weight to solvent ratio of 3% wt/v 
PDLLA-DMC in solution. The mixture was then stirred using a magnetic stirrer for at 
least 12 hours to obtain a homogenous polymer solution. 68 grams of 45S5 Bioglass
®
 
powder were added to the 3% wt/v PDLLA-DMC solution to give a 66% wt/v 
Bioglass
®
-PDLLA solution and the mixture was stirred vigorously for 1 hour using a 
magnetic stirrer. 
  
4.2.2 Preparation of green bodies 
 
The polyurethane (PU) foam (as shown in Fig. 4.2) was cut to give samples of final 
dimensions 5mm x 5mm x 10mm after sintering (considering a 50% linear shrinkage 
during sintering). Green bodies were prepared by slurry-dipping. The cut PU foams 
were immersed in the above prepared 45S5 Bioglass
®
 slurry for 3 minutes; the foams 
were manually retrieved from the suspension as quickly as possible and the extra 
slurry was squeezed out vigorously by hand. The samples (green bodies) were then 
                                               
1  This experiment was carried out by Ms Ranjana Rai (University of Westminster, UK) 
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placed on tissue paper and dried under a fume hood at room temperature for at least 
12 hours. 
4.2.3 Heat treatment of the green bodies 
 
The green bodies were sintered in an electric furnace using different heat treatment 
programs, as shown in Fig. 4.3. First, the green body was sintered at 550
o
C for 3 
hours using a heating rate of 2
o
C/min to burn out the PU foam used as the replica 
template. Then, the temperature of the furnace was increased, in different series of 
scaffold production to 1100
o
C, 1000
o
C, 970
o
C, 950
o
C, 930
o
C, and 900
o
C at the rate of  
2
o
C/min, respectively, and the dwelling time was set for 2 hours in order to sinter the 
45S5 Bioglass
®
 scaffolds. The effect of different sintering times on the mechanical 
properties of the 45S5 Bioglass
®
 based scaffolds was also investigated by sintering 
the scaffolds at 1000
o
C at different sintering times of 2 hours, 1 hour and 0.5 hours, 
respectively. Finally, the temperature of the furnace was reduced to room temperature 
at 5
o
C/min before the sintered scaffolds were taken out from the furnace. 
 
 
 
 
 
Figure 4.3 Heat treatment program designed for burning-out polyurethane 
templates and sintering of 45S5 Bioglass
®
 scaffolds. 
 
5
o
C/min(5) 
Sintering temperature (variable)(4) 
2
o
C/min (3) 
550
o
C/3hr (2) 
2
o
C/min (1) 
R.T. 
T
em
p
er
at
u
re
 
Time 
 70 
 
4.2.4 Selection of binders 
 
In this part of the study, the preparation of 45S5 Bioglass
®
 based scaffolds was 
carried out according to the method described in section 4.2.1, 4.2.2 and 4.2.3 with 
some modifications. A new method involves the use of a new type of binder, i.e. 
PVA, in the preparation of the Bioglass
® 
scaffolds. For the preparation of the 45S5 
Bioglass
®
 slurry; 5 grams of PVA were weighted. This PVA amount was dissolved in 
50 ml of water at 80
o
C using a hot plate stirrer for 1 hour. After complete dissolution 
of PVA, 30 grams of 45S5 Bioglass
®
 powder were added and the mixture was stirred 
for 1 hour. For the preparation of the green body, the PU foams were immersed in the 
45S5 Bioglass
®
 slurry for 2 minutes and then they were manually retrieved from the 
suspension. The excess slurry was manually squeezed vigorously by hand. The green 
bodies were placed in the oven at 60
o
C for 24 hours to dry prior to being sintered at 
different sintering conditions following the heat-treatment programme in Fig. 4.3. 
 
 
4.2.5 Functionalisation of 45S5 Bioglass® scaffolds with ALP 
enzyme 
4.2.5.1 Cleaning of the scaffolds 
 
This part of the experimental work was done at the Department of Material Science 
and Chemical Engineering, Polytechnic of Turin, Italy. First, 45S5 Bioglass
®
 
scaffolds were put in a clean beaker and acetone was added just to cover the whole 
scaffolds. Then, the beaker was placed in an ultrasonicator for 5 minutes. After 5 
minutes, the scaffold was transferred into a clean beaker with 70 ml distilled water. 
The beaker was then put into an ultrasonicator for 5 minutes. The cleaning procedure 
for washing with distilled water was repeated three times. Finally, the scaffolds were 
dried on a clean tissue paper for few hours. 
4.2.5.2   Silanisation of the scaffolds 
 
A silanisation solution was prepared using 150ml ethanol and 35µl of silane (3-
aminopropyltrietoxysilane). The mixture was stirred using a magnetic stirrer for 
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proper mixing. After that, dried scaffolds were put into the silane solution for 6 hours. 
Then, the scaffolds were transferred into a clean beaker for thermal treatment in an 
oven at 100
o
C for 1 hour and they were let to cool down for one day. Finally, the 
sample was washed in ethanol for 5 minutes in ultrasonicator. 
4.2.5.3 Preparation of enzyme (ALP) solutions 
 
Phosphatase alkaline from bovine intestinal mucosa (ALP) was chosen as the model 
enzyme for the functionalisation of the 45S5 Bioglass
®
 scaffolds. The standard 
protocol for the preparation of 5 mg of enzyme requires 1 ml of PBS (phosphate 
buffer solution) to dissolve. For each scaffold, 10 ml of PBS is required for the 
functionalisation, therefore, in this experiment, 60 ml of PBS were required to 
dissolve 1.3 grams of ALP for six scaffolds. The ALP enzymes were stirred using a 
magnetic stirrer in PBS until they were completely dissolved. Then 10 ml of the 
enzyme solution were transferred into a 30 ml nalgene bottle containing the scaffold. 
The nalgene bottle was then put in an incubator at 37
o
C for 24 hours. The enzymatic 
activity of the functionalised Bioglass
®
 scaffolds was measured using UV-VIS 
spectroscopy at 405nm absorbance. 
4.3 Synthesis of P(3HB) polymers using bacterial fermentation 
4.3.1 Growing bacteria in nutrient broth (inoculum) 
 
Bacillus cereus SPV, used for the production of P(3HB), was available from the 
Department of Life Sciences, University of Westminster (UK). First, 0.039 grams of 
nutrient broth were dissolved in distilled water (30ml) and autoclaved at 121
o
C for 15 
minutes. Then, a single colony of Bacillus cereus SPV strain was used to inoculate the 
autoclaved nutrient broth (30ml) and incubated at 30
o
C for 24 hours at 150 rev min
-1 
(Stuart Scientific Orbital Shaker, S150).  
 
4.3.2 Growing bacteria in nitrogen limiting medium (production 
medium) 
 
The production medium used was a specific nutrient limiting with glucose as the 
carbon source. First, glucose (20g/L), yeast extract (2.5g/L), potassium chloride 
(3.0g/L) and ammonium sulphate (5g/L) were dissolved in 270 ml water (production 
 72 
medium). Then, 30 ml of soybean dialysate were added to the above dissolved 
solution of nitrogen limiting medium. The pH of the production medium was 
maintained at 6.8. The production medium solution was then autoclaved at 110
o
C for 
10 min. Next, 30 ml of the inoculum prepared above (section 4.3.1), at an optical 
density of 4.5 was added into the production medium (300 ml). Finally, the inoculum 
in the production medium was incubated at 30
o
C for 72 hours at 150 rev min
-1
in a 
temperature controlled orbital shaker (Stuart Scientific Orbital Shaker, S150). 
 
4.3.3 Isolation/harvesting the bacteria 
 
After 72 hours incubation period, the bacterial cells were isolated from the production 
medium by centrifuging at 5682g for 10 min. After 10 min centrifugation, the 
supernatant was discarded while the cell pellets at the bottom of the centrifuge tube 
were kept. Then the harvested cell pellets were kept in the freezer at -80
o
C for at least 
24 hours. Finally the frozen cell pellets were freeze-dried in a freeze-dryer for 24 
hours. 
  
4.3.4 Extraction of polymer  
 
First, the freeze-dried cell pellet was weighed to determine its dry cell weight. Then 
the dry pellet was crushed and dissolved in 30% sodium hypochlorite solution and 
chloroform in a ratio of (1:1). The solution mixture was then incubated at 30
o
C for 2 
hrs at 150 rev min
-1
. Next, the mixture was centrifuged at 5682g for 18 minutes. Three 
different layers were formed. The first layer was a hypochlorite solution, the middle 
layer contained non-P(3HB) cell materials and undisrupted cells. The bottom layer 
was chloroform containing the P(3HB). After removal of the top and middle layer, 
polymer was precipitated from the CHCI3 solution by introducing it into cold chilled 
methanol with continous stirring. Finally, the polymer was dried in an oven at 50
o
C. 
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4.4 Synthesis of P(3HO) using bacterial fermentation2 
4.4.1 Growing bacteria in nutrient broth and production media 
 
P(3HO) production with a two stage seed culture preparation was carried out using 
Pseudomonas mendocina obtained from the Department of Life Sciences, University 
of Westminster (UK). The first seed culture was prepared by inoculating sterile 
nutrient broth using single colony of Pseudomonas mendocina and growing it for 24 
hours in a temperature controlled orbital shaker (Stuart Scientific Orbital Shaker, 
S150) at 30
o
C and at a speed of 200 rev min
-1
. This was then used for inoculating 
sterile P(3HO) production medium to prepare the second stage seed culture. The 
organism was again grown under the same culture conditions of 30
o
C and 200 rev 
min
-1
. The P(3HO) production medium used is a mineral salt medium (MSM) [171] 
which contained (g/l): (NH4)2SO4, 0.4; Na2HPO4, 3.65; KH2PO4, 2.8; MgSO4, 0.5. 
Sodium octanoate and MgSO4 were autoclaved separately and then added aseptically 
to the rest of the medium. The medium also contained trace element solution, (1ml/L), 
whose composition was: CoCl2, 0.218; FeCl3, 9.7; CaCl2, 7.8; NiCl3, 0.118; 
CrCl6.H2O, 0.105; CuSO4.5H2O, 0.156 g in 1 L of 0.1 N HCl. The final pH of the 
medium was 7.  
 
The second seed culture at an optical density (OD) of 3.3 was then used to inoculate 
the final PHA production medium (sterile, MSM media) and it was grown under the 
same culture conditions. The final working volume was 300 ml in 1L flasks and 
incubated for 72 hours in a temperature controlled orbital shaker (Stuart Scientific 
Orbital Shaker, S150) at 30
o
C and at a speed of 200 rev min
-1
.  
4.4.2 Extraction of polymer 
 
Dried bacterial biomass was incubated in a dispersion containing 80% NaOCl and 
CHCl3 in a 1:4 ratio at 30
o
C for 2.30 hours and 150 rev min
-1
. It was then centrifuged 
at 5682g for 18 minutes following which three layers were formed. The topmost layer 
was that of hypochlorite, the middle layer contained the cell debris and the bottom 
layer was the CHCl3 containing the dissolved polymer. Polymer was precipitated out 
by introducing the CHCl3 layer into ice cold methanol with continuous stirring. 
                                               
2
 This experiment was conducted by Ms Ranjana Rai (collaborator from University of Westminster, 
UK) 
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Finally, the polymer was dried at room temperature (25
o
C). An established protocol 
has been developed by the collaborator at the University of Westminster to remove 
the bacterial component present in the polymers in order to reduce contaminations.   
 
4.4.2.1 Removal of bacterial components. 
 
Lipopolysaccharide, LPS is an integral component of the Gram negative bacteria cell 
wall and is pyrogenic in nature.  As P(3HO) is produced from P. mendocina a Gram 
negative bacteria therefore the polymer was subjected to repeated steps of polymer 
purification to remove the co precipitated contaminating LPS.   
The polymer was extracted from the lyophilised bacterial cells using the sodium 
hypochlorite dispersion method and subjected to sequential repeated steps of 
precipitation to remove the LPS as described below: 
1st step precipitation:  A non solvent, 50% each of methanol and ethanol was used. 
2nd precipitation: The polymer was dissolved in CHCl3 and again precipitated in 
chilled methanol. 
3rd precipitation: The polymer was dissolved in acetone and again precipitated in 
methanol 
4th precipitation: The polymer was again dissolved in acetone and preciptated in 50% 
each of methanol and ethanol. 
The endotoxin level in the purified polymer was then quantified using the FDA 
approved Limulus Amebocyte Lysate (LAL) test. The endotoxin level in the purified 
P(3HO) was found to be 7 Endotoxin units gram
-1
. This complies with the endotoxin 
requirements of the FDA for biomedical applications such as implants and drug 
delivery systems [172]. 
 
4.5 Coating of 45S5 Bioglass® scaffolds with PDLLA 
 
The scaffolds were coated with PDLLA by a solution dipping method. The 
dimensions of the sintered 45S5 Bioglass
®
 scaffolds were measured using a digital 
calliper (Mitutoyo, UK) and the weight of the scaffolds was measured using an 
electronic analytical weighing balance (Ohaus, USA). Then, the scaffolds were slowly 
immersed in a solution of 5% wt/v PDLLA-DMC for 2 hours. After 2 hours 
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immersion time, the scaffolds were taken out from the PDLLA-DMC solution and put 
on tissue paper to dry at room temperature for at least 12 hours. Finally, the weight of 
the dried scaffolds was measured using an electronic analytical weighing balance and 
the dimensions were measured using a digital calliper (Mitutoyo, UK). 
 
4.6 Coating of 45S5 Bioglass® based scaffolds with P(3HB) 
and P(3HO) 
 
Bioglass
®
 based scaffolds were coated with P(3HB) and P(3HO) by a suspension –
dipping method. First, the synthesised P(3HB) polymer was dissolved in chloroform 
to make a 5% wt/v solution until the polymer was completely dissolved using a 
magnetic stirrer. Then the dimensions of the scaffolds were measured using a digital 
calliper and the weight of the scaffold was determined using an electric weighing 
balance. After the P(3HB) was completely dissolved, the scaffolds sintered at various 
sintering conditions were slowly immersed in the 5wt% P(3HB)-chloroform solution 
for 2 hours. After 2 hours immersion time, the scaffolds were taken out from the 
P(3HB)-chloroform solution with tweezers and were placed on a tissue paper to dry 
for at least 12 hours in normal air. Finally, the weight of the dried scaffold was 
measured using an electric weighing balance (Ohaus, USA) and the dimensions were 
measured using a digital calliper (Mitotuyo, UK). The same procedure was used for 
P(3HO) polymer coatings with slight different drying process which was of 1 week in 
normal air.  
4.7 45S5 Bioglass® pellets with PDLLA polymer coating 
 
To fabricate cylindrical Bioglass
®
 pellets, 0.3 grams of 45S5 Bioglass
®
 powder were 
poured into a clean stainless steel cylindrical die of 10mm diameter. Then, a plunger 
was inserted into the die and the 45S5 Bioglass
®
 powder was uniformly compacted. 
Next, the die was positioned at the centre of a uniaxial hydraulic press and the valve 
of the press was closed. The pressure was increased to 30-40 MPa and the die was left 
at that pressure for 2 minutes. Then, the valve was opened to release the pressure. The 
pellet of 45S5 Bioglass
® 
was taken out of the die by applying a low pressure. 
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After that, the 45S5 Bioglass
®
 pellets were sintered using the same heat treatment 
program as the one used for 45S5 Bioglass
®
 scaffolds which involved heating to 
550
o
C for 3 hours at a heating rate of 2
o
C/min, and then increasing the temperature to 
1000
o
C at 2
o
C/min for densification, the dwelling time were set at 2 hours. The 
temperature of the furnace was reduced to room temperature at 5
o
C/min prior to the 
pellets being taken out. 
 
Finally, the sintered 45S5 Bioglass
®
 pellets were coated with a solution of 5%wt/v 
PDLLA-DMC by a dip coating method (ratio of solid to coating solution volumes 
being about 1:50) for 2 hours. After 2 hours immersion time, the pellets were taken 
out from the solution with tweezers and were placed on tissue paper to dry for at least 
12 hours in normal air.  
 
4.8 45S5 Bioglass® pellets with P(3HB) and P(3HO) polymer 
coatings 
 
The preparation 45S5 Bioglass
®
 pellets and the sintering conditions were described in 
section 4.7. The sintered pellets were then coated with a solution of 5% wt/v P(3HB)-
chloroform for 2 hours by a dip coating process. After 2 hours completely immersed 
in the P(3HB)-chloroform solution, the pellets were taken out using tweezers and 
were dried in air at room temperature for at least 12 hours. The same procedure was 
followed for coatings with P(3HO) coatings with a slight difference in the drying 
process which was 1 week in this case. 
 
4.9 Preparation of PDLLA fibres on 45S5 Bioglass®pellets 
and scaffolds by electrospinning method 
 
This part of the experiment was designed to develop polymer fibre coated Bioglass
®
 
derived sintered substrates. The process involved the production of polymer fibres by 
electrospinning, an electric field assisted process.  
 
A custom made electrospinning apparatus (developed at Department of Mechanical 
Engineering, UCL (UK)) was used in this study, which is shown schematically in 
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Figure 4.4. First, a 5% wt/v PDLLA-DMC solution was prepared by dissolving 
0.5gram PDLLA in 10ml DMC which was stirred for at least 12 hours using a 
magnetic stirrer. DMC was chosen as the solvent because of its suitable evaporation 
rate during electrospinning. Then, the above prepared PDLLA-DMC solution was 
poured into a 1ml syringe attached to a needle (inner diameter 300µm) and the 
polymer solution was pumped continuously using a specially designed perfusor pump 
(PHD4400, HARVARD apparatus) at various rates in the range 2-10 µl min
-1
. The 
needle was coupled to a high power voltage supply (Glassman, Europe Ltd) capable 
of delivering 30 kV. The flowing solutions were subjected to an applied voltage 
between 8 and 15 kV. 45S5 Bioglass
®
 pellets of 10 mm diameter and 2 mm height 
were processed by cold uniaxial pressing (pressure 30-40 MPa) and sintering at 
1000°C for 2 hours (as described above). These sintering conditions are the same used 
to fabricate 3D porous scaffolds from the same Bioglass
®
 powder. Sintered pellets 
were polished using silicon carbide paper of 1200 grit for 10 minutes. 
 
In a typical experiment, the polished 45S5 Bioglass
®
 pellet was positioned directly 
underneath the tip of the needle at a distance of 15 cm for collection of the PDLLA 
fibres during 5-10 minutes, as schematically shown in Figure 4.4. The 45S5 Bioglass
®
 
scaffolds sintered at 1100
o
C for 2 hours, sintered at 1000
o
C for 2 hours and coated 
with 5wt% PDLLA were also positioned underneath the tip of the needle for 
collection of the PDLLA fibres for 10 minutes, 30 minutes and 2 hours deposition 
time. Finally, the fibre coated 45S5 Bioglass
®
 pellets and scaffolds were kept in a 
dessicator until characterisation was carried out, as detailed below (section 4.10). 
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Figure 4.4  Schematic diagram showing the setting-up of the electro-spinning 
apparatus. (Mech.Eng Department, UCL)  
 
4.10 Materials Characterisation 
 
4.10.1 Physical characteristics of Bioglass® scaffolds 
 
The density of the scaffolds (ρ foam) was determined from the mass and volume of the 
scaffolds before and after coating with PDLLA. The porosities before (P1) and after 
(P2) coatings were determined as follows (Equations 4.1and 4.2): 
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where W1 and W2 are the weight of the scaffolds before and after coating, 
respectively; V1 and V2 are the volume of the scaffolds before and after coating with 
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v
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PDLLA, respectively. The density ρBG = 2.7g/cm
3
 is the theoretical density of 45S5 
Bioglass
® 
and ρPDLLA = 1.26g/cm
3
 is the density of the solid PDLLA (provided by the 
supplier). The same equations were used to determine porosity of P(3HB) and 
P(3HO) coated scaffolds. In this case, ρP(3HB) = 1.21 g/cm
3 is the density of 
P(3HB)[170] and the density of  P(3HO) is ρP(3HO) = 1.06 g/cm
3
.  
 
4.10.2 Microstructural characteristics  
 
The microstructure of the Bioglass
®
 based scaffolds was characterised in a JEOL 
5610LV scanning electron microscope (SEM), before and after coating with 5wt% 
PDLLA, P(3HB) and P(3HO). Samples were gold-coated and observed at an 
accelerating voltage of 10-20 kV.  
 
The energy dispersive X-ray (EDS) spectra (Kα) of Bioglass
®
 pellets coated with 
5wt% PDLLA, 5wt% P(3HO) and 5wt% P(3HB) after immersion in SBF and 1.5 SBF 
(see section 4.10.4) were collected at 10kV in a field emission gun (FEG) SEM 
(Leo15). The data were processed using an INCA (Oxford instruments) program. At 
least 3 measurements were taken for each condition investigated. Selected pellets 
were also characterised using X-ray diffraction (XRD) analysis with the aim to 
investigate the formation of HA crystals on coated Bioglass
®
 pellets after different 
times of immersion in SBF. Data were collected using a Phillips PW1710 
diffractometer over a range of 2θ = 5-70
o
 using a step size of 0.04
o
 and a counting 
time of 2s per step. 
 
The microstructure of the PDLLA fibres deposited by electrospinning on  Bioglass
®
 
pellets, scaffolds and on glass slides was also characterised using the JEOL 5610LV 
SEM. Samples were gold coated and observed at an accelerating voltage of 10-20kV. 
The EDS spectra of the selected PDLLA fibre coated pellets and scaffolds, before and 
after SBF immersion for 7, 14 and 28 days were collected at 10kV in the field 
emission gun (FEG) SEM (Leo 15). XRD analysis was also done using the above 
mentioned parameters with the aim to investigate the formation of HA crystals on the 
samples. 
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4.10.3 Mechanical properties 
 
The compressive strength of the 45S5 Bioglass
®
 scaffolds before and after coating 
with 5 wt% PDLLA, 5 wt% P(3HB) and 5wt% P(3HO) was measured using a 
Zwick/Roell Z010 universal testing machine. The compressive strength of the coated 
and uncoated selected scaffolds after 3 months in SBF was also determined. The 
samples were prismatic in shape, with dimensions: 10mm in height and 5mm x 5mm 
in cross-section. The cross-head speed was set at 0.5mm/min. During compression 
strength test, the load was applied until the compressive strain in (%) reached 70%. 
To make sure that the samples were correctly aligned perpendicularly to the bottom 
and top platens of the compression testing machine, the samples were carefully 
trimmed with a razor blade before being coated with PDLLA, P(3HB) and P(3HO) 
polymer (section 4.5 and 4.6). A Teflon film of 0.05mm thickness was also used to 
cover the bottom and top platens of the testing machine to prevent the samples from 
misalignment. To assess the parallelism of the samples, measurements of the sample 
size were taken at three different points with an error margin of ± 0.001mm. The error 
in measuring the load in this testing machine was assumed to be 5%, according to 
previous studies [53]. SEM images of the fracture surface were taken using a JEOL 
5610LV SEM to evaluate the interaction of the polymer coating with the 45S5 
Bioglass
®
 scaffold strut structure during fracture. 
 
4.10.4 SBF treatment of polymer coated 45S5 Bioglass® pellets and 
scaffolds 
 
1.0 SBF and 1.5 SBF solutions were prepared according to the standard procedure 
introduced by Kokubo et al. [173] (see Table.4.2). The PDLLA, P(3HB) and P(3HO) 
coated 45S5 Bioglass 
®
 pellets (section 4.7 and 4.8) were immersed in 30ml of 1.0 
SBF in a clean centrifuge tube, which had previously been washed with deionised 
water. The PDLLA coated 45S5 Bioglass
®
 pellets were also immersed in the 1.5SBF 
(a more concentrated solution than SBF) to compare the difference in scaffold 
behaviour in the different media. The samples were placed inside an incubator at a 
controlled temperature of 37
o
C. The size of all cylindrical samples was 10mm in 
diameter x 0.2mm in thickness. Samples were extracted from the SBF solution after 1, 
2 and 4 weeks. The SBF was replaced twice a week because the cation concentration 
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changed during the course of the experiment and also to simulate a dynamic flow of 
SBF, as shown in the literature [135]. Once removed from the incubator, the samples 
were rinsed gently with deionised water and left to dry at ambient temperature in a 
dessicator. The same procedure was followed for the PDLLA fibre coated 45S5 
Bioglass
®
 pellets and scaffolds (section 4.9). 
 
Table 4.2 Amounts of reagents used for preparation of 1.0 SBF and 1.5 SBF 
[173] . 
Order Reagent SBF ( 1000ml) 1.5 SBF ( 1000 ml) 
#0 Ultra-pure water 750 750 
#1 NaCl 7.996g 11.994g 
#2 NaHCO3 0.350g 0.525g 
#3 KCl 0.224g 0.336g 
#4 K2HPO4.3H20 0.228g 0.342g 
#5 MgCl2.6H20 0.305g 0.458g 
#6 1N  HCl 40ml 60ml 
#7 CaCl2 0.278g 0.417g 
#8 Na2SO4 0.071g 0.107g 
#9 (CH2OH)3CNH2 6.057g 9.086g 
#10 1 kmol/m
3
 HCl Appropriate amount for adjusting pH to 
7.4 (7.25) at 36.5
o
C. 
 
 
4.10.5 Polymer/Bioglass® bonding strength in composite scaffolds 
 
The bonding strength at the polymer/ceramic interface was evaluated qualitatively 
using a crack indentation method developed by Becher et al. [174] where cracks are 
generated by Vickers indentation and are propagated towards the interface at different 
impingement angles to discern whether they penetrate or are arrested at the interface. 
PDLLA and P(3HB) coated 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
were mounted in resin and polished to a 3µm finish. Vickers hardness indents were 
made in the sintered 45S5 Bioglass
®
 pellets approximately 100µm from the interface 
using a microhardness tester (Zwick/Roell Indentec). Three to five indents were made 
on each sample with loads ranging between 100 and 500g in order to generate corner 
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cracks that would propagate towards the polymer/Bioglass
® 
interface. Crack 
trajectories were examined using optical microscopy and characterised in the JEOL 
5610LV (SEM) to record the incidence angle and the crack path. The crack path, i.e. 
the interfacial deflection or penetration into the polymer, and the interface debond 
length, ldb, were recorded. A schematic diagram showing the expected behaviour is 
shown in Figure 4.5 
 
 
 
Figure 4.5 A schematic diagram showing the crack propagation from a Vickers 
indentation on a sintered Bioglass
®
 pellet (developed using the microhardness 
tester). 
 
4.10.6 White light interferometry (Zygo®)  
 
The surface roughness introduced by the PDLLA fibres on the polished Bioglass
®
 
pellets was characterised by surface topography measurement using the Zygo
®
 white 
light interferometer instrument. White light interferometry is a surface imaging 
technique that uses white light to obtain images of the sample surface [175]. This 
method was used to characterise the sample surfaces before and after PDLLA fibre 
deposition by electrospinning. The quantification of the surface roughness can be 
obtained by using dedicated software connected to the instrument. Rms is one of the 
useful quantitative roughness parameters, which is statistically given by the root-mean 
Crack 
propagation 
direction 
Sintered Bioglass
®
 pellet 
Polymer phase  
Vickers 
indentation 
impression 
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square deviations from a central line on the surface, and it can be expressed by 
Equation 4.3: 
 
               Rms=√ y1
2
+ y2
2
 +…..+ yn
2
/n…           (4.3) 
 
where y1,y2…yn are deviations of n discrete elements from a central line defined as 
the best fit surface selected with the remove control. The remove control is an option 
of the software that permits to remove from the data a surface figure and it is 
fundamental for the data to be meaningful. Rms is an average of the surface 
roughness analysed and therefore it can be considered representative of that particular 
surface. Ra is the average roughness or deviation of all points from a plane fit to the 
test surface, given by the following equation: 
 
                 Ra= y1+y2+…+yn/n…     (4.4) 
 
Where y1, y2….yn are the deviations from the central line selected with the remove 
control and n is the number of discrete elements.  
 
 
4.10.7 Permeability study 
 
The permeability test used to measure the intrinsic permeability of scaffolds (m
2
), as 
shown in Fig. 4.6 was performed at the Aragon Institute of Engineering Research, 
Universidad de Zaragoza, Spain. The experimental procedure will be briefly 
explained. A pressure-induced permeability test was performed using deionized water 
(µ=10
-3
 Pa.s). The fluid was moved with the use of a peristaltic pump and was taken 
from an open reservoir to the air (see Fig. 4.6). Permeability tests were performed 
following the Darcy’s law: 
                    k =  µt Q/ A ∆p                 (4.5) 
 
 
where  k = intrinsic permeability (m
2
) 
            t  = specimen thickness (m) 
           A = cross-sectional area (m
2
) 
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           Q = flow rate (m
3
/s) 
           ∆p = pressure drop (Pa) 
           µ = dynamic fluid viscosity [Pa.s] 
          
The pressure drop was measured between two points at the inlet and outlet of the 
reductor with a pressure meter Digitron 2080P (Digitron Instrumentation). Due to the 
set-up of the test, the measured pressure drop is attributed to the scaffold 
microstructure (∆p) and section change (∆psec). Therefore, the following equation 
can be written: 
                                  
                                      ∆pTotal = ∆p + ∆psec                              (4.6) 
 
with ∆pTotal being the measured pressure drop by the pressure meter and, 
               
                                   ∆psec = 2Q2p/π [1/d1
2
 – 1/d2
2
]
                              
(4.7)
 
 
Two samples, labelled (1) and (2), were tested. The samples were fabricated by the 
standard conditions (sintering temperature of 1100
o
C for 2 hours). Different fluid flow 
regimes were applied controlling the flow rate with the peristaltic pump on the two 
samples of Bioglass
®
 foams. The thickness of the samples were 8.52 and 8.11mm for 
samples (1) and (2), respectively, being in both cases the cross-sectional area A= 
πd2
2
/4. The corresponding ∆p - Q curves were obtained for both samples and the 
intrinsic permeability values were estimated from the acquired data. 
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Figure 4.6 Schematic diagram showing the permeability assay rig used to obtain 
Darcy’s permeability. [176]  
 
4.10.8 Capillary test using calf-serum 
 
This part of the experiment was done at and in collaboration with the Department of 
Materials Science and Chemical Engineering, Polytechnic of Turin, Italy. Calf-serum, 
iron supplemented and originated from fed calves was stored at -20
o
C. It was 
purchased from Sigma-Aldrich. The calf serum was thawed at room temperature until 
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it was melted. A small amount of the calf-serum was then added into double-distilled 
water with a dilution ratio of 30:70. Then, 1.5ml of the diluted calf-serum was 
transferred into a small weighing boat using a plastic pipette for the capillary test. 
45S5 Bioglass
®
 scaffolds sintered at 1000
o
C and 1100
o
C for 2 hours of dimensions 
5mm x 5mm x10 mm were used to perform the capillary test. Red inks drops were 
added to the prepared solution to better observed the capillary-take of the fluid into 
the scaffolds porosity (see Fig. 4.7). The uptake of the calf-serum by the capillary 
action was recorded using a video-camera (see movie in supplementary CD).  
 
 
Figure 4.7 Photograph showing the experimental set-up for the capillary test. 
 
 
4.10.9 Characterisation of P(3HB) and P(3HO) polymers
3
 
4.10.9.1 Structural characterisation  
 
i) Gas Chromatography-Mass Spectrometry, GC-MS  
The PHA monomer was identified by carrying out GC-MS analysis of the 
methanolysed polymer. Methanolysis was carried out as described by Furrer et al. 
[177]. The reaction mixture contained 10 mg of polymer, 1 ml of methylene chloride 
containing 10 mg/ml of 2-ethyl-2-hydroxybutyric acid. The polymer was left to 
dissolve at room temperature for 1 hour. 1 ml of Boron trifloride (BF3) in methanol 
(0.65 M) was also added, after which the tube was tightly sealed, vigorously shaken 
and then heated for 20 hours at 80
o
C. After the reaction, the tubes were cooled on ice 
for 5 min, 2 ml HPLC water was added and the tubes were vortexed for 1 min. After 
                                               
3 Experiment was conducted by Ms Ranjana Rai (collaborator from University of Westminster, UK) 
1cm 
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phase separation, the bottom organic phase was collected, dried over anhydrous 
Na2SO4 and neutralized by adding Na2CO3. It was then filtered and used for carrying 
out the GC-MS study.  
 
4.10.9.2 Physical characterization 
 
i) Crystallinity 
XRD data were collected using a Phillips PW1710 diffractometer over a range 2θ = 5-
70
o
 using a step size of 0.04
o
 and a counting time of 0.05s per step. Crystallinity (%) 
of the polymer was calculated from mathematical modal functions, Gauss and 
Lorentzian functions of the different aged polymer samples.  
ii) Contact angle study 
To evaluate the wettability of the polymer film, static contact angle measurements 
were carried out on 5 wt/v % solvent cast films. An equal volume of water (<10 ml) 
was placed on every sample by means of a gas tight micro-syringe forming a drop. 
Photos (frame interval: 1 s, number of frames: 100) were taken to record the shape of 
the drops. The water contact angles on the specimens were measured by analysing the 
recorded drop images using the Windows based KSVCam software. Six repeats for 
each sample were carried out. The experiment was done on a KSV Cam 200 optical 
contact angle meter (KSV Instruments Ltd). 
iii) Molecular weight analysis  
The molecular weight of the polymer was determined by carrying out gel permeation 
chromatography (GPC) analysis. The eluent used was tetrahydrofuran, THF 
((CH2)4O), 10 mg/ml of polymer solution was introduced into the GPC system at a 
flow rate of 1 ml/min. The eluted polymer was detected with a differential 
refractometer. The data were collected and analysed using Viscotek Trisec 2000 and 
Trisec 3.0 software. 
iv) Thermal properties 
The thermal properties of the polymer, i.e. glass transition temperature (Tg) and 
melting temperature, (Tm), were studied by carrying out differential scanning 
calorimetry (DSC) using a Perkin Elmer Pyris Diamond DSC (Perkin Elmer 
Instrument). The amount of polymer used for the study ranged from 8 to 10 mg. The 
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sample was encapsulated in standard aluminium pans. All tests were carried out under 
inert nitrogen. The samples were heated/cooled/heated at a heating rate of 20
o
C min
-1
 
between -50 and 200
o
C. 
 
4.10.10 In-vitro Assessment-Cell culture4 
 
4.10.10.1   Preparation of chondrocytes cells line (ATDC) 
 
In vitro cell culture studies were carried out on various samples using ATDC 
chondrocyte cell line in-house stock in Eastman Dental Institute at University College 
London. Trypsin, phosphate buffer saline without Ca
2+/
Mg
2+
 (PBS) and low-glucose 
Dulbecco’s modified eagle medium (DMEM) was purchased from PAA The Cell 
culture Company (UK). Cell culture flasks were procured from BD Biosciences 
(Oxford, UK). Penicillin and streptomycin was purchased from Invitrogen (Paisley, 
UK).   
 
The cells were resurrected from their frozen state by thawing them and transferring 
them quickly to centrifuge tubes containing 10 mL of warmed DMEM (supplemented 
with 10% fetal calf serum, 100 U/mL penicillin and 100 µg/mL of streptomycin). The 
cell suspension was centrifuged at room temperature for 3 min at 1000 rpm. The cell 
pellet was carefully re-suspended using 5 mL of DMEM and 2 mL of the re-
suspended cell suspension was added in the tissue culture flasks (gas permeable; 
surface area of 80 cm
2
), followed by adding 8 mL of fresh DMEM. The flasks were 
incubated in a humidified atmosphere, in 5% CO2 and at 37 °C. Spent medium was 
changed every 2 days and the cells were regularly observed using phase microscopy. 
Once the cells were approximately 80% confluent, they were passaged to maintain 
steady growth.  
 
For cell passage, medium was removed from the flask and washed with 5 mL of PBS 
followed by adding 2-3 mL (1 mL/cm
2
) of trypsin/EDTA onto the washed cell 
monolayer and incubated at 37 °C for 2 min. The cells were examined under inverted 
phase microscope to observe the detachment of the cells and 8 mL (3-4x the volume 
                                               
4
  Experiment was conducted in collaboration with Dr.V. Salih (Eastman Dental Institute, UCL, 
London, UK)  
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of trypsin) of fresh DMEM was added to the flask. The cell suspension was then 
centrifuged for 3 min at 1000 rpm. The cell pellet was resuspended using 5 mL of 
fresh DMEM. After that 3 mL of the re-suspended cell suspension was further divided 
into three new flasks (1 mL each) and 9 mL of fresh DMEM medium was added. The 
cells were then further allowed to grow until the required for new experiments. The 
cells were not passaged for more than 3-4 times and were frozen in ampoules and 
stored in liquid nitrogen at -196
o
C for further use. 
 
4.10.10.2  Sterilisation of samples 
 
All the samples (10 mm diameter of pellets and 3D scaffold (5mm in thickness x 
5mm in width x 5mm in length) were sterilised using ultra-violet (UV) light. The 
samples were kept in 24-well microplates and placed under UV for 60 min, having 
been turned once after 30 min. This form of sterilisation was employed in order not to 
affect the chemical or, indeed, physical composition of the materials had more 
conventional methods been employed such as autoclaving, dry-heat sterilisation or 
alcohol treatment. The scaffolds architecture and surface properties seems not change 
due to the treatment with UV light. This is also a common technique of sterilisation 
for tissue engineering scaffolds. However, a more thorough study on the effect of the 
sterilisation to the materials properties will be study for future works. Sterilisation 
was followed by passivating the samples by immersing the samples in 1 mL of the 
cell culture medium (DMEM) and incubating (37 °C, 5% CO2) for 24 h, and then 
followed by cell seeding.  
 
4.10.10.3  Cell proliferation of ATDCs in porous (3D) scaffolds and   
pellets 
i) Cell seeding on substrates 
The semi-confluent ATDC cells were released from the flasks by trypsinisation and 
concentrated by centrifugation (1000 rpm, 3 min). A cell count was performed using 
trypan blue dye and haemocytometer. A seeding density of 20,000 cells/cm
2
 and 
50,000 cells/cm
3
 was used for the films and scaffolds, respectively. The samples were 
seeded with the ATDC cells and all experiments were performed in 24 well 
microplates. Passivated films on pellets were seeded with 25 µl contaning 20,000 
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cells whereas, the 3D scaffolds were seeded with 5 µL (50,000 cells) of DMEM and 
left for 3 h to allow for cell attachment. After this time, 1 mL of fresh DMEM 
medium was added on to the wells containing the scaffolds. The plates were incubated 
in a humidified environment (37°C, 5% CO2) for a period of up to 14 days.  The 
medium of the wells was changed every second day and samples were analysed at 
various time points to measure the cell proliferation. Cell culture studies were carried 
out on triplicates samples per experiment. Standard tissue culture plastic was used as 
the control surface.    
ii) Assessment of proliferation of ATDC 
The proliferation of ATDCs in porous scaffolds was assessed with AlamarBlue at 1, 
4, 7 and 10 days post seeding with the AlamarBlue dye reduction assay. Cell numbers 
were assayed by adding 100 µL (10%v/v) of AlamarBlue to each well for 4 h and 
measuring fluorescence intensity of culture supernatant using absorption at 560nm 
and emission at 590 nm at the selected time point.  
 
4.10.10.4  Preparation of SEM samples 
 
Specimens from Days 1, 7 and 14 were fixed in 3% glutaraldehyde in 0.1 M 
cacodylate buffer for a minimum of 24h at 4 °C. Subsequent dehydration using a 
series of graded ethyl alcohols (50%, 70%, 90% and 100%) was performed. Samples 
were then critical point dried by immersion in hexamethyldisilazane for 1 min and left 
in a fume cupboard for 2 h. The dried samples were then attached to aluminium stubs, 
gold/palladium coated and examined under SEM (JEOL 5610LV, JEOL, USA) at 
various magnifications. 
 
4.10.10.5  Statistics 
 
The in-vitro cellular proliferation tests were performed on six samples for each 
material. Raw data from the study were transferred to SPSS for Windows software 
(version 12.0.1, SPSS, Chicago, Ill) was used for statistical analysis.  
i) Individual Components on 2D surfaces (pellets) 
A three-way analysis of variance (ANOVA) was performed to compare the mean 
values of cell growth between the three days, four materials and six replicates. 
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Because the constant variance assumption was violated in this analysis, it was 
repeated after taking a logarithmic transformation of the data. The assumptions of this 
second ANOVA were checked by a study of the residuals and were satisfied. If a 
main effect (either days or materials) was significant in the ANOVA, a post hoc 
comparison using the Bonferroni correction was employed to assess which means 
differed. A significance level of p < 0.05 was used. 
 
 
ii) Cell proliferation on 3D surfaces (bilayered scaffolds) 
A hierarchical repeated measures ANOVA was performed to compare the mean 
values of cell growth with six replicates nested within each of the three materials 
having repeated measures over the four days. Because there was a significant 
interaction between materials and days, no overall conclusions could be drawn about 
the differences between the means for either materials or days. Instead, a one-way 
analysis of variance was performed to compare the mean values of cell growth for 
each day; if statistically significant, this was followed by post hoc comparisons with 
the Bonferroni correction to assess which two means differed from each other. A 
study of the residuals indicated that the assumptions of the hierarchical repeated 
measures ANOVA and each of the one-way ANOVAs were satisfied. Because of 
multiple testing, a significance level of 0.025 was used instead of the conventional 
0.05 to avoid spuriously significant conclusions.  
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Chapter five 
5 Optimisation of scaffolds by developing 
composite structures 
 
5.1 Introduction  
 
As discussed in Chapter 2, for bone tissue engineering scaffolds must be designed 
such that they mimic the structure and properties of the bone extracellular matrix. The 
strategy followed in this project is to combine biodegradable polymers and bioactive 
glass-ceramics (based on Bioglass
®
) to fabricate composite scaffolds. The intention is 
to mimic the natural bone composite structure which comprises about 60 wt% 
hydroxyapatite (inorganic phase) the rest being organic phase (collagen) and water. It 
is also well known that the fracture behaviour of mineralised tissue such as bone (and 
dentin) is influenced by the optimal interaction of the inorganic and organic phases, 
and toughening mechanisms induced by the presence of collagen fibrils in bone are 
starting to be elucidated [178;179]. Thus, the addition of a polymer phase to a porous 
bioactive glass (or ceramic) scaffold is expected to enhance the fracture toughness of 
the composite and to allow the functionalisation of the surface to induce bioreactivity. 
 
Some of the Bioglass
®
-based foams fabricated in this work are extremely weak 
because they are only partially densified in order to leave residual micropores which 
should be filled by the polymer thus leading to improvement of their mechanical 
properties. It is expected that the fracture toughness of the brittle foams can be 
improved by coating the struts with a polymer layer and achieving penetration of the 
polymer into the residual pores and micro-cracks of the partially sintered struts. 
Previous investigations on dense materials have shown improved mechanical 
properties in interpenetrating polymer/ceramic composites, as compared to monolithic 
brittle ceramics or glasses [128]. However, very few investigations have been 
published on polymer coated ceramic scaffolds for tissue engineering [180]. 
Therefore, in the framework of this thesis, specific biodegradable polymer-coated 
45S5 Bioglass
®
 scaffolds and biodegradable polymer 45S5 Bioglass
®
 scaffolds with 
interpenetrating network microstructures were developed. The purpose of this 
investigation was to produce coatings and interpenetrating network microstructures of 
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45S5 Bioglass
®
 based glass-ceramic scaffolds using a commercially available 
biodegradable polymer (PDLLA) and synthesised natural polymers from Basillus. 
Cereus SPV bacteria (P(3HB)) and Pseudomonas. Mendocina bacteria (P(3HO)). The 
physical and mechanical properties, morphology, microstructure, interfacial properties 
and bioactivity assessment of PDLLA, P(3HB) and P(3HO) coated 45S5 Bioglass
®
 
derived glass-ceramic scaffolds intended for bone tissue engineering will be evaluated 
and compared in this chapter. The experimental details about the materials used and 
detailed information on scaffolds fabrication and polymer coatings procedures have 
been given in chapter four.          
              
5.2 Results 
 
Two series of sintering conditions were carried out to synthesize the partially sintered 
45S5 Bioglass
®
 based glass-ceramic scaffolds, as summarised in Table.5.1  
 
Table 5.1  Processing Condition for 45S5 Bioglass
®
 based glass-ceramic 
Scaffolds. 
Series number Sintering Condition 
900-1100 Sintering Temperature: 900, 930, 950, 970, 1000, 1050 
and 1100
o
C; 
Sintering Time: 2 hours 
1000 Sintering Temperature: 1000
o
C 
Sintering Time:  0, 0.5, 1 and 2 hours. 
 
 
5.2.1 Characterisation of the porous structure of 45S5 Bioglass® 
based scaffold (As-sintered) 
 
The details of the fabrication of the porous scaffolds sintered at different sintering 
conditions (900-1100 and 1000 series) were given in chapter 4 (section 4.2) 
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Figure 5.1 Graph showing the porosities of 45S5 Bioglass
®
 based scaffolds at 
different sintering conditions (900-1100 series). 
 
. 
0.86
0.87
0.88
0.89
0.9
0.91
0.92
0.93
0.94
0.95
0.96
Sintering temperature (
o
C)/time
P
o
ro
s
it
y
1000-0.5hrs 1000-1hr 1000-2hrs
 
Figure 5.2 Graph showing the porosities of 45S5 Bioglass
®
 based scaffolds at 
different sintering conditions (1000 series). 
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The porosities of 45S5 Bioglass
®
 based scaffold prepared by the replication method 
and sintered under different conditions are given in Fig. 5.1 and Fig. 5.2. For 45S5 
Bioglass
®
 based scaffolds sintered from 900
o
C to 1100
o
C at fixed 2 hours sintering 
time (900-1100 series), the porosities are in the range of 80-95%, except for scaffolds 
sintered at 1100
o
C for 2 hours which have porosities in the range of 75-85% (see Fig. 
5.1). The trend showing that porosity decreased with increasing sintering temperature 
can be generally observed for the samples in the 900-1100 series, as expected. The 
figure shows a large scattering of data which is a well known issue when determining 
the porosity of such highly porous structures fabricated by sintering of glass or 
ceramic powders [1]. Certainly a higher number of measurements (samples tested) 
would be required to draw a meaningful quantitative conclusion of statistical 
relevance from this data. Nevertheless the expected trend of porosity decreasing with 
increasing temperature can be expected for the samples in the 900-1000 series.  
 
The porosity of the 45S5 Bioglass
®
 based scaffolds sintered for 1000
o
C at different 
sintering times of 0.5 hrs, 1 hr and 2 hrs (1000 series) should also decrease with 
increasing sintering time, as it is well known from sintering by viscous flow. The 
porosities of the scaffolds (1000 series) were in the range of 88%-95% (see Fig. 5.2). 
As mention above, a much higher number of samples should has been tested to 
identify a clear quantitative trend between sintering condition and porosity, however 
the established decreasing trend of porosity with increasing sintering time seems to 
hold also for this scaffolds series. 
  
There was a scatter of results at each sintering condition for both series, which 
indicates that the porosity of scaffolds fabricated by the foam replica method is very 
sensitive to the parameters of the procedure. The scatter of results might be caused by 
1) initial irregular thickness of the glass coating on the polymer foams during foam 
replica fabrication and 2) inhomogeneous temperature field inside the furnace. 
Typical pore structures of the 45S5 Bioglass
®
 based scaffolds for the 1000 series are 
illustrated in Fig. 5.3. The pore size ranges between 300 and 500µm. 
 
From the SEM images in Fig. 5.3, it can be confirmed that the porosity of scaffolds at 
different sintering times (1000 series) did not change substantially with increasing 
sintering time. Summarising, highly porous scaffolds were produced for both series of 
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sintering conditions, which is an important criterion for the application of these 
structures intended in bone tissue engineering. Moreover, it was confirmed that by 
changing sintering time and temperature, the porosity can be controlled but to a 
limited extent due to the intrinsic variability of the process. 
 
 
 
 
Figure 5.3 SEM images showing the pore structure of 45S5 Bioglass
®
 based 
scaffolds sintered at 1000
o
C for A) 0.5 hours, B) 1 hour and C) 2 hours. The 
magnification for all images is the same (X 50). 
 
 
5.2.1.1 Capillary test  
The experimental details of the capillary test are given in chapter 4 (section 4.10.8) 
  
This test using a bovine calf serum was carried out on selected scaffolds. The test 
showed that porous 45S5 Bioglass
®
 scaffolds sintered at 1000
o
C and 1100
o
C for 2 
hours were able to absorb the serum by capillary action in 1-2 seconds, which was 
A) B) 
C) 
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recorded by a video camera (see Fig. 4.21). Red ink was added to the serum for better 
observation (see movie in supplementary CD). The measurements were repeated 3 
times. The uptake of the bovine serum by capillary action was indicated by the colour 
of the scaffolds, which changed to red during uptake of the liquid. Figure 5.4 (A-D) 
shows summary of the results documented by the video camera. The whole and 
internal parts of the scaffolds were turned to red colour due to the capillary action (see 
Fig. 5.4 C-D). This capillary action indicates that the micropores of the 45S5 
Bioglass
®
 scaffolds sintered at 1000
o
C and 1100
o
C for 2 hours were highly 
interconnected. The results of this capillary test are similar to those of Verne et al. on 
similar silicate based scaffolds [181]. 
  
  
Figure 5.4 Photographs showing the 45S5 Bioglass
®
 derived scaffolds (sintered at 
1000
o
C for 2 hours) before capillary test: A) whole scaffolds and B) internal 
section of scaffolds. Bioglass
® 
derived scaffolds after capillary test (2 seconds 
immersion in bovine calf serum): C) whole scaffolds and D) internal section of 
scaffolds. 
 
5.2.1.2 Permeability test 
The experimental details of the permeability test are given in chapter 4 (section 
4.10.7). 
 
A) B) 
C) D) 
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Permeability is a key parameter for microstructural design of scaffolds, since it is 
related to their capability for waste removal and nutrients/oxygen supply. Darcy’s 
experiments were carried out in order to determine the relationship between the 
pressure drop gradient and the fluid flow velocity in Bioglass
®
-based scaffolds to 
obtain the scaffold’s permeability. Figure 5.5 shows the results for the variation of ∆P 
with Q for two Bioglass
®
 scaffold samples sintered at 1100
o
C for 2 hours. Using 
deionised water as working fluid, the measured average permeability value on 
scaffolds of 90-95% porosity was k = 1.96 x 10
-9 
m
2
. This quantitative value lies in 
the published range of permeability values of trabecular bone. For cancellous bovine 
bone [182], values between k = 2.0 x 10
-9
 and 9.5 x 10
-9
 m
2
 have been reported for 
porosities in the range 80-90%. In addition, values of k = 7.22 x 10
-9
 and 5.13 x 10
-9
 
m
2
 have been found for human cancellous bone of vertebral body and proximal femur, 
respectively, although high variation from these values may be obtained dependent on 
the site region and overall porosity [183]. Li et al. [184] established k = 2.13 x 10
-
10
m
2
 for porous biomaterials of 70% porosity. Thus, it can be confirmed for the first 
time based on the present experiments that there is quantitatively strong resemblance 
between the Bioglass
®
-based scaffold pore interconnectivity and that of trabecular 
bone, via measurement of permeability. 
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Figure 5.5 Relationship ∆p[Pa]–Q for two Bioglass® scaffold specimens (sintered 
at 1100
o
C for 2 hours) tested  in deionised water ( N= two samples tested ). 
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5.2.1.3 Surface functionalisation of 45S5 Bioglass® scaffolds 
 
The details of this experiment are described in chapter 4 (section 4.2.5). Scaffolds 
sintered at 1000
o
C for 2 hours were used. Alkaline phosphatase was chosen as a 
model enzyme to functionalise the surface of 45S5 Bioglass
®
 scaffolds via silane 
group in this study because it is quite simple and relatively low cost, being of interest 
because it promotes bone regeneration and mineralization [185]. The results of the 
ALP specific enzyme activity measurement (using UV-Vis absorbance at 405 nm 
after reaction with p-nitrophenylphosphate) showed that the enzyme ALP was 
successfully bond through chemical bonding, i.e. of the COOH
-
 group of the ALP to 
the NH2 group of the silane (3-aminopropyltriethoxysilane) at 37
o
C, as shown in Fig. 
5.6.  It was also confirmed that the presence of ALP on the silanised 45S5 Bioglass
®
 
scaffolds was in an active state at 37
o
C. The enzymatic activity, where p-
nitrophenylphosphate is hydrolysed by the alkaline phosphatase to produce p-
nitrophenol giving a yellow colour, is shown by equation 5.1. Fig. 5.7 shows a 
photograph of the yellowish coloured functionalized scaffold after reaction with p-
nitrophenylphosphate indicating qualitatively ALP enzyme was successfully attached. 
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Figure 5.6 ALP specific enzymatic activity on silanised 45S5 Bioglass
®
 scaffolds 
(BG-SIL-37-1) as compared to non-silanised scaffolds (BG 37) at 37
o
C.  Values 
are presented by mean ± standard deviation (s.d) for N = 3 samples . 
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Figure 5.7 Photograph showing the yellowish functionalised scaffold (above) as 
compared to the non-functionalised scaffold (below). 
 
5.2.1.4 Optimisation of the binder (i.e. poly-vinyl-alcohol (PVA)) 
for scaffold fabrication using the foam replica method 
 
The possibility of using a cost-effective binder, as opposed to PDLLA, for the 
fabrication of Bioglass
®
 based scaffolds was investigated. The goal of this part of the 
study was to achieve a reduction of the cost of the fabrication without compromising 
the quality of the scaffolds. Two types of binders which are of lower cost than the 
original binder (PDLLA) have been investigated. These binders are gelatine and PVA. 
15wt/v% and 20wt/v% gelatine concentrations were investigated and it was found that 
the mechanical properties of scaffolds (compressive strength) were lower than those 
of scaffolds in which PDLLA was used as a binder. In addition, 0.5wt/v% and 10 
wt/v% of PVA concentrations as binder in the fabrication process were investigated. 
A concentration of 10 wt/v% PVA was found to be the optimal concentration, and 
relevant results will be presented in this section. 
 
1 cm 
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Figure 5.8 Typical pore structure of 45S5 Bioglass
®
 scaffold sintered at 1100
o
C 
for 2 hours using a 10 wt/v% PVA binder in the starting Bioglass
®
 slurry. 
 
Fig. 5.8 shows a typical pore structure of a 45S5 Bioglass
®
 scaffold fabricated using a 
10wt/v% PVA binder. The pore structure of the scaffold is similar to that of scaffolds 
fabricated using PDLLA as a binder (see Fig. 5.3).  
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Figure 5.9 Graph showing the porosities of 45S5 Bioglass
®
 scaffolds sintered at 
different sintering temperature for 2 hours using 10 wt/v% PVA as binder. 
 
The porosities of the scaffolds sintered at various sintering conditions; 950, 1000, 
1050 and 1100
o
C for 2 hours using 10wt/v% PVA as binder are shown in Fig. 5.9. 
The porosity of the sintered scaffolds decreased as the sintering temperature increased 
from 950 to 1100
o
C, as expected. The porosity values are in the range 80-95% 
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depending on the sintering conditions. The porosity range of 80-95% was similar to 
the porosity range of sintered scaffolds using PDLLA as binder (section 5.2.2), which 
is suitable for bone TE applications, as discussed in Chapter 2. 
 
The mechanical properties (compressive strength) of the scaffolds sintered at different 
sintering condition and coated with 5wt/v% PDLLA, as compared to the as-sintered 
samples, are shown in Fig. 5.10. The values of the compressive strength of PDLLA 
coated scaffolds using 10 wt% PVA as binder are between 0.2 and 0.7MPa for 
sintering temperatures between 950 and 1100
o
C and sintering time of 2 hours (see 
Fig. 5.10). This compressive strength values are comparable to the compressive 
strength values of the scaffolds fabricated using PDLLA as binder (similar sintering 
conditions) which will be discussed in the next section.  
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Figure 5.10 Graphs showing the compressive strength (MPa) of the 45S5 
Bioglass
®
 scaffolds sintered at different sintering conditions (temperature-time) 
using a 10 wt% PVA suspension as binder. Values are presented as mean ± 
standard deviation (s.d) where N = 5 samples for as-sintered and N = 5 samples 
for PDLLA coated samples. 
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Figure 5.11 SEM images showing the microstructure of strut cross-section of 
45S5 Bioglass
®
 scaffolds fabricated using 10 wt% PVA suspension as a binder 
sintered at 1000
o
C for 2 hours; A) before coating and B) after coating with 5 
wt% PDLLA.  
 
The microstructure of the as-sintered scaffolds and PDLLA coated scaffolds partially 
sintered at 1000
o
C for 2 hours using 10wt% PVA solution as binder (see Fig. 5.11 A, 
B) also show a similarity with that of scaffolds fabricated using PDLLA as binder 
(same sintering condition) (discussed in the next section). Thus, in the future and for 
the part of the results reported in this thesis, 10 wt% PVA as an optimum 
concentration for the binder in the fabrication of 45S5 Bioglass
®
 scaffolds will be 
considered, which represents an improvement over previous developments [1] due to 
economic considerations. 
5.2.1.5 Effects of concentration of the PDLLA coating solution and 
of immersion time  
 
Details of the PDLLA coating procedures have been given in chapter four (section 
4.5). Different polymer concentrations were used to evaluate the effects of the 
polymer infiltration on partially sintered scaffolds. 2.5 wt% and 5 wt% PDLLA 
concentrations of the coating solution were used. Fig. 5.12 shows the effect of the 
different concentrations of the PDLLA polymer solution to coat partially sintered 
scaffolds. It is obvious that the polymer layer is thinner when using 2.5 wt% PDLLA 
(see Fig. 5.12 A) than when using 5 wt% (see Fig. 5.12 B) which proves that higher 
concentrations can increase the amount of polymer which is coating and infiltrating 
the struts. A very high concentration polymer solution (20 wt%) was also tried but it 
was difficult to infiltrate the micropores with it, and it was seen to block the 
A) B) 
PDLLA 
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macropores. The problem with high concentration of polymer is that a high polymer 
content increases the viscosity of the solution, reducing the fluidity making thus 
difficult to efficiently infiltrate the micropores and macropores of the 3D scaffolds. 
 
   
Figure 5.12. SEM images of the 45S5 Bioglass
® 
scaffolds sintered at 1000
o
C for 2 
hours and immersed in PDLLA solution with different concentration; A) 2.5wt% 
B) 5wt%. 
 
Different immersion time ranges were used to investigate their effects on the quality 
of the polymer infiltrations and coatings. Fig. 5.13 A represents a sample which was 
soaked for 2 hours while the sample in Fig. 5.13 B was immersed for 24 hours. No 
significant difference can be observed. The reason is that after immersing the sample 
in the solution for a while, the pressure inside the cracks reaches a balance with the 
outside pressure and thus the polymer stops flowing into the crevices even with a 
prolonged immersion time. Therefore, for the results reported in this thesis, 5 wt% 
PDLLA concentration and 2 hours immersion time are adopted for the fabrication of 
the coated scaffolds. The same procedure will also be applied with the coating 
procedure using different biodegradable polymers, i.e. P(3HB) and P(3HO), reported 
in this thesis, in section 5.2.4 and 5.2.5, respectively. 
 
A) B) 
PDLLA 
PDLLA 
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Figure 5.13. SEM images of the 45S5 Bioglass
® 
scaffolds sintered at 1000
o
C for 2 
hours and immersed in the 5wt% PDLLA solution at different times; A) 2hours 
and B) 24hours 
 
5.2.2 Characterisation of 45S5 Bioglass® based scaffolds coated 
with PDLLA film 
5.2.2.1 Physical properties of scaffolds of the 900-1100 Series 
 
The results of the compressive strength and porosity of 45S5 Bioglass
®
 based 
scaffolds fabricated at various sintering temperatures of  900, 930, 950, 970, 1000, 
1050 and 1100
o
C  for 2 hours (900-1100 series) after coating with 5 wt% PDLLA 
polymer for 2 hours are shown in Table 5.2. 
 
Table 5.2 Compressive strength values (MPa) and porosity (%) of PDLLA 
coated 45S5
 
Bioglass
®
 based scaffolds of the 900-1100 series. 
Compressive strength values (MPa) and porosity (%) of PDLLA coated samples. 
(900-1100 series) 
 
Sample 
No. 900-2hrs 930-2hrs 950-2hrs 970-2hrs 1000-2hrs 1050-2hrs 1100-2hrs 
0.01  0.20  0.31  0.17  0.37  0.34  0.70  1. 
88% 84% 83% 88% 89% 90% 75% 
0.08  0.17  0.26  0.25  0.29  0.33  0.60  2. 
93% 88% 81% 87% 65% 90% 80% 
0.07  0.18  0.18  0.23  0.28  0.32  0.57  3. 
94% 88% 89% 87% 82% 91% 83% 
0.12  0.12  0.13  0.29  0.31 0.41  0.71  4. 
87% 91% 55% 82% 84% 89% 84% 
0.11  0.24  0.24  0.32  0.28 0.51  0.70  5. 
89% 85% 83% 85% 88% 88% 84% 
6. 0.11  0.25  0.21 0.18  0.25  - 0.58  
A) B) PDLLA PDLLA 
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88% 86% 82% 87% 85% - 84% 
0.13  0.22  0.21  0.21  0.24 - 0.60  7. 
90% 84% 84% 81% 86% - 82% 
- 0.19  0.24  0.27  0.45  - - 8. 
- 85% 85% 82% 85% - - 
- - - - 0.37  - - 9. 
- - - - 86% - - 
- - - - 0.50  - - 10. 
- - - - 83% - - 
- - - - 0.40  - - 11. 
- - - - 86% - - 
 Mean values of compressive strength (MPa) 
 0.09  
± 0.04 
0.20 
± 0.04 
0.22 
± 0.06 
0.24 
± 0.06 
0.34 
± 0.08 
0.38 
± 0.08 
0.64 
± 0.06 
 Mean values of porosity (%) 
  90% 
± 3 
86% 
± 2 
84% 
± 3 
 
85% 
± 3 
 
83% 
± 8 
 
90% 
± 1 
79% 
± 4 
 
Table 5.3 Compressive strength values (MPa) and porosity (%) of as-sintered 
(uncoated) samples of the 900-1100 series. 
Compressive strength values (MPa) and porosity (%) of as-sintered samples 
(900-1100 series) 
Sample 
No. 
900-2hrs 930-2hrs 950-2hrs 970-2hrs 1000-2hrs 1050-2 1100-2hrs 
0.04 0.05 0.04 0.07 0.16 0.11 0.57 1. 
89% 91% 93% 90% 89% 88% 83% 
- 0.02 0.05 0.09 0.13 0.22 0.40 2. 
- 96% 93% 94% 91% 92% 84% 
3. - 0.04 0.10 0.08 0.12 0.13 0.57 
 - 93% 92% 94% 88% 93% 84% 
- 0.04 0.05 0.19 0.09 0.13 0.52 4. 
- 94% 91% 94% 92% 93% 85% 
- 0.03 0.04 0.09 0.09 0.11 0.60 5. 
- 93% 93% 90% 92% 89% 66% 
- 0.04 0.04 0.07 0.07 - 0.80 6. 
- 94% 94% 93% 89% - 73% 
 Mean values of compressive strength (MPa) 
 - 
 
0.04 
± 0.01 
0.05 
± 0.02 
0.10 
± 0.05 
0.11 
± 0.03 
0.14 
± 0.05 
0.58 
± 0.13 
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 Mean values of porosity (%) 
 - 94% 
± 2 
93% 
± 1 
93% 
± 2 
90% 
± 2 
91% 
± 2 
79% 
± 8 
 
 
The effect of porosity on the mechanical properties (compressive strength) of PDLLA 
coated 45S5 Bioglass
®
 based scaffold of the 900-1100 series is shown in the graphs in 
Figure 5.14. 
 
The graphs of compressive strength against porosity  of coated scaffolds fabricated at 
various sintering temperatures (from 900 to 1100
o
C) for 2 hours showed that, in 
general, the compressive strength values decreased as porosity increased (see Fig. 
5.14), as expected. The porosity of the PDLLA coated scaffolds sintered at 900-
1000
o
C for 2 hours is in the range of 80-90%. However, the PDLLA coated scaffolds 
sintered at 1100
o
C for 2 hours have a lower porosity range of 74-85% which could be 
due to higher volume shrinkage at higher sintering temperature. Thus, the 
compressive strength values of the 45S5 Bioglass
®
 based scaffolds strongly depend 
on porosity for scaffolds sintered at: 900, 930, 950, 970, 1000, 1050 and 1100
o
C for 2 
hours. The average porosity reduction of the PDLLA coated samples, as compared to 
the as-sintered scaffolds, for the 900-1100 series was around 7% (see Table 5.2 and 
5.3). The average wt% of polymer incorporated in the struts structure was around 
20wt% calculated based on the difference in the weight of the scaffolds before and 
after drying. 
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Figure 5.14 Graphs showing compressive strength values (MPa) against porosity 
of PDLLA coated 45S5 Bioglass
®
 based scaffolds of the 900-1100 series. 
 
 
 109 
Figure 5.15  Typical microstructures of 45S5 Bioglass
®
 scaffolds sintered at 
1100
o
C for 2 hours: A) before coating, B) after coating, C) strut surface before 
coating and D) strut surface after coating with 5wt% PDLLA. The 
inhomogenous coating due to strut’s roughness is indicated in (D). 
 
Typical pore structures of the 45S5 Bioglass
®
 based scaffolds before and after coating 
with PDLLA for 2 hours are illustrated in Fig. 5.15 (A-B). Highly porous scaffolds 
were produced as shown by the porosity values in Table 5.2 and 5.3 at all sintering 
conditions (900-1100 series). From the SEM images in Fig. 5.15, it can be concluded 
that the PDLLA coating of the scaffolds does not affect significantly the overall 
porosity. It was observed that extensive sintering of 45S5 Bioglass
®
 scaffolds occur at 
1100
o
C for 2 hours, as shown in Fig. 5.15 (C), revealing the partially crystallised 
microstructure of the struts with grain sizes between 0.5 to 2µm. The typical 
morphology of the scaffold strut surfaces coated with PDLLA is shown in Fig. 5.15 
(D). The polymer phase was shown not to homogenously coat the struts surface, as 
indicated by the darker phase (PDLLA) and the lighter phase (45S5 Bioglass
®
), which 
is evident in Fig. 5.15 (D) due to the marked surface roughness of the as–sintered 
 
V 
H 
A) B) 
C) D) 
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scaffolds (Fig. 5.15 C). The coatings become thinner at the hill positions (H) and 
thicker at the valley positions (V), as shown in Fig. 5.15 (D).  
 
5.2.2.2 Mechanical property - microstructure correlation of the 
900-1000 series scaffolds 
 
The relationship between microstructure and mechanical properties of the 900-1000 
series scaffolds is presented in this section. The results of compressive strength (MPa) 
of  PDLLA coated 45S5 Bioglass
® 
scaffolds sintered at 900, 930, 950, 970, 1000, 
1050 and 1100
o
C for 2 hours, compared to the as-sintered values, are summarised in 
the graph in Fig. 5.16.   
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
900-2 930-2 950-2 970-2 1000-2 1050-2 1100-2
Sintering Condition ( Series 1)
C
o
m
p
re
s
s
iv
e
 S
tr
e
n
g
th
 (
M
P
a
)
COATED PDLLA AS
 
Figure 5.16 Graph showing the compressive strength values (MPa) of PDLLA 
coated Bioglass
®
 scaffolds of the 900-1100 series compared with the values of as-
sintered samples. All values are presented as mean ± standard deviations (s.d) 
where N = at least 10 samples (coated samples); N = at least 5 samples (as-
sintered samples). 
 
The graph shows that, in general, there was a gradual increase in the compressive 
strength values of the coated samples as the sintering temperature increased from 
900
o
C to 1100
o
C when compared to the non-coated (as-sintered) samples, 
respectively. The improvement in the compressive strength values after coating with 
PDLLA is probably due to the PDLLA effectively infiltrating into micropores and 
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mirocracks of the partially sintered 45S5 Bioglass
®
 based scaffolds, as mentioned 
above and suggested in the literature [180]. This behaviour will be illustrated by the 
SEM images of the struts microstructure, as presented next, and discussed in detail 
below.  
 
For comparison, the average compressive strength value of the 45S5
 
Bioglass
®
 based 
scaffolds sintered at 1100
o
C for 2 hours was the highest (0.58MPa) due to the fully 
densified strut, e.g. absence of residual porosity in the struts which would weaken the 
material. The microstructure of the scaffold struts at various sintering temperatures in 
the range 900
o
C to 1100
o
C at fixed 2 hours sintering time (900-1100 series) is 
illustrated by the SEM images in Figure 5.17.  
 
From the cross-section view of the microstructure of the struts (as-sintered), it was 
observed that numerous micropores are present in scaffolds sintered at the lower 
sintering temperatures of 900, 930 and 950
o
C (Fig. 5.17 A-C). The microstructure of 
the struts became less porous at the higher sintering temperature of 970, 1000 and 
1050
o
C (Fig. 5.17 D-F). It was also observed that the microstructure of the struts 
sintered at 1100
o
C for 2 hours (Fig. 5.17 G) was fully dense. It should be pointed out 
that the hollow nature of the struts is a common feature of sintered ceramic foams 
synthesised by the polymer-sponge method [186]. 
 
In addition, it was also observed from the microstructure of the struts (as-sintered) 
that extensive sintering of 45S5 Bioglass
®
 particles did not occur at temperatures of 
900 and 930
o
C; sintered for 2 hours. The scaffolds sintered at 900 and 930
o
C were 
indeed very fragile to handle before the coating treatments. However, the scaffolds 
were stronger to handle after coating with 5wt% PDLLA. It was concluded that after 
being infiltrated with the 5wt% PDLLA polymer, the mechanical strength of the 45S5 
Bioglass
®
 based scaffolds sintered at 900 and 930
o
C for 2 hours increased 
significantly when compared to the as-sintered samples (see also Fig. 5.16). 
 
Similarly, the microstructure of the struts of as-sintered uncoated scaffolds sintered at 
950, 970 and 1000
o
C for 2 hours indicated that 45S5 Bioglass
®
 particles were 
partially sintered, as shown in Figure 5.17 A-G. It was also observed on the SEM 
images that the number of micropores in the struts decreased as the temperature 
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increased from 950 to 1000
o
C. It was concluded that the struts became significantly 
denser as the sintering temperature increased from 950
o
C to 1000
o
C. Moreover, after 
coating with 5wt% PDLLA; the compressive strength of the scaffolds sintered at 950, 
970 and 1000
o
C for 2 hours gradually increased due to the infiltration of the polymer 
into the micropores of the struts of the scaffolds (see Fig. 5.16) 
 
For comparison, the microstructure of the struts sintered at 1050 and 1100
o
C for 2 
hours showed a fully densified structure (see Fig. 5.17 F-G). A fully sintered and 
crystallised strut will lead to increased mechanical properties of the scaffolds but it 
could possibly also decrease the bioactivity of the 45S5
 
Bioglass
®
, as discussed in the 
literature [51]. 
 
In conclusion, there is, as expected, a direct relationship between the microstructure 
of the struts and the mechanical properties (compressive strength) of the 45S5
 
Bioglass
®
 based scaffolds for the 900-1100 series both in the as-sintered and coated 
scaffolds. 
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Figure 5.17 SEM images showing the microstructure of Bioglass
®
based scaffold 
struts cross sections before and after coating with 5wt% PDLLA for the 
following sintering conditions: before coating: A) 900
o
C, B) 930
o
C C) 950
o
C, D) 
970
o
C, E) 1000
o
C,  F) 1050
o
C and G) 1100
o
C, sintered for 2 hours ; after coating: 
A1) 900
o
C B1) 930
o
C, C1) 950
o
C, D1) 970
o
C, E1) 1000
o
C, F1) 1050
o
C and G1) 
1100
o
C, sintered for 2 hours. 
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Figure 5.17 Cont. 
 
 
5.2.2.3 Physical analysis of the 1000 series scaffolds  
 
The effect of sintering time at fixed sintering temperature of 1000
o
C on the 
compressive strength values of partially sintered 45S5 Bioglass
®
 scaffolds was also 
investigated. The results of the compressive strength and porosity measurements of 
the PDLLA coated 45S5 Bioglass
®
 based scaffolds sintered at 1000
o
C for 0.5, 1 and 2 
hours (1000 series) are shown in Table 5.4. 
 
 
 
PDLLA 
PDLLA 
F F1 
G G1 
PDLLA 
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Table 5.4 Compression strength values (MPa) and porosity (%) of PDLLA 
coated 45S5
 
Bioglass
®
 based scaffolds of the 1000 series. 
Compressive strength values (MPa) and porosity (%) of PDLLA coated samples 
(1000 series) 
Sample 
No. 
 1000-2hrs 1000-1hrs 1000-0.5hrs 
MPa 0.37 0.33 0.43 1. 
Porosity 89% 86% 84% 
MPa 0.29 0.38 0.32 2. 
 Porosity 65% 82% 84% 
MPa 0.28 0.53 0.47 3. 
Porosity 82% 83% 85% 
MPa 0.31 0.38 0.30 4. 
Porosity 84% 85% 88% 
MPa 0.28 0.23 0.21 5. 
Porosity 88% 89% 88% 
MPa 0.25 0.56 0.43 6. 
Porosity 85% 86% 84% 
MPa 0.24 0.30 0.20 7. 
Porosity 86% 71% 86% 
MPa 0.45 0.22 0.60 8. 
Porosity 85% 99% 70% 
MPa 0.37 0.78 0.15 9. 
Porosity 86% 73% 80% 
MPa 0.5 0.93 0.43 10. 
Porosity 83% 71% 70% 
MPa 0.4 - - 11. 
Porosity 86% - - 
 Mean values of compressive strength (MPa) and porosity (%) 
 MPa 0.34 ± 0.08 0.46 ± 0.24 0.35 ± 0.14 
 Porosity 85% ± 3 84% ± 2 85% ± 2 
 
Table 5.5 Compressive strength values (MPa) and porosity of as-sintered 
samples of the 1000 series 
Compressive strength values (MPa) and porosity (%)  of  as-sintered (uncoated) 
samples (1000 series ) 
Sample 
No. 
 1000-2hrs 1000-1hrs 1000-0.5hrs 
1. MPa 0.16 0.07 0.04 
 Porosity 89% 92% 94% 
2. MPa 0.13 0.08 0.06 
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 Porosity 90% 92% 94% 
3. MPa 0.12 0.10 0.06 
 Porosity 90% 93% 94% 
4. MPa 0.09 0.18 0.05 
 Porosity 92% 79% 95% 
5. MPa 0.09 0.10 0.05 
 Porosity 88% 87% 94% 
 Mean values of compressive strength (MPa) and porosity (%) 
 MPa 0.11 ± 0.03 0.11± 0.06 0.05 ± 0.01 
 Porosity 90% ± 1 89% ± 6 94% ± 4 
 
The effect of porosity on the compressive strength of PDLLA coated scaffolds 
sintered at 1000
o
C for 2, 1 and 0.5 hours is shown in Fig. 5.18 (A-C). 
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Figure 5.18 Graphs showing the relationship between compressive strength 
values and porosity of PDLLA coated scaffolds at different sintering conditions: 
A) 1000
o
C-0.5 hrs, B) 1000
o
C-1hrs and C) 1000
o
C-2hrs. 
 
Fig. 5.18 shows the relationship between compressive strength values and porosity 
values of PDLLA coated scaffolds at different sintering condition (1000 series). The 
c) 
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porosity values for all scaffolds sintered at 1000
o
C fall in the range 80-90% (see Table 
5.4 and 5.5). The graphs generally show the direct correlation between compressive 
strength values and porosity. It is very important to be able to control the porosity of 
the scaffolds in order to achieve smaller standard deviations, however, in the foam 
replica method being investigated here, it is very difficult to completely control the 
processing parameters, as mentioned earlier, and a certain scatter of porosity values is 
always expected [187]. 
 
5.2.2.4 Mechanical property-microstructure correlation in 1000 
series scaffolds 
 
The results of the compressive strength values of the 45S5 Bioglass
®
 based scaffolds 
sintered at 1000
o
C at different sintering times (1000 series) is summarised by the bar 
graph in Figure 5.19. 
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Figure 5.19 Graph showing compressive strength values of scaffolds of the 1000 
series before and after PDLLA coating. All values are presented as mean ± 
standard deviations (s.d) where N = 10 samples (Coated samples); N = 5 samples 
(As-sintered samples).  
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The compressive strength values of the samples coated with 5wt% PDLLA showed a 
significant improvement when compared to the non-coated (as-sintered) samples. In 
general, the compressive strength values increased as the sintering time decreased (see 
Figure 5.19). The increased in compressive strength values as the sintering time 
decreased indicates that higher amounts of polymer can be infiltrated into the partially 
sintered struts because there are more micropores and crevices formed in the partially 
sintered struts at the lower sintering time compared to the higher densification 
achieved for higher sintering time, which was confirmed by SEM investigations as 
discussed next.  
 
SEM images of the microstructure of the scaffold struts, before and after coating, are 
illustrated in Figure 5.20. The cross-section images of the struts microstructure before 
and after coating show that the number of micropores increased as sintering time 
decreased. Therefore, as sintering time decreases, more polymer can infiltrate the 
micropores of the 45S5Bioglass
®
 scaffold, which will lead to improved compressive 
strength values (see Fig. 5.19). SEM observations of the strut walls microstructure for 
all samples (see Fig. 5.21) indicate that the 45S5Bioglass
®
 particles were partially 
sintered, suggesting that the glass particles were not completely softened to form a 
smooth surface by viscous flow. The PDLLA layer (darker phase) seems to infiltrate 
through the micropores of the partially sintered scaffolds which is indicated by the 
lighter phases, as shown by the arrow in Fig. 5.21. 
 
In conclusion, there was a clear qualitative correlation between the microstructure of 
the 45S5 Bioglass
®
 scaffolds sintered at 1000
o
C for 2, 1 and 0.5 hours and the 
scaffolds compressive strength values. 
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Figure 5.20 SEM images showing the microstructure of scaffold strut cross 
sections before and after coating with PDLLA at different sintering conditions of 
scaffolds of the 1000 series. Before coating: A) 0.5 hr, B) 1 hrs and C) 2 hrs; after 
coating: A1) 0.5 hr, B1) 1 hr and C1) 2 hrs. 
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Figure 5.21 SEM images showing the surface morphology of the 45S5 Bioglass
® 
scaffold struts sintered at different sintering times before and after coating with 
5wt% PDLLA. Before coating: A) 0.5 hr, B) 1 hr and C) 2 hrs; after coating: A1) 
0.5 hr, B1) 1 hr and C1) 2 hrs. The arrow indicates infiltration of PDLLA into 
the micropores of the partially sintered scaffold. 
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5.2.2.5 Mechanical properties of PDLLA coated 45S5 Bioglass® 
scaffolds 
 
 
 
 
Figure 5.22  Schematic diagram showing different stages (regimes) of the stress-
strain curve for polymer coated scaffolds. 
 
 
 
Figure 5.23 Typical compressive stress-strain curves of A) an as-sintered 
Bioglass
®
 scaffold and B) a poly(D,L-Lactic acid) coated scaffold. Series 1000 
scaffolds sintered at 2 hours. 
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Figure 5.24 Photographs of scaffolds after compressive strength test (failure): A) 
as-sintered and B) PDLLA coated scaffolds sintered at 1000
o
C for 2 hours. 
 
A schematic diagram showing the expected compressive stress-strain curve of a 
coated scaffold is shown in Figure 5.22 while Figure 5.23 shows actual stress-strain 
curves for coated and uncoated scaffolds.  The typical jagged curves show four stages 
with increasing strain: 1) stress increase (uncoated and coated scaffold), 2) stress 
decrease (uncoated and coated scaffold), 3) plateau (coated scaffold), and 4) 
densification stage (coated scaffolds), are shown in Figure 5.23. The first stage 
represents a linear elastic behaviour followed by a drop of the stress loading, which 
leads to a plateau stage during which the stress remains roughly constant while the 
strain reaches several milimeters depending on the infiltration method, before the 
densification process occurs for coated scaffolds. During loading, with increasing 
stress, the scaffolds are compressed layer by layer. Starting from about 50% 
compression strain, densification of the foams occurs, which is a typical behaviour of 
highly porous scaffolds [1].  
 
The compressive stress-strain curve of the coated scaffolds was less jagged, compared 
with the curve of as-sintered Bioglass
®
 scaffolds. The reduction in jagging could 
indicate that coated scaffolds had fewer microcracks on the surface of the struts. As 
mentioned above, the improvement in mechanical stability is thought to be due to the 
PDLLA coating infiltrating the micropores and microcracks on the strut surfaces. Fig. 
5.24 shows photographs of the scaffolds after compressive strength test. It was 
confirmed PDLLA coated scaffolds can maintain their structure (shape) after failure 
A) B) 
5mm 
 124 
while as-sintered scaffolds were broken into particulates, which qualitatively confirms 
the increased in fracture toughness of the PDLLA coated scaffold. 
 
The improvements in compressive strength and modulus with PDLLA coating were 
significant and the area under the stress-strain curve, which represents the fracture 
energy of the material, also increased with the coated samples. The increased of 
fracture toughness is possibly due to the local fracture of the scaffold struts being held 
together by the polymer layers which have penetrated the microcracks. As crack 
opening progresses, the polymer layers stretch leading to the formation of fibrils 
which can bridge the crack. The fibrils possibly appeared and developed along with 
the crack opening displacement until this reaches a critical value where the polymer 
fibrils will progressively deform (elongate) until their fracture. Thus, the presence of 
the polymer and its deformation makes the material to absorb extra energy before 
complete fracture and this phenomenon is usually more significant under tensile 
loading. This effect is in fact similar to the toughening mechanisms in bone based on 
crack bridging by collagen fibrils, which has been described in the literature [179].
 
The composite scaffold struts, representing thus an interpenetrating microstructure of 
PDLLA and 45S5 Bioglass
®
, exhibits a similar mechanical behaviour to bone. Figure 
5.25 shows the microstructures of the foam struts after fracture in which crack 
bridging (A) and  pull-out (C, D) of the polymeric fibrils can be observed and 
compared with the fracture of bone, which exhibits toughening mechanisms based on 
crack bridging induced  by the collagen fibrils (B). 
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Figure 5.25 SEM images of the PDLLA coated 45S5 Bioglass
®
 based scaffolds 
after fracture: (A) polymer bridging between the crack surfaces, (B) collagen 
fabrils bridging crack in bone [179] ,(C) polymer fibres pulled out at the fracture 
surface (D) partially magnified image of (C). 
 
 
5.2.3 Characterisation of 45S5 Bioglass® sintered pellets coated 
with PDLLA film 
 
5.2.3.1 Interface properties  
 
This part of the investigation on 45S5 Bioglass
®
 pellets coated with PDLLA film was 
carried out to characterise the interface between the polymeric layer and the sintered 
45S5 Bioglass
® 
surface. This interface is easier to characterise on planar surfaces than 
on the coated 3D scaffolds. Optical images of the coated 45S5 Bioglass
®
 pellets 
indicate the presence of a very thin PDLLA film deposited on the pellets surface. The 
thickness of the polymer film coating was determined to be around 10 micron (see 
Fig. 5.26). 
PDLLA fibrils 
Bridging 
PDLLA 
Pulled out 
A B 
C D 
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Figure 5.26 Optical image of PDLLA coating on a 45S5 Bioglass
®
 pellet sintered 
at 1000
o
C for 2 hours.  
 
 
Figure 5.27 SEM image showing crack propagation at the interface between the 
PDLLA coating and the Bioglass
® 
substrate. The crack was formed by 
microindentation at a load of 200g applied at a 50µm distance from the interface, 
on the sintered Bioglass
®
 substrate.  
 
The adhesion strength of the interface between the PDLLA coating and the 45S5 
Bioglass
®
 substrate was determined by applying a load of 200g at a 50µm distance 
from the interface layer using a micro-indenter. Under these testing conditions, a 
microcrack was created which propagated in a controlled manner towards the 
interface. Detachment of the PDLLA layer at the interface, at a ~45
o 
angle between 
the direction of the propagating microcrack and the interface, was observed to occur, 
as indicated by the arrow in Fig. 5.27. This detachment possibly indicates that the 
PDLLA polymer adhesion strength at the interface is not very strong which could also 
possibly explain the formation of bridging fibrils at the surface, as mentioned earlier 
(Fig. 5.25 A). The present assessment of the Bioglass
®
/PDLLA interface is only 
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qualitative. Nevetheless it provides information on the ability of the polymer to 
partially detach from the Bioglass
®
 surface and thus to interpret the toughening 
mechanisms identified during scaffold fracture discussed above. 
 
5.2.3.2 Bioactivity assessment of coated 45S5 Bioglass® pellets and 
scaffolds 
 
i ) Bioactivity analysis in SBF (45S5 Bioglass
®
 pellets) 
 
45S5 Bioglass
®
 pellets were used for the quantitative assessment of the bioactivity of 
PDLLA coated 45S5 Bioglass
®
 composites at different SBF concentrations assuming 
that the PDLLA coatings was homogenous on the planar surfaces. First of all, the 
bioactivity of the 45S5 Bioglass
®
 pellets partially sintered at 1000
o
C for 2 hours and 
coated with 5 wt% PDLLA for 2 hours was investigated in SBF solution for 7, 14 and 
28 days immersion period. 
 
SEM observations and EDS analysis were carried out on the surface of the Bioglass
®
 
pellets after immersion times of 7, 14 and 28 days in SBF. SEM images of the 
selected Bioglass
®
 pellets after immersion in SBF are shown in Fig. 5.28. The images 
showed a different morphology of the surface layer for 7, 14 and 28 days of 
immersion in SBF. The formation of HA-like cauliflower clusters on the surface of 
the coated Bioglass
®
 pellets was clearly observed by SEM after 28 days in SBF (Fig. 
5.28 C-D). The broken area (crack) of the coating, as shown in Fig. 5.28 B, should 
provide a channel for SBF to flow into and come in direct contact with the bioactive 
glass-ceramic substrate. With increasing immersion time in SBF, a large surface area 
of the bioactive glass is being exposed to SBF, and thus the HA-like phase will 
eventually covered the whole surface of the substrate which is indicated by the 
formation of the cauliflower like HA clusters, as shown in Fig. 5.28 (C). At higher 
magnification the HA crystals show the typical needle like structure, as shown in Fig 
5.28 (D) [188]. 
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Figure 5.28 SEM images of surfaces of PDLLA coated pellets sintered at 1000
o
C 
for 2 hours and immersed in SBF for: A) 7, B) 14 and C, D) 28 days, showing 
formation of hydroxyapatite (HA) layers on the surface of the pellets at different 
magnifications. 
 
EDS analyses were done to confirm the elements present on the surface of the coated 
pellets after immersion in SBF. For EDS analysis, 3 measurements were taken and 
typical EDS spectra for each immersion time in SBF are shown in Fig. 5.29. Cr peaks 
in the spectrum were due to the coatings used to prepare the specimens for SEM.  
 
From the EDS analysis, the presence of phosphorus (P) and calcium (Ca) peaks at 
around 2 keV and 3.8keV, respectively, was confirmed at 14 and 28 days. Although 
the analysis is not quantitative, it was determined that the relative intensity of the Ca 
and P peaks increased as the immersion time in SBF increased from 7 to 28 days. A 
high level of carbon was contributed by PDLLA on day 7, and this level decreased as 
the immersion time increased indicating that the PDLLA coating is being covered by 
the HA layer. The EDS analysis of the as-sintered (non-coated) 45S5Bioglass
®
 pellets 
immersed in SBF for 28 days also showed the presence Ca and P peaks.  
A) B) 
C) D) 
HA 
HA 
HA 
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Figure 5.29 EDS spectra of 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
(PDLLA-coated) after immersion in SBF for A) 7, B) 14 and C) 28 days 
compared to a non-coated samples (D) and an as-sintered sample (E). 
 
 Thus, it can be assumed that the bioactivity of the PDLLA coated samples after 28 
days immersion in SBF in terms of HA formation is similar to that of the non-coated 
samples, indicating that PDLLA did not negatively affect the bioactivity of the 45S5 
Bioglass
®
 substrates.  This result is relevant considering the application of PDLLA 
coated Bioglass
® 
based scaffolds in bone tissue engineering. 
A) 
B) 
C) 
D) 
E) 
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XRD analysis was done to confirm the formation of crystalline hydroxyapatite on the 
surface of the PDLLA coated pellets sintered at 1000
o
C for 2 hours after immersion in 
SBF for 7, 14 and 28 days. Results are shown in Figure 5.30. There was an increased 
in the height of peaks at 2θ = 32
o
 and 26
o
, which correspond to HA peaks 
(commercial HA powder), when the immersion time in SBF increased from 7 to 28 
days, as shown in Fig. 5.30.  
 
 
 
Figure 5.30 XRD spectra of PDLLA coated 45S5 Bioglass
®
 pellets sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days, compared to 
the spectrum of commercial crystalline HA. The major peaks of Na2Ca2Si3O9 
phase and hydroxyapatite are marked by (∆) and (●) respectively. 
 
ii) Bioactivity analysis in 1.5 SBF (PDLLA coated 45S5 Bioglass
®
 
pellets) 
 
The bioactivity of selected 45S5 Bioglass
®
 pellets coated with PDLLA was 
investigated in 1.5 SBF for 7, 14 and 28 days immersion period to determine the 
formations of a surface HA layer in comparison with the results in normal SBF. SEM 
and EDS analyses were carried out on the surface of the PDLLA coated Bioglass
®
 
pellets sintered at 1000
o
C for 2 hours. SEM images of the selected Bioglass
®
 pellets 
after immersion in 1.5 SBF for 7, 14 and 28 days ar
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Figure 5.31 SEM images of the surface of 45S5 Bioglass
®
 pellets coated with 
PDLLA sintered at 1000
o
C for 2 hours  after immersion in 1.5 SBF at A) 7, B) 14 
and C, D ) 28 days, showing the different morphologies on the surfaces. 
 
SEM images showed a different surface morphology for 7, 14 and 28 days of 
immersion in 1.5 SBF (see Fig. 5.31). The formation of HA-like crystalline apatite on 
the surface of the coated 45S5 Bioglass
®
 was clearly observed by SEM after 
immersion in 1.5 SBF for 14 days and longer time. At 28 days immersion time, the 
presence of a thick layer of calcium phosphate on the substrates was observed (Fig. 
5.31 C-D).  
 
EDS analyses were carried out to confirm the elements present on the surface of the 
PDLLA coated 45S5 Bioglass
®
 pellets. For EDS analysis, 3 measurements were taken 
and typical EDS spectra for each immersion time in 1.5SBF are shown in Figure 5.32.  
Au and Cr peaks in the spectrum were caused by the gold and chromium coating, 
respectively, used for the SEM-EDS sample preparation. 
 
A) B) 
C) D) 
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Figure  5.32 EDS spectra of 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
(PDLLA-coated) after immersion in 1.5SBF for A) 7, B) 14 and C) 28 days 
compared to a non-coated sample (D) and to an as-sintered sample (E). 
 
From the EDS analysis, the presence of phosphorus (P) and calcium (Ca) peaks at 
around 2 keV and 3.8keV, respectively, was confirmed at 28 days. Although the 
analysis is not quantitative, it can be observed that the intensity of the Ca and P peaks 
increases as the immersion time in SBF increases from 7 to 28 days. A high level of 
carbon was contributed by PDLLA on day 7, and the level decreased as the 
A)  
B) 
C) 
D) 
E) 
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immersion time in 1.5 SBF increased. The EDS analysis of the as-sintered (non-
coated) 45S5Bioglass
®
 pellets immersed in SBF for 28 days also showed the Ca and P 
peaks. Thus it could be assumed that the bioactivity of the coated samples after 28 
days immersion in SBF in terms of CaP formation is similar to that of the non-coated 
samples, indicating that the PDLLA polymer did not negatively affect the bioactivity 
of the 45S5 Bioglass
® 
substrate when immersed in 1.5 SBF.   
 
 
Figure 5.33 X-ray diffraction spectra of PDLLA coated 45S5 Bioglass
®
 pellets 
sintered at 1000
o
C for 1, 0.5 and 0 hrs after immersion for 14 and 28 days in 1.5 
SBF. The major peaks of Na2Ca2Si3O9 phase and hydroxyapatite are marked by 
(∆) and (●) respectively. 
 
XRD analyses of the PDLLA coated 45S5 Bioglass
®
 specimens sintered at different 
sintering times;  0, 0.5, and 1hr, at 1000
o
C (1000 series) after immersion in 1.5 SBF 
for 14 and 28 days were carried out to investigate the kinetic of HA formation, as 
shown in Fig. 5.33. It was observed that as the sintering time decreased, the two major 
peaks of Na2Ca2Si3O9, at 2(θ) = 34
o
 and 35
o 
decreased from 14 to 28 days and from 
sintering time of 1 to 0 hour. The presence of Na2Ca2Si3O9 is typical in bioactive 
glass-ceramics fabricated from Bioglass
®
 by sintering at T>900 °C [53]. Thus, it can 
be assumed that the kinetic of apatite growth is faster as the sintering time is 
decreased from 1 to 0 hours. In addition, when comparing the  HA formation on 
coated pellets sintered at 1000
o
C for 2 hours and immersed in 1Molar SBF solution 
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for 28 days, there was a clear increased of heights of peaks at 2θ = 32
o 
, which 
corresponds to HA peaks [53]. Thus it can be assumed that in PDLLA coated 45S5 
Bioglass
®
-based scaffolds, the bioactivity, e.g. formation of the HA surface layer, will 
be delayed, as shown by XRD spectra in Fig. 5.33, but not suppressed. 
  
Figure 5.34 X-ray diffraction spectra of PDLLA coated 45S5 Bioglass
®
 pellets 
sintered at 1000
o
C for 0 hrs after immersion in 1.5 SBF for 0, 7, 14, 28 and 60 
days as compared to the spectrum for commercial HA. The major peaks of 
Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●) respectively. 
 
XRD analyses were done on PDLLA coated 45S5 Bioglass
®
 pellets sintered at 
1000
o
C for 0 hours and after 0, 7, 14, 28 and 60 days immersion in 1.5 SBF (see Fig. 
5.34) in order to evaluate bioactivity at a longer period of time. There was an absence 
of peaks at 2(θ) = 32
o
 corresponding to typical crystalline HA peaks (compared to 
commercial HA powder) from 7 to 14 days immersion in 1.5 SBF.  However, there 
was an increased of peaks at 2(θ) = 29
o
 corresponding to CaCO3 and a decreased of 
the two major peaks of Na2Ca2Si3O9 at 2(θ) = 34
o
 and 35
o
 from 0 to 60 days 
immersion time in 1.5 SBF. These peaks eventually disappear, leaving a typical halo 
(produced by an amorphous phase) overlapped by the sharp diffraction peaks of the 
HA phase. When immersion time in 1.5 SBF was increased to 28 days, there was an 
increase of the sharp peak at 2(θ) = 32
o
, which corresponds to the HA phase. At a 
longer immersion period of 60 days, there was indication of an increase of the 
amorphous phase, overlapped with sharp diffraction peaks of HA phase. The 
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formation of HA layer observed after 60 days could indicate formation of secondary 
crystalline apatite layer on the surface of an amorphous calcium phosphate when 
immersed in 1.5 SBF in comparison to the formation of primary apatite layer when 
immersed in the normal SBF solution for the same immersion time. Therefore, the 
kinetic of HA formation is faster when immersed in 1.5 SBF as compared to SBF, 
also on PDLLA coated specimen, which is thus confirmed for the first time in the 
present study. 
 
 
iii) Bioactivity analysis of 45S5 Bioglass
®
 composite scaffolds in SBF 
 
Fig. 5.35 shows SEM images of the 45S5 Bioglass
®
 scaffolds sintered at 1000
o
C for 2 
hours and coated with 5 wt% PDLLA after immersion in SBF for 7, 14 and 28 days. 
There was a clear formation of HA crystals on the surface of the scaffolds after 7 days 
immersion in SBF indicated by the cauliflower-like apatite clusters formed on the 
surface of the composite scaffolds (as shown in Figure 5.35 A), almost covering the 
entire 3D scaffolds structure. The formation of the HA clusters on the composite 
scaffolds surfaces increased with immersion time in SBF increasing from 7 to 28 
days, as expected. At higher magnification, a needle-like crystalline morphology of 
HA was observed after 14 days immersion in SBF (see Fig. 5.35 B1-C1). 
 
The results obtained by SEM were confirmed by EDS analysis as shown in Fig. 5.36. 
The morphology of the scaffold surfaces also indicates qualitatively that surface 
roughness has increased due to the HA layer formation from 7 to 28 days immersion 
in SBF (see Fig. 5.36 A-C).  
 
EDS spectra of the scaffolds’ surface at different immersion times of 7, 14 and 28 
days were obtained to confirm the formation of HA, which was indicated by the P and 
Ca peaks at 2keV and 3.8 keV, respectively (see Fig. 5.36 A1 to C1). The Ca/P ratio 
gradually increased, accompanied by a decreased of the Si, Na, C and O peaks with 
increasing immersion time. The Ca/P ratio was determined to be 1.67 at 28 days 
immersion time.  
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Figure 5.35 SEM images of PDLLA coated scaffolds sintered at 1000
o
C for 2 
hours after immersion in SBF at A), A1) 7 days, B), B1) 14 days and C), C1) 28 
days, at different magnifications showing formation of HA. 
 
A 
B 
B1 
C 
C1 
A1 
HA 
HA 
HA 
HA 
HA 
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Figure 5.36 SEM-EDS results for PDLLA coated scaffolds sintered at 1000
o
C for 
2 hours and immersed in SBF:  A, A-1) 7 days,  B, B-1) 14 days and C, C-1) 28 
days, showing formation of hydroxyapatite layers on the surface of the scaffolds.  
 
 
A
B 
C 
A1 
B1 
C1 
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Figure 5.37 XRD spectra of the PDLLA coated 45S5 Bioglass
®
 scaffolds sintered 
at 1000
o
C for 2 hours and immersed in SBF for 7, 14 and 28 days. The peaks of 
hydroxyapatite phase are marked (●) (The peaks of Na2Ca2Si3O9 are not visible)  
 
 
Figure  5.38  XRD spectra of the as-sintered 45S5 Bioglass
®
 scaffolds sintered at 
1000
o
C for 2 hours and immersed in SBF for 7, 14 and 28 days. The major peaks 
of Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), 
respectively. 
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Figure 5.39 XRD spectra of the PDLLA coated 45S5 Bioglass
®
 scaffolds sintered 
at 1100
o
C for 2 hours and immersed in SBF for  7, 14 and 28 days. The major 
peaks of Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), 
respectively. 
 
 
 
 
Figure 5.40 XRD spectra of the as-sintered 45S5 Bioglass
®
 scaffolds sintered at 
1100
o
C for 2 hours and immersed in SBF for 7, 14 and 28 days. The major peaks 
of Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), 
respectively. 
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XRD analysis was done to confirm the formation of HA and to compare the kinetic of 
crystalline hydroxyapatite (HA) formation on the surface of the PDLLA coated 
scaffolds sintered at 1000
o
C and 1100
o
C for 2 hours after immersion in SBF for  7, 14 
and 28 days. There was an increased in the peaks at 2θ = 32
o
, which corresponds to 
HA peaks when the immersion time in SBF increased from 7 to 28 days for coated 
scaffolds sintered at 1000
o
C and 1100
o
C for 2 hours, as shown in Fig. 5.37 and Fig. 
5.39 respectively. However, peaks corresponding to Na2Ca2Si3O9 at 2(θ) = 34
o
 and 
35
o 
are present in the spectra of the scaffolds sintered at 1100
o
C for 2 hours after 7 
days in SBF (see Fig. 5.39). Comparison of Fig. 5.37 with Fig. 5.39 reveals that the 
kinetics of HA formation was faster in the coated scaffolds sintered at 1000
o
C for 2 
hours than in those sintered at 1100
o
C for 2 hours after 1 week of immersion in SBF. 
A comparison was also done using the non-coated scaffolds (as-sintered). Comparison 
of Fig. 5.37 with Fig 5.38 reveals that the kinetics of HA formation at day 7 was faster 
in the PDLLA coated scaffolds than in the non-coated scaffolds sintered at 1000
o
C for 
2 hours. A similar trend was also followed for coated scaffolds sintered at 1100
o
C for 
2 hours at day 7 and day 14. Summarising, XRD analysis shows that coated and 
uncoated scaffolds sintered at 1000
o
C for 2 hours exhibited HA formation after 2 
weeks in SBF. However, the coated and uncoated scaffolds sintered at 1100
o
C for 2 
hours exhibited HA formation only after 4 weeks in SBF. These results therefore 
confirm that PDLLA coated 45S5 Bioglass
® 
based glass-ceramic scaffolds sintered at 
lower sintering temperature have a higher bioactivity when compared to the scaffolds 
sintered at higher sintering temperature of 1100
o
C for 2 hours. This finding is similar 
to previous studies [1]. In addition, coated scaffold also showed an improvement in 
the bioactivity as compared to the non-coated scaffolds. However, this finding is in 
contrast to the results of previous investigations [1]. The previous result may be due 
to the fact that PDLLA was used to coat the outer layer of the dense struts in the 
fabrication of scaffolds and the bulk degradation of PDLLA film is different from the 
degradation rate of PDLLA in a composite. Hence, it is difficult to directly compare 
the present results with previous studies since this is the first time that 
PDLLA/Bioglass
®
 composites with interpenetrating network microstructure has being 
investigated. The results of this study could specifically be due to the interpenetrating 
network of PDLLA/Bioglass
®
 scaffolds. A previous study by Okuno et al. has shown 
that the degradation rate of PLLA in a composite is faster than bulk PLLA. [189] 
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Thus it can be concluded from the SEM, EDS and XRD analyses, that PDLLA 
coatings do not impair the bioactivity of the scaffolds sintered at 1000
o
C for 2hours 
and furthermore the PDLLA incorporated in the interpenetrating microstructure 
improves the kinetic of HA formation.  
 
 
5.2.4 Characterisation of 45S5 Bioglass® scaffolds coated with 
P(3HB) films 
5.2.4.1 Characterisation of synthesised P(3HB) from bacteria 
fermentation 
 
Production of P(3HB) was carried out using bacteria Bacillus Cereus SPV strain 
[190]. The bacteria synthesise and accumulate the P(3HB) as inclusion bodies within 
the bacteria cell cytoplasm under nitrogen limiting conditions in the presence of 
excess carbon source. The synthesised polymer was characterised by GC-MS (Gas 
chromatography-mass spectroscopy) in order to determine the chemical structure of 
the components for each retention time. The chromatogram of methanolysed P(3HB) 
produced in this investigation gave a peak at retention times of 6.81 mins (see Fig. 
5.41). The mass spectra of the compound gave m/z=117 corresponding to methyl 
ester of 3HB (Mw=118). 
 
From the GC (Figure 5.41) and MS analysis (Figure 5.42) it can be confirmed that the 
polymer synthesised is mostly poly(3-hydroxybutyrate) P(3HB) using the library 
match search (Table 5.6). Table 5.6 shows the compounds identified for each 
retention time by the GC-MS analysis for the synthesised methanolysed P(3HB). 
When compared to results reported in the literature the present values showed the 
presence of 3HB monomer in the isolated polymer [190]. 
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Figure 5.41. Chromatogram of the methanolysed P(3HB) produced in this 
investigation showing the peaks of each component separated at different 
retention times. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.42  MS spectra of the methanolysed P(3HB) with a retention time of 
6.81 min.  
 
RT: 0.00 - 24.00
0 2 4 6 8 10 12 14 16 18 20 22
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
e
la
tiv
e
 A
b
u
n
d
a
n
c
e
9.41
105.0
11.30
59.1 14.13
69.0
6.81
43.2
16.31
69.0
4.10
82.9
15.86
69.113.60
69.1
17.71
69.0
18.11
69.0 19.30
207.0
15.01
74.1
10.69
69.1
20.41
207.0
21.33
207.0
4.55
28.2
22.74
207.0
4.93
28.2
7.35
49.0
11.96
44.1
8.24
49.1
NL:
2.94E7
TIC  MS 
05gc196
Methyl-3-
hydroxybutyrate 
05gc196 #331-360 RT: 6.76-7.00 AV: 30 SB: 230 7.99-9.21, 5.81-6.48 NL: 1.13E6
T: {0,0} + c EI det=350.00 Full ms [ 20.00-540.00]
20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
43.1
74.1
45.1
71.1
103.1
87.1
42.1
61.159.1
29.2 31.2 85.1
58.1 75.127.2 100.169.1
46.1 57.1 88.1 104.1 117.026.2 76.1 99.062.2 119.1 129.1 136.1 155.4 193.5162.1142.8 170.2 179.0 187.0
 143 
Table 5.6 Compounds in P(3HB) identified for each retention time (GC-MS 
measurement). 
Retention Time                                            Compound from GC-MS library match 
6.76-7.0 Butyric acid. 3-hydroxy-. Methyl ester        
9.44-9.54  Benzoic acid.methyl ester 
11.27-11.33 Butyric acid, 4-methoxy-, methyl ester 
13.58-13.63 5-Methyl-isoxazolidin-3-one 
 
 
5.2.4.2 Physical analysis of scaffolds of the 900-1100 Series 
 
The results of the compressive strength and porosity of 45S5 Bioglass
®
 based 
scaffolds fabricated at various sintering temperatures of 930, 950, 970, 1050 and 
1100
o
C  for 2 hours (900-1100 series) after coating with 5 wt% P(3HB) polymer for 2 
hours are shown in Table 5.7. 
 
Table 5.7 Compression strength values (MPa) and porosity (%) of P(3HB) 
coated 45S5
 
Bioglass
®
 based scaffolds of the 900-1100 series. 
Compressive strength values (MPa) and porosity (%) of  5 wt% P(3HB) coated scaffolds 
(900-1100 series) 
Sample 
No. 
 930-2hrs 950-2hrs 970-2hrs 1000-2hrs 1050-2hrs 1100-2hrs 
MPa 0.21 0.11 0.49 0.39 0.29 0.43 1. 
Porosity 87% 92% 86% 89% 88% 89% 
MPa 0.31 0.11 0.19 0.21 0.31 0.44 2. 
Porosity 91% 86% 89% 90% 90% 86% 
MPa 0.11 0.15 0.29 0.41 0.39 0.28 3. 
Porosity 87% 88% 89% 87% 87% 89% 
MPa 0.08 0.22 0.29 0.27 0.26 0.95 4. 
Porosity 90% 89% 90% 90% 89% 67% 
5. MPa 0.18 0.16 0.22 0.27 0.29 1.11 
 Porosity 89% 91% 88% 88% 87% 80% 
  Mean values of compressive strength (MPa) and porosity (%) 
 MPa 0.14 
± 0.05 
0.18 
± 0.05 
0.30 
± 0.12 
0.31 
± 0.5 
0.31 
± 0.05 
0.64 
± 0.29 
 Porosity 89% 
± 9 
89% 
 ± 2 
89% 
± 2 
89% 
 ± 1 
88% 
 ± 1 
82% 
± 9 
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Table 5.8 Compressive strength values (MPa) and porosity (%) of as-sintered 
(uncoated) samples of the 900-1100 series. 
Compressive strength values (MPa) and porosity (%) of as-sintered (uncoated) scaffolds 
(900-1100 series) 
Sample 
No. 
 930-2hrs 950-2hrs 970-2hrs 1000-2hrs 1050-2hrs 1100-2hrs 
MPa 0.02 0.05 0.07 0.15 0.22 0.57 1. 
Porosity 96% 93% 94% 89% 91% 83% 
MPa 0.04 0.08 0.09 0.13 0.13 0.40 2. 
Porosity 93% 92% 94% 90% 93% 84% 
MPa 0.04 0.05 0.08 0.12 0.13 0.57 3. 
Porosity 94% 91% 94% 90% 92% 84% 
MPa 0.03 0.04 0.19 0.09 0.11 0.52 4. 
Porosity 93% 93% 90% 92% 91% 85% 
5. MPa 0.04 0.04 0.09 0.09 - 0.60 
 Porosity 94% 94% 93% 87% - 66% 
  Mean values of compressive strength (MPa) and porosity (%) 
 MPa 0.04 
± 0.01 
0.05 
± 0.02 
0.10 
± 0.05 
0.11 
± 0.05 
0.14 
± 0.05 
0.53 
± 0.08 
 Porosity 94% 
± 1 
93% 
± 1 
93% 
± 2 
90% 
± 2 
92% 
± 1 
80% 
± 8 
 
The graphs of compressive strength against porosity of P(3HB) coated scaffolds 
fabricated at various sintering temperatures; from 900 to 1100
o
C, for 2 hours showed 
that, in general, the compressive strength values decreased as porosity increased (see 
Fig 5.43), as expected. The porosity of the P(3HB) coated scaffolds sintered at 900-
1100
o
C for 2 hours is in the range 82-90%. Thus, the compressive strength values of 
the 45S5 Bioglass
®
 based scaffolds strongly depend on porosity for scaffolds sintered 
at: 900, 930, 950, 970, 1000, 1050 and 1100
o
C for 2 hours. Moreover, the average 
porosity of the P(3HB) coated samples is slightly lower than the average porosity of 
the non-coated samples for the 900-1100 series due to the effects of thickening of the 
struts with polymer coating. (see Table 5.7 and 5.8).  
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Figure 5.43 Graphs showing the relationship between the compressive strength 
values and porosity for the 900-1100 series of P(3HB) coated scaffolds. 
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Figure 5.44 SEM images showing 45S5 Bioglass
® 
scaffolds after coatings with 
P(3HB): A)  scaffold pore structure, B) high magnification image showing 
P(3HB) polymer coating of a pore wall, C) strut surface and D) high 
magnification of strut surface. The arrow in (D) indicates Bioglass
®
 particles can 
protrude from the P(3HB) coatings, leading to direct contact of the bioactive 
material and the local environment.  
 
Typical pore structures of the 45S5 Bioglass
®
 scaffolds after coating with P(3HB) are 
illustrated in Fig. 5.44 (A-D). Highly porous scaffolds were produced as shown by the 
porosity values in tables 5.7 and 5.8 at all sintering conditions (900-1100 series). 
From the SEM images (Fig. 5.44), it can be concluded that the P(3HB) coating does 
not affect greatly the porosity ((see Fig 5.44 (A)). However, it was also observed that 
the coating did not homogenously cover the struts of the scaffolds, as shown in Fig 
5.44 (B). The non-homogenous coatings could also due to the hydrophobic nature of 
the polymer. The same observations were made in a previous study [135]. The SEM 
P(3HB) morphology observations show that the polymer exhibits a mesh-like 
structure and a rougher surface than the PDLLA coatings (e.g. see Fig. 5.21 B1), 
possibly due to the rigid and brittle nature of P(3HB) in comparison to PDLLA. The 
A B 
C D 
45S5 Bioglass® 
P(3HB) 
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P(3HB) coating on the struts is seen as the darker phase and the Bioglass
®
 surface is 
observed as the lighter phase (see Fig. 5.44 C-D). It was observed that glass-ceramic 
particles can protrude from the P(3HB) coating due to the mesh-like structure of these 
coatings (see arrow in Fig. 5.44 (D)).  
 
5.2.4.3 Mechanical property- Microstructure correlation in 900-
1100 series scaffolds 
 
The relationship between microstructure and mechanical properties of the 900-1000 
series scaffolds is discussed in this section. The results of the compressive strength of  
P(3HB) coated 45S5 Bioglass
® 
scaffolds sintered at 930, 950, 970, 1000, 1050 and 
1100
o
C for 2 hours compared to the as-sintered values (Table 5.7 and 5.8) are 
summarised in a bar graph, as shown in  Fig. 5.45. 
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Figure 5.45 Graph showing the compressive strength values (MPa) of  P(3HB) 
coated Bioglass
®
 scaffolds of  the 900-1100 series compared with the values of  as-
sintered samples. All values are presented as mean ± standard deviation (s.d) 
where N = 5 samples (Coated samples); N = 5 samples (As-sintered samples)  
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The graph shows that, in general, there was an increased in the compressive strength 
values of the coated samples as the sintering temperature increased from 930
o
C to 
1100
o
C when compared to the non-coated (as-sintered) samples, respectively. The 
improvement in the compressive strength values after coating with P(3HB) film is 
probably due to the (P3HB) infiltrating into micropores and mirocracks of the 
partially sintered 45S5 Bioglass
®
 based scaffolds. This behaviour will be illustrated 
by SEM images of the struts microstructure, as presented next.  
 
At lower sintering temperature partially sintered scaffolds (sintered at temperatures 
between 930
o
C and 1000
o
C for 2 hours) exhibited considerable microporosity which 
has been completely infiltrated by the P(3HB), as shown in Fig. 5.46 A-D. The non-
coated scaffolds (partially sintered) were very fragile to handle before coating. As a 
comparison, scaffolds sintered at higher sintering temperatures of 1050 and 1100
o
C 
for 2 hours showed denser struts and the P(3HB) phase appears as coating in the 
interior of the scaffolds (see Fig. 5.46 E- F). 
 
In conclusion, there was a direct relationship between the microstructure of the struts 
and the mechanical properties (compressive strength) of the 45S5
 
Bioglass
®
 based 
scaffolds for the 900-1100 series of P(3HB) coated and non-coated scaffolds, and this 
correlation, in the case of coated scaffolds, was related to the degree of penetration of 
the polymer into the microcracks and micropores of the partially sintered struts. 
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Figure 5.46 SEM images showing the microstructure of Bioglass
®
based scaffold 
struts (cross sections) after coating with  5wt% P(3HB) for the following 
sintering conditions: A) 930
o
C, B) 950
o
C, C) 970
o
C, D) 1000
o
C, E) 1050
o
C and  F) 
1100
o
C, sintered for 2 hours. 
A) B) 
C) D) 
E) F) 
P(3HB) P(3HB) 
P(3HB) P(3HB) 
P(3HB) 
P(3HB) 
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5.2.4.4 Physical analysis of the 1000 series scaffolds  
The results of the compressive strength and porosity of 45S5 Bioglass
®
 based 
scaffolds at different sintering times of 2, 1 and 0.5 hours (1000 series) after coating 
with 5 wt% P(3HB) for 2 hours are shown in Table 5.9 
 
Table 5.9 Compressive strength values (MPa) and porosity of P(3HB) coated 
45S5
 
Bioglass
®
 based scaffolds of the 1000 series. 
Compressive strength values (MPa) and porosity (%) of P(3HB) coated samples 
(1000 series) 
Sample 
No. 
 1000-2hrs 1000-1hrs 1000-0.5hrs 
1. MPa 0.39 0.27 0.19 
 Porosity 89% 92% 89% 
2. MPa 0.21 0.32 0.22 
 Porosity 91% 90% 90% 
3. MPa 0.41 0.57 0.52 
 Porosity 87% 83% 85% 
4. MPa 0.27 0.39 0.44 
 Porosity 89% 88% 90% 
5. MPa 0.27 0.37 0.15 
 Porosity 87% 84% 89% 
 Mean values of compressive strength (MPa) and porosity (%) 
 MPa 0.31 ± 0.09 0.38 ± 0.09 0.30 ± 0.17 
 Porosity 89% ± 2 87% ± 4 89% ± 2 
 
Table 5.10 Compressive strength values (MPa) and porosity (%) of as-sintered 
(uncoated) samples of the 1000 series. 
Compressive strength values (MPa) and porosity (%) of uncoated samples 
(1000 series) 
Sample 
No. 
 1000-2hrs 1000-1hrs 1000-0.5hrs 
1. MPa 0.16 0.07 0.04 
 Porosity 89% 92% 94% 
2. MPa 0.13 0.08 0.06 
 Porosity 90% 92% 94% 
3. MPa 0.12 0.10 0.06 
 Porosity 90% 93% 94% 
4. MPa 0.09 0.18 0.05 
 Porosity 92% 79% 95% 
5. MPa 0.09 0.10 0.05 
 Porosity 88% 87% 94% 
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 Mean values of compressive strength (MPa) and porosity (%) 
 MPa 0.11 ± 0.03 0.11 ± 0.06 0.05 ± 0.01 
 Porosity 90% ± 1 89% ± 6 94% ± 1 
 
The graphs of compressive strength against porosity of coated scaffolds fabricated at 
various sintering times( 2, 1 and 0.5 hours) at sintering temperature of 1000
o
C showed 
that, in general, the compressive strength values decreased as porosity increased (see 
Fig. 5.47), as expected. The porosity of the P(3HB) coated scaffolds is in the range 
82-90%. Thus, the compressive strength values strongly depend on porosity for 
scaffolds sintered at 1000
o
C. In addition, the average porosity reduction of the 
P(3HB) coated scaffolds as compared to the non-coated samples for the 1000 series is 
around 3% due to thickening of the struts with P(3HB) coating (see Table 5.9 and 
5.10). 
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Figure 5.47 Graphs showing the relationship between the compressive strength 
values and porosity for the 1000 series of P(3HB) coated scaffolds. 
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5.2.4.5 Mechanical property- microstructure correlation in 1000 
series scaffolds  
 
The relationship between microstructure and compressive strength of the 1000 series 
scaffolds is discussed in this section. The results of the compressive strength (MPa) of  
P(3HB) coated 45S5 Bioglass
® 
scaffolds sintered for 2, 1 and 0.5 hours at fixed 
temperature of 1000
o
C compared to the as-sintered values are summarised by the 
graph in Fig. 5.48. 
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Figure 5.48 Graph showing the compressive strength values of scaffolds of the 
1000 series before and after P(3HB) coating. All values are presented as mean ± 
standard deviations (s.d) where N = 5 samples (Coated samples); N = 5 samples 
(As-sintered samples). 
 
The graph shows that, in general, there was a significant increase of the compressive 
strength of the coated samples as the sintering time increased from 0.5 hours to 2 
hours when compared to the non-coated (as-sintered) samples, respectively. The 
improvement in the compressive strength values after coating with P(3HB) is 
probably due to the P(3HB) at least partially infiltrating into micropores and 
mirocracks of the partially sintered 45S5 Bioglass
®
 based scaffolds, as discussed 
above (section 5.2.2.5) for PDLLA coated scaffolds. This behaviour will be illustrated 
by SEM images of strut microstructures, as shown in Fig. 5.49.  
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There is, as expected, a direct relationship between the microstructure of the struts 
and the mechanical properties (compressive strength) of the scaffolds for the 1000 
series both for coated and non-coated scaffolds. 
 
 
 
 
Figure.5.49 SEM images showing the microstructure of scaffold struts cross-
section before and after coating with  5wt% P(3HB) for the following sintering 
conditions: A) 0.5 hrs, B) 1 hrs and C) 2 hours sintered  at 1000
o
C. 
 
The cross-section images of the strut microstructure after coating shows that the 
number of micropores increased as sintering time decreased. Therefore, as the 
sintering time decreased, more polymer can infiltrate the micropores and macropores 
in the centre of the struts (see Fig 5.49 C) (formed from the foam replica fabrication) 
in order to improve the compressive strength. SEM observations of the strut walls 
microstructure for all samples indicate that the 45S5 Bioglass
®
 structure was only 
A) B) 
C) 
P(3HB) 
 
P(3HB) 
P(3HB) 
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partially sintered since the glass particles were not completely softened to form a 
smooth surface by viscous flow at 1000
o
C.  
 
Figure 5.50 Typical compressive stress-strain curves of A) an as-sintered 
Bioglass
®
 scaffold and B) a P(3HB) coated scaffold. Series 1000 scaffolds sintered 
for 2 hours. 
 
Figure 5.51 Photograph of the scaffolds after compressive strength test: A) as-
sintered and B) P(3HB) coated scaffolds sintered at 1000
o
C for 2 hours. 
 
Typical compressive stress-strain curves of uncoated and P(3HB) coated scaffolds are 
shown in Figure 5.50. The compressive stress-strain curve corresponding to coated 
scaffolds was seen to be slightly less jagged compared with the curve of as-sintered 
scaffolds. As mentioned above, the improvement in mechanical stability is thought to 
A) B) 
1cm 
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be due to the P(3HB) polymer infiltrating the micropores and macropores on the strut 
surfaces. Fig. 5.51 shows photographs of scaffolds after compressive strength test for 
the as-sintered (Fig. 5.51 A) and the P(3HB) coated scaffolds (Fig. 5.51 B). The 
(P3HB) coated scaffolds sample is seen to retain some of its original structure after 
failure while the as-sintered scaffold was collapsed into particulates, which 
qualitatively confirms the increased in the fracture toughness of the P(3HB) coated 
scaffold. 
 
The improvements in compressive strength and modulus with P(3HB) coating were 
significant and the area under the stress-strain curve, which represents the work of 
fracture of the material, also increased for the coated samples. As explained above 
(Section 5.2.4.5), the increased of toughness can be ascribed to the polymer phase 
which has infiltrated the micropores and microcracks of the partially sintered 
scaffolds and can induce toughening mechanism such as crack bridging and polymer 
fibril pull-out. Thus, the presence of the polymer will contribute to the material 
absorbing extra energy before fracture which is limited to the plastic deformation of 
the polymer phase. Figure 5.52 shows the microstructure of scaffolds after fracture in 
which polymeric elongated fibrils, bridging cracks can be observed.  
 
 
Figure 5.52 SEM image of the fracture surface of a P(3HB) coated Bioglass
®
 
scaffolds after compressive strength testing, showing P(3HB) polymer fibrils 
formed due to P(3HB) infiltration into micropores.  
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5.2.4.6 Characterisation of 45S5 Bioglass® pellets coated with 
P(3HB) film 
i) Interface properties  
 
This part of the investigation on 45S5 Bioglass
®
 pellets coated with P(3HB) film was 
carried out to study the interface between the polymeric P(3HB) layer and the sintered 
45S5 Bioglass
® 
surface. This interface is easier to characterise on planar surfaces than 
in the coated 3D scaffolds. The pellets were sintered following the same heating 
scheduled used for scaffolds, e.g. the microstructure of the pellets is expected to be 
similar to that of scaffolds, as demonstrated also in the literature [135]. SEM images 
of coated 45S5 Bioglass
®
 pellets indicate a very thin P(3HB) film deposited on the 
pellets surface. The thickness of the polymer film coating was determined to be 
around 6 -7 µm (see Fig. 5.53). 
 
 
Figure 5.53 SEM image of a P(3HB) coated 45S5 Bioglass
®
 pellet sintered at 
1000
o
C for 2 hours.  
 Epoxy resin 
 
P(3HB) 
45S5 Bioglass
® 
pellet 
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Figure 5.54 SEM image showing the crack propagation at the interface between 
P(3HB) layer and 45S5 Bioglass
®
 substrate. The crack was formed using 
microindentation applying a load of 200g at a distance of 50µm from the 
interface. 
 
The adhesion strength between the P(3HB) layer and sintered 45S5 Bioglass
®
 
substrate was determined qualitatively by microindentation, applying on the glass 
substrate a load of 200g at a 50µm distance from the interface. The crack propagation 
was seen to stop at the interface between the P(3HB) (see arrow in Fig 5.54) and 45S5 
Bioglass
®
, indicating that, qualitatively, the P(3HB) polymer adhesion at the interface 
is stronger as compared to that found for PDLLA layers, as discussed earlier ( section 
5.2.3.1). The strong adhesion of P(3HB) to Bioglass
®
 slightly altered the bioactivity 
of the coated pellets, which is discussed next.  
 
ii) Bioactivity analysis of the P(3HB) coated 45S5 Bioglass
®
 pellets  
 
45S5 Bioglass
®
 pellets were used for the quantitative assessment of the bioactivity of 
P(3HB) coated 45S5 Bioglass
®
 pellets at different immersion times of 7, 14 and 28 
days in SBF, considering that the P(3HB) coatings would be homogenous on the 
planar surfaces of the pellets.  
 
P(3HB) 
45S5 Bioglass
® 
pellet 
Epoxy resin 
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Figure 5.55 SEM images of the surfaces of P(3HB) coated pellets sintered at 
1000
o
C for 2 hours and immersed in SBF for A) 7, B) 14 and C,D) 28 days, 
showing the change of surface morphology and formation of hydroxyapatite 
(HA). 
 
The bioactivity of the 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours and 
coated with 5 wt% P(3HB) for 2 hours was investigated. SEM and EDS analyses were 
carried out on the surfaces of the Bioglass
®
 pellets after immersion time of 7, 14 and 
28 days in SBF. SEM images of the selected Bioglass
®
 pellets after immersion in SBF 
are shown in Fig. 5.55. SEM images showed a different morphology for 7, 14 and 28 
days of immersion in SBF. The formation of HA-like crystals on the surface of the 
coated 45S5 Bioglass
®
 pellets was indicated by SEM after 28 days (Fig. 5.55 C). The 
broken areas of the coating at day 7 and 14, as shown in Fig. 5.55 (A, B), should 
provide a channel for SBF to flow into and come in contact with the bioactive 
material. With increasing immersion time in SBF, a large surface area of the bioactive 
glass is being exposed to SBF (see Fig. 5.55 C), and thus HA-like crystals will 
A B 
C D 
HA HA 
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eventually cover the whole surface of the substrate. A similar behaviour was found for 
PDLLA coated specimens (section 5.2.3.2 (i)).  
 
EDS analyses were done to confirm the elements present on the surface of the P(3HB) 
coated 45S5 Bioglass
®
 pellets. For EDS analysis, 3 measurements were taken and 
typical EDS spectra of each immersion time in SBF are shown in Fig. 5.56. Cr peaks 
in the spectrum are due to the conducting coatings used to prepare the sample for 
SEM.  
 
A high level of carbon was contributed by P(3HB) on day 7 and 14, and the level 
decreased as the immersion time increased. From the EDS analysis, the presence of 
phosphorus (P) and calcium (Ca) peaks at around 2 keV and 3.8keV, respectively, 
was confirmed at 28 days. The EDS analysis of the as-sintered (non-coated) 
45S5Bioglass
®
 pellets immersed in SBF for 28 days also showed the Ca and P peaks. 
Thus it could be assumed qualitatively at least, that the bioactivity of the P(3HB) 
coated samples after 28 days immersion in SBF in terms of CaP formation is similar 
to that of the non-coated samples, indicating that the P(3HB) coating did not 
negatively affect the bioactivity of the 45S5 Bioglass
®
.   
 
XRD analysis was done to confirm the crystallinity of the calcium phosphate formed 
on the surface of the P(3HB) coated pellets sintered at 1000
o
C for 2 hours after 
immersion in SBF for 7, 14 and 28 days. There was an increase in the peaks at 2θ = 
32
o
 corresponding to HA peaks (commercial HA powder) when the immersion time in 
SBF increased from 7 to 28 days, as shown in Fig 5.57. A comparison with the XRD 
analysis of PDLLA coated pellets (Fig. 5.30) on scaffolds produced at the same 
sintering conditions reveals that the peaks intensity at 2θ = 32
o
 is higher than in the 
P(3HB) coated pellets (Fig. 5.57) at day 28, indicating that HA formation has 
occurred to a greater extent in PDLLA coated pellets than in  P(3HB) coated pellets. 
This result can be explained by the stronger adhesion exhibited by the P(3HB) coating 
(section 5.2.4.6) on the sintered Bioglass
®
 surface compared to PDLLA (section 
5.2.3.1). The strongly adhered P(3HB) layer reduces the extent of SBF contact with 
the bioactive material leading to a comparatively lower level of HA formation under 
similar conditions.  
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Figure 5.56 EDS spectra of 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
(P(3HB)-coated) after immersion in SBF for A) 7, B) 14 and C) 28 days 
compared to a non-coated sample (D) 
 
A 
B 
C 
D 
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Figure 5.57 XRD spectra of P(3HB) coated 45S5 Bioglass
®
 pellets sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days, as compared 
to the pattern of commercial HA. The major peaks of Na2Ca2Si3O9 phase and 
hydroxyapatite are marked by (∆) and (●) respectively. 
 
 
iii) Bioactivity analysis of the P(3HB) coated 45S5 Bioglass
®
 scaffolds.  
 
45S5 Bioglass
®
 scaffolds sintered at 1000
o
C for 2 hours and coated with 5wt% 
P(3HB) were immersed in 30 ml solution of SBF for 7,14 and 28 days in an incubator 
at 37
o
C. The bioactivity assessment of the coated scaffolds after immersion in SBF 
was characterised by SEM, EDS and XRD which is presented in this section. 
  
Fig. 5.58 shows SEM images of  45S5 Bioglass
®
 based scaffolds sintered at 1000
o
C 
for 2 hours and coated with 5 wt% P(3HB) after immersion in SBF for 7, 14 and 28 
days. There was a clear formation of HA crystals on the surface of the scaffolds after 
7 days immersion in SBF indicated by some cauliflower-like apatite clusters formed 
on the surface of the composite scaffolds (as shown in Figure 5.58 A), almost 
covering the entire scaffolds. The formations of the apatite clusters on the composite 
scaffolds increased as SBF immersion time increased from 7 to 28 days.  
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Figure 5.58 SEM images showing the formation of HA on the 5wt% P(3HB) 
coated  45S5 Bioglass
®
 scaffolds sintered at 1000
o
C for 2 hours after immersion 
in SBF for A) 7 days , B) 14 days and C) 28 days.  
 
The results obtained by SEM were confirmed by EDS analysis as shown in Fig. 5.59. 
The morphology of the scaffold also showed that the surface roughness increased due 
to HA formation from 7 to 28 days of immersion in SBF (see Fig. 5.59 A-C).  
 
 EDS spectra of scaffold surfaces at different immersion times of  7, 14 and 28 days 
were obtained to confirm the formation of HA, which was indicated by the P and Ca 
peaks present at 2keV and 3.8 keV, respectively (see Fig. 5.59 A1 to C1). The Ca/P 
ratio gradually increased, accompanied by a decreased of the Si, Na, C and O peaks 
with increasing immersion time. The Ca/P ratio was found to be 1.60 at 28 days of 
immersion in SBF.  
  
A B 
C 
HA 
HA 
HA 
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Figure 5.59 SEM images and EDS spectra of the surface of P(3HB) coated 
scaffolds sintered at 1000
o
C for 2 hours and immersed in SBF for A, A1) 7, B, 
B1) 14 and C,C1) 28 days, showing formation of hydroxyapatite on the surface of 
the scaffolds. 
 
A) 
B) 
C 
A1 
B1 
C1 
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Figure 5.60 XRD spectra of P(3HB) coated 45S5 Bioglass
® 
scaffolds sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days. The major 
peaks of Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), 
respectively. 
 
 
XRD analysis was done to confirm the formation of crystalline hydroxyapatite on the 
surface of the P(3HB) coated scaffolds sintered at 1000
o
C for 2 hours after immersion 
in SBF for 7, 14 and 28 days. There was an increased in the height of peaks at 2θ = 
32
o
, which correspond to HA peaks, when the immersion time in SBF increased from 
7 to 28 days, as shown in Fig. 5.60. At 7 days, peaks corresponding to the 
Na2Ca2Si3O9 phase at 2(θ) = 34
o
 and 35
o
 were identified. The crystalline phase 
Na2Ca2Si3O9 transformed to an amorphous phase when the coated scaffolds were 
soaked in SBF for 14 days and longer, as expected also from the literature [1]. 
 
Thus, it can be concluded from SEM, EDS and XRD analyses, that P(3HB) coatings 
do not impede the bioactivity of the scaffolds sintered at 1000
o
C for 2 hours coated 
with P(3HB). This finding complements preliminary studies by Bretcanu et al. [135] 
on P(3HB) coated Bioglass
®
 scaffolds sintered at higher sintering temperature of 
1100
o
C for 1 hour.  
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iv) Compressive strength after SBF immersion 
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Figure 5.61 Compressive strength values of PDLLA and P3HB coatead scaffolds 
compared to non-coated scaffolds after SBF immersion. All values are presented 
as mean ± standard deviations (s.d) where N = 7 samples for PDLLA and P(3HB) 
coated samples and N = 7 samples for AS (as-sintered) samples. 
 
Compressive strength tests were carried out on dry scaffolds partially sintered at 
1000
o
C for 2 hours, after immersion in SBF for selected time periods.  It was found 
that the mechanical strength of both PDLLA and P(3HB) coated samples were 
gradually deteriorated after immersion in SBF for 7 days due to the transformation of 
the crystalline phase (Na2Ca2Si3O9) into an amorphous phase, as shown by the XRD 
analysis in Fig. 5.37 and 5.60, respectively. The reduction in mechanical strength is 
not unexpected, considering the fragility of the amorphous structure in comparison 
with the highly crystalline structure of as-coated samples before SBF immersion. 
Nevertheless the compressive strength of P(3HB) coated scaffolds was seen to be less 
deteriorated compared to that of PDLLA coated scaffolds, which could be due to the 
lower degradation rate of P(3HB) in SBF. 
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5.2.5 Characterisation of 45S5 Bioglass® scaffolds coated with 
P(3HO) films 
 
5.2.5.1 Characterisation of poly-3-hydroxyoctanoate P(3HO). 
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Figure 5.62 A) The gas chromatogram for the methanolysis product of PHA 
produced from P. mendocina when grown in octanoate. (B) Mass spectra 
showing molecular ion related mass fragments of octanoic acid 3 hydroxymethyl 
ester.  
 
A) 
B) 
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Gas chromatography and mass spectrometry (GC-MS) was used to identify the 
monomer accumulated from the extracted polymer of P. mendocina grown on 
octanoate using MSM medium. The monomer in the accumulated polymer chain was 
identified as poly-3-hydroxyoctanoate, P(3HO). Mass spectrum of the GC peak at 
retention time 10.69 minutes (Figure 5.62 A) showed the molecular ion-related mass 
fragments due to methyl esters of 3HO with m/z =127 (Figure 5.62 B). 
 
5.2.5.2 Characterisation of 45S5 Bioglass® pellets coated with 
P(3HO) film 
 
i) Bioactivity analysis of P(3HO) coated 45S5 Bioglass
®
 pellets  
 
 
 
Figure 5.63 SEM images of the surfaces of P(3HO) coated pellets sintered at 
1000
o
C for 2 hours and immersed in SBF for A) 0, B) 7 and C)14 and D) 28 days, 
showing formation of hydroxyapatite (HA). 
 
HA 
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Sintered pellets were used for the quantitative assessment of the bioactivity of P(3HO) 
coated 45S5 Bioglass
®
 sintered substrates at different immersion times of 7, 14 and 
28 days in SBF, assuming that the P(3HO) coatings would be homogenous on planar 
surfaces. 
 
SEM images showed a different surface morphology for 0, 7, 14 and 28 days after 
immersion in SBF (see Fig. 5.63). The formation crystalline HA on the surface of  
P(3HO) coated 45S5 Bioglass
®
 pellets was not clearly observed by SEM after 
immersion in SBF for 7 and 14 days. However, the formation of hydroxyapatite 
clusters was clearly observed after immersion in SBF for 28 days. 
 
EDS analyses were done to confirm the elements present on the surface of the P(3HO) 
coated 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours. For EDS analysis, 3 
measurements were taken and typical EDS spectra of each immersion time in SBF are 
shown in Figure 5.64. Cr peaks in the spectrum were caused by the chromium 
coating, used for the SEM-EDS sample preparation. From the analysis, it was shown 
that there was a slight increase in Si, P and Ca after 7 and 14 days immersion time in 
SBF, indicating the surface is covered by the silica gel. The Ca and P peaks increased 
with a decrease of the Si peak after 28 days immersion in SBF, indicating the 
formation of HA on top of the silica gel. Thus these EDS results confirm the 
formation of HA agglomerates and the presence of silica gel layer underneath them. 
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Figure 5.64 EDS spectra of 45S5 Bioglass
®
 pellets sintered at 1000
o
C for 2 hours 
(P(3HO) -coated) after immersion in SBF for A) 0, B) 7 , C) 14 and D) 28 days  
 
 
A) 
B) 
C) 
D) 
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Figure 5.65  XRD spectra of P(3HO) coated 45S5 Bioglass
®
 pellets sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days, as compared 
to the pattern of commercial HA. The major peaks of Na2Ca2Si3O9 phase and 
hydroxyapatite are marked by (∆) and (●), respectively. 
 
 
XRD analysis was carried out to confirm the formation of crystalline HA on the 
surface of the P(3HO) coated pellets sintered at 1000
o
C for 2 hours after immersion in 
SBF for 7, 14 and 28 days. There was an increased in the height of peaks at 2θ = 32
o
 
corresponding to crystalline HA when the immersion time in SBF increased from 7 to 
28 days, as shown in Fig. 5.65. A comparison with the XRD analysis of PDLLA 
coated pellets (Fig. 5.30) fabricated at the same sintering conditions reveals that the 
peaks intensity at 2θ = 32
o
 is higher than that of the P(3HO) coated pellets at day 28, 
indicating that HA formation is enhanced on PDLLA coated pellets in comparison to 
P(3HO) coated pellets. These results can be explained by the higher degradation rate 
of PDLLA in SBF, related to the amorphous nature of PDLLA. A comparison with 
the XRD analysis of P(3HB) coated pellets revealed that the peaks intensity at 2θ = 
32
o
  is about the same, which is related to the slower degradation rate of highly 
crystalline P(3HB) and P(3HO). The rate of degradation will determine the rate at 
which SBF will come in contact with the partially crystallined 45S5 Bioglass
®
 
sintered surface, determining thus the kinetic of HA formation. 
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5.2.5.3 Mechanical property -microstructure correlation in 1000 
series scaffolds coated with P(3HO)  
 
The relationship between microstructure and mechanical properties of the 1000 series 
scaffolds is discussed in this section. The results of the compressive strength (MPa) of  
P(3HO) coated 45S5 Bioglass
® 
scaffolds sintered at 1000
o
C for 2 hours, 1 hour and 
0.5 hours are summarised in Table 5.11 below. 
 
Table 5.11 Compressive strength values (MPa) and porosity of P(3HO) coated 
45S5
 
Bioglass
®
 based scaffolds of the 1000 series. 
Compressive strength values (MPa) and porosity(%) of coated samples 
(1000 series) 
Sample 
No. 
 1000-2hrs 1000-1hrs 1000-0.5hrs 
1. MPa 0.30 0.19 0.18 
 Porosity 84% 84% 84% 
2. MPa 0.30 0.14 0.12 
 Porosity 84% 82% 85% 
3. MPa 0.35 0.15 0.06 
 Porosity 82% 84% 85% 
4. MPa 0.30 0.20 0.08 
 Porosity 85% 83% 85% 
5. MPa 0.20 0.24 - 
 Porosity 86% 82% - 
 Mean values of compressive strength (MPa) and porosity (%) 
 MPa 0.29 ± 0.05 0.18 ± 0.04 0.11 ± 0.05 
 Porosity 84% ± 1.5 83% ± 1 84% ± 0.5 
 
 
Typical pore structures of the 45S5 Bioglass
®
 scaffolds after coating with P(3HO) are 
illustrated in Fig. 5.66. From the SEM images it can be concluded that the P(3HO) 
coating does not affect greatly the porosity (see Fig. 5.66 A). However, it was also 
observed that the coating did not homogenously cover the struts of the scaffolds, as 
shown by Fig 5.66 (B) indicated by the arrow. Similar behaviour is observed for 
PDLLA coatings, as described previously in section 5.2.2.1. This non-homogenous 
coating is due to the uneven surface of the scaffolds. At higher magnification, the 
polymer (darker phase) is seen to infiltrate the macropores of the partially sintered 
 172 
struts (lighter phase) as shown in Fig. 5.66 C. Fig. 5.66 D shows that P(3HO) filled 
the micropores of the partially sintered Bioglass
®
 particles leaving however some 
open micropores on the struts. 
 
 
Figure 5.66  SEM images showing the 45S5 Bioglass
® 
scaffolds after coating with 
P(3HO) at different magnifications. The presence of a non-homogenous coating 
is indicated by the arrow in (B). 
 
 
 
 
 
A B 
C D 
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Figure 5.67  SEM images showing the microstructure of Bioglass
® 
based scaffold 
strut cross sections before and after coating with 5wt% P(3HO) for the following 
sintering conditions: A) 2 hrs and B) 1 hr sintered  at 1000
o
C. 
 
 
SEM images of the microstructure of the scaffold strut cross-section after coating with 
5wt% P(3HO) are illustrated in Figure 5.67. The cross-section images of the struts 
microstructure after coating show that the number of micropores increased as 
sintering time decreased. Therefore, as the sintering time decreased, more polymer 
can infiltrate the micropores of the 45S5 Bioglass
®
 scaffold, which will have a 
positive effect on the overall scaffold toughness (see Fig. 5.68). The  P(3HO) polymer 
coatings seem to be thinner than the P(3HB) coatings discussed earlier because in this 
case the polymer has efficiently filled and covered most of the micropores and 
microcracks present in the partially sintered scaffolds, therefore leaving no excess 
polymer at the macropores level and on the surface of the struts. 
A B 
P(3HO) 
P(3HO) 
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Figure 5.68 Typical compressive stress-strain curves of A) as-sintered Bioglass
®
 
scaffold and B) a P(3HO) coated scaffold. Series 1000 scaffolds sintered at 2 
hours. 
 
 
Figure 5.69 Photographs of the scaffolds after compressive strength test: A) as-
sintered and B) P(3HO) coated scaffolds sintered at 1000
o
C for 2 hours. 
 
Typical compressive stress-strain curves of uncoated and P(3HO) coated scaffolds are 
shown in Figure 5.68. The jagged curves show the four regimes discussed above with 
increasing strain: 1) stress increase (uncoated and coated scaffold), 2) stress decrease 
(uncoated and coated scaffold), 3) plateau (coated scaffold) and 4) densification stage 
(coated scaffolds). Following the discussion above, the improvement in mechanical 
integrity of the scaffold is thought to be due to the P(3HO) coating efficiently 
infiltrating the micropores and microcracks in the struts. The compressive stress-strain 
A B 
0. 5 cm 
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curve of the coated scaffolds was less jagged compared with the curve of as-sintered 
scaffolds. Moreover, comparing with the stress-strain curve of P(3HB)(Fig. 5.50) and 
PDLLA (Fig. 5.23) coated scaffolds, as presented above, the trace for P(3HO) coated 
scaffolds is seen to be less jagged than that of P(3HB) but has a similar pattern to that 
of PDLLA coated scaffolds. In addition, the work of fracture, i.e, the area under the 
stress-strain curve for P(3HO) is slightly higher than that for PDLLA and P(3HB) 
coated scaffolds due to higher plateau level of the P(3HO) coated scaffolds (Fig. 5.68) 
compared to those of PDLLA (Fig. 5.23)  and P(3HB) coated scaffolds (Fig. 5.50) of 
similar compressive strength values (measured at 5% strain). This behaviour is 
suggested to be due to more efficient infiltration of the P(3HO) polymer into the 
micropores and crevices of the partially sintered scaffolds compared to PDLLA and 
P(3HB). This result could be due to both the elastomeric nature of the P(3HO) 
polymer and the higher wettability property (i.e. lower contact angle) of P(3HO) in 
comparison with PDLLA and P(3HB), as shown in Table 4.1. The level of plateau 
also depends on the quantity of polymer phase inside the scaffolds [83]. In addition, in 
the second stage of the curve, the drop in stress loading is not abrupt but progressive, 
indicating that continous damage occurs in the structure, as compared to the sudden 
drop in stress with P(3HB) coated samples sintered at the same condition, which 
could be due to non-homogenous coatings and lack of extensive plastic deformation 
of P(3HB) (see Fig. 5.50), compared to P(3HO). 
 
Fig. 5.69 shows photographs of scaffolds after compressive strength test for the as-
sintered (5.69 A) and the P(3HO) coated scaffolds (5.69 B). The (P3HO) coated 
scaffolds is seen to retain its original structure (shape) after failure while the as-
sintered scaffold was broken into particulates, which qualitatively confirms the 
significant increase in the toughness of the P(3HO) coated scaffold (see movie in 
supplementary CD). This behaviour is similar to PDLLA coated scaffolds, as 
described in section 5.2.2.5 and qualitative better than that of P(3HB) coated scaffold. 
 
The improvement in compressive strength with P(3HO) coating was significant and 
the area under the stress-strain curve, which represents the work of fracture of the 
material, also significantly increased for the coated samples. As explained above, the 
expected increase of fracture toughness can be ascribed to the presence of the polymer 
phase which has infiltrated the micropores and microcracks of the partially sintered 
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scaffold. Thus, the presence of the deformable polymer will contribute to the material 
absorbing extra energy before fracture. Figure 5.70 shows the microstructure of a 
scaffold after fracture in which the polymeric fibrils bridging cracks can be observed. 
This effect is in fact similar to the toughening mechanisms in bone based on crack 
bridging by collagen fibrils [179] The fibrils bridging the crack in P(3HO) coated 
scaffolds are seen to be slightly longer than PDLLA  (Fig. 5.25 A) and P(3HB) fibrils 
(Fig. 5.52), as described above, due to the elastomeric property (higher flexibility) of 
P(3HO).  
 
Figure 5.70 SEM image of the fracture surface of a P(3HO) coated Bioglass
®
 
scaffold after compressive strength testing, showing P(3HO) polymer fibrils 
formed due to efficient P(3HO) infiltration into micropores (arrows). 
 
5.2.5.4 Bioactivity analysis in SBF  
 
SEM-EDS spectra of scaffold surfaces at different immersion times of  7, 14 and 28 
days in SBF were obtained to confirm the formation of HA, which was indicated by 
the P and Ca peaks at 2keV and 3.8 keV, respectively (see Fig. 5.71 A1 to C1). The 
Ca/P ratio is non-stoichoimetric after 28 days, which indicates that the formation of 
HA on the surface of P(3HO) coated scaffold was delayed as compared to PDLLA 
and P(3HB) coated scaffolds. The surface of the P(3HO) coated scaffolds seems less 
rough than the surface of PDLLA and P(3HB) coated scaffolds due to the lower 
extent of formation of HA. This result could be due to a lower degradation rate of 
P(3HO), thus fewer microcracks and crevices form during immersion in SBF for the 
direct contact of the fluid with bioactive glass and for activation of the ion exchange 
processes. 
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Figure 5.71 SEM images and EDS spectra of the surface of P(3HO) coated 
scaffolds sintered at 1000
o
C for 2 hours and immersed in SBF at A, A1) 7, B, B1) 
14 and C, C1) 28 days showing formation of hydroxyapatite layers on the surface 
of the scaffolds. 
 
A 
B 
C 
A1 
B1 
C1 
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XRD analysis was done to confirm the formation of crystalline hydroxyapatite on the 
surface of the P(3HO) coated scaffolds sintered at 1000
o
C for 2 hours after immersion 
in SBF for 7, 14 and 28 days (see Figure 5.72). There was an increased in the height 
of the peak at 2θ = 32
o
, which correspond to the HA peak, when the immersion time 
in SBF increased from 7 to 28 days, as shown in Fig. 5.72. At 7 days, peaks 
corresponding to Na2Ca2Si3O9  (at 2(θ) = 34
o
 and 35
o
) were identified, which indicate 
the cystallinity of the
 
 partially sintered scaffolds coated with P(3HO). The crystalline 
phase Na2Ca2Si3O9 transformed to an amorphous or weakly crystalline calcium 
phosphate phase when the coated scaffolds were soaked in SBF for 14 days and 
longer, according to the literature [53].  
 
Thus, it can be concluded from the SEM, EDS and XRD analyses, that P(3HO) 
coatings do not impede the bioactivity of the Bioglass
®
 based scaffolds sintered at 
1000
o
C for 2 hours coated with P(3HO).  
 
 
 
Figure 5.72 XRD spectra of P(3HO) coated 45S5 Bioglass
®
 scaffolds sintered at 
1000
o
C for 2 hours and immersed in SBF for 0, 7, 14 and 28 days. The major 
peaks of Na2Ca2Si3O9 phase and hydroxyapatite are marked by (∆) and (●), 
respectively. 
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5.3 Discussion 
 
In this section, the results of the investigation on the novel family of scaffolds 
developed in the framework of this project are discussed in relation to mechanical 
properties, microstructure and bioactivity in the wider context of available bioactive 
bone tissue scaffolds. 
5.3.1 Comparison of the compressive strength of 45S5 
Bioglass®/Polymer composite scaffolds with spongy bone 
and with previous investigations 
 
Scaffolds produced by the foam replication method are very similar to spongy bone 
(also called cancellous bone) in terms of their pore structure. The partially sintered 
45S5 Bioglass
®
 scaffolds prepared using polymer sponge as porogen exhibit a highly 
porous structure with large pore sizes (300-500µm) combined with high porosity (85-
90%) and high pore interconnectivity, as shown by the results of the capillary test in 
Section 5.2.1.1 and permeability test in Section 5.2.1.2. High porosity and pore 
interconnectivity should permit sufficient tissue ingrowth and vascularisation into the 
scaffolds in in-vivo applications. PDLLA, P(3HB) and P(3HO) coatings of the 
partially sintered 45S5 Bioglass
®
 scaffolds did not significantly decrease the pore 
size, porosity or pore interconnectivity of the original scaffolds. In addition, XRD 
analysis indicated that PDLLA and P(3HB) coatings did not change the crystal phase 
composition of 45S5 Bioglass
®
 scaffolds, as shown in Fig. 5.30 and 5.57, 
respectively.  
 
In this investigation, PDLLA, P(3HB) and P(3HO) coatings were found to 
significantly improve the compressive strength and compressive modulus of the 
partially sintered 45S5 Bioglass
®
 scaffolds, as compared to the non-coated scaffolds. 
The correlation between strain-stress behaviour and microstructure of scaffolds was 
dicussed earlier in Sections 5.2.2.5, 5.2.4.5 and 5.2.5.3. There are many reports on the 
mechanical strength of cancellous bone [191]. The compressive strength of spongy 
bone (not the strut) is in the range of 0.2-4 MPa, when the relative density is ~ 0.1 
[192]. The measured compressive strength values of the partially sintered composite 
scaffolds (0.3-0.4 MPa) and of the fully sintered composite scaffolds (0.5-0.6MPa) 
coated with PDLLA, P(3HB) and P(3HO) fall in this range, but lie closer to the lower 
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bound. These values are also consistent with data reported in the literature on similar 
coated scaffold materials [1;135]. Previous studies have shown that the compressive 
strength of PCL coated hydroxyaptite scaffolds of similar porosity range to those 
studied here (porosity 84%-89%) fabricated via sponge replica method was ~ 
0.03MPa [133]. Compressive strength data of porous HA-based scaffolds reported in 
literature [8;133] have been collected and the values are always lower than 0.3MPa. 
The compressive strength of the present scaffolds is higher than that of HA-based 
scaffolds of similar porosities. From this investigation, it is shown that a compressive 
strength of 0.3-0.4 MPa (partially sintered scaffolds coated with PDLLA, P(3HB) and 
P(3HO)) is sufficient for the scaffolds to be handled for SBF test and for safe cutting 
of the samples for mechanical tests, compared to scaffolds without polymer coatings, 
which are extremely weak and brittle (0.04-0.14 MPa). In addition, it has been 
reported that the compressive strength of HA scaffolds significantly increases [193] 
due to tissue in-growth in vivo. It has also been speculated that it might be not 
necessary to fabricate a scaffold with a mechanical strength equal to that of bone 
because cultured cells on the scaffolds and new tissue formation in vivo will create a 
biocomposite (e.g. by collagen secreted by cells) increasing the time-dependent 
strength of the scaffolds significantly [17].  
 
An ideal scaffold should have at least a proper compression strength and fracture 
toughness to allow it to be manipulated adequately for tissue engineering applications. 
The present polymer coated 45S5 Bioglass
®
 composite scaffolds possess such suitable 
mechanical competence, in term of toughness, when the polymer phase (i.e. PDLLA, 
P(3HB) or  P(3HO)) has infiltrated the micropores and microcracks of the partially 
sintered scaffolds. A uniform and continous polymer network can be introduced in the 
scaffold struts, which prevents it from collapsing due to an interlocking mechanism 
provided by the ductile polymer phase. In addition, our investigations showed that 
during fracture, a micron-scale crack-bridging mechanism occurs by polymer 
ligament stretching upon crack opening along the crack wake. This effect is similar to 
the toughening mechanism in bone based on crack bridging by collagen fibrils [179]. 
Hence, in principle, the composite systems investigated here mimic the natural bone 
in terms of fracture behaviour. To the author’s knowledge, there is no fracture 
toughness data available for cancellous bone. The proposed toughening mechanisms 
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for the partially sintered scaffolds coated with PDLLA, P(3HB) and P(3HO) are 
discussed next in Section 5.3.2.  
5.3.2 Proposed toughening mechanisms 
 
Three different mechanisms of toughening are proposed for the three different 
polymer phases used to infiltrate the partially sintered 45S5 Bioglass
®
 scaffolds based 
on the stress-strain curve and SEM fracture surface observations. The differences in 
the stress-strain curve of the scaffolds are proposed to be related to the physical 
property of the polymer used in each case since the method of infiltration applied was 
the same for all three polymers, i.e. immersion in 5 wt% polymer solution for 2 hours. 
The physical properties of the polymers used are relatively different to each other, as 
shown in Table 4.1. According to Table 4.1, PDLLA and P(3HB) are of thermoplastic 
type while P(3HO) is a thermoplastic elastomeric  polymer with very low Tg value (-
35
o
C). Moreover PDLLA and P(3HO) are ductile in comparison to P(3HB), which is 
a rather brittle polymer. Both PDLLA and P(3HB) are more hydrophobic than 
P(3HO) as revealed by static water contact angle measurements. PDLLA has a 
molecular weight (Mw) of 200,000 gmol
-1
, the Mw of P(3HO)  is 225,000 g mol
-1
 and 
P(3HB) has a Mw of 850,000 g mol
-1
. These physical properties will influence the 
respective behaviours during polymer infiltration into the microcracks and micropores 
of the partially sintered scaffolds.  
 
 P(3HO) has the lowest Tg value (-35
o
C) compared to PDLLA (55
o
C) and 
P(3HB)(2.7
o
C), P(3HO) is a thermoplastic elastomeric polymer [194]. 
Morphologically it consists of both crystalline and amorphous phases at room 
temperature and it has rubber-like elasticity. P(3HO) has a liquid-like behaviour at 
room temperature as compared to a glass-like behaviour of a thermoplastic polymer. 
This liquid-like behaviour of P(3HO) can improve the infiltration into the microcracks 
and micropores of the partially sintered scaffolds leading to increased depth of 
infiltration of the polymer due to better flow behaviour (hydrodynamic) at room 
temperature in comparison to PDLLA and P(3HB). Therefore, P(3HO) will fill the 
mircocracks and micropores of the partially sintered scaffolds more efficiently than 
the other polymers. 
 
 182 
On the other hand, PDLLA is an amorphous polymer while P(3HB) is a semi-
crystalline polymer as shown in Table 4.1. The amorphous character of PDLLA will 
favour its hydrodynamic behaviour due to more flexible chains present, as compared 
to the more rigid chains present in the semi-crystalline P(3HB). This will increase the 
infiltration capability of PDLLA into the microcracks and micropores of partially 
sintered scaffolds, as compared to infiltration using P(3HB). 
 
Based on the stress-strain curves, SEM observations of fracture surfaces and 
morphology the polymer infiltration behaviour for each biodegradable polymer can be 
proposed, as schematically shown in Figure 5.73: 
 
Figure 5.73 Schematic diagram showing the infiltration behaviour for 1) P(3HB), 
2) PDLLA and 3) P(3HO) coating of partially sintered 45S5 Bioglass
®
 scaffolds.  
 
Briefly, Fig. 5.73 (1) shows the infiltration behaviour proposed for P(3HB). P(3HB) 
coating does not infiltrate deeper down the micropores or microcracks of the partially 
sintered scaffold struts due to lower flowing ability (semi-crystalline structure) of 
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P(3HB). Therefore, more polymer will be present in the macropores and on the strut 
surfaces, as shown in Fig. 5.46. The PDLLA infiltration as proposed in Fig. 5.73(2) is 
better leading to a higher amount of polymer inside the micropores and microcracks 
probably due to the amorphous structure of PDLLA leading to higher flow ability, as 
compared to P(3HB). Therefore, only some polymer is still present in the macropores 
and on strut surfaces, as indicated in Fig. 5.17. Fig. 5.73 (3) shows the proposed 
mechanism for P(3HO) infiltration which indicates efficient infiltration of mircopores 
and microcracks as a result of the elastomeric property of the polymer. 
5.3.3 Comparison of 45S5 Bioglass®/polymer composites: 
assessment in simulated body fluid 
 
The bioactivity of the scaffolds was confirmed after immersion tests in SBF for 7, 14 
and 28 days. From the SEM, EDS and XRD analyses of PDLLA, P(3HB) and P(3HO) 
coated scaffold, it was confirmed that the bioactivity is maintained after a certain 
period of immersion in SBF. SEM and EDS analyses were used to evaluate the 
precipitation of HA while the crystallinity of HA crystals was studied using XRD. 
The mechanism of formation of HA on bioactive glass based substrates was discussed 
in detail in the literature review (section 2.6.1). Different physical properties of the 
polymers used have an effect on the bioactivity of the coated scaffolds. Molecular 
weight and adhesion strength are thought to have the greatest effect on the bioactivity 
of the coated pellets and scaffolds. PDLLA which has the lowest Mw showed the 
fastest formation of HA compared to P(3HB) and P(3HO). In addition, the adhesion 
strength of PDLLA to the sintered Bioglass
®
 substrate (Fig. 5.48) is lower than that of  
P(3HB) (Fig. 5.75). 
 
Based on the experimental results on PDLLA and P(3HB) coated Bioglass
®
 pellets, 
the mechanism of bioactivity is proposed to be related to the formation of cracks in 
the coatings , which will provide a channel for SBF to come into direct contact with 
the bioactive glass for effective ion exchange and formation of HA on the surface of 
the pellets. The same mechanism is active in all scaffolds because they were 
fabricated under the same conditions, although the thickness of the polymer layer is 
slightly different in each. The thickness of the PDLLA coating on the scaffolds is in 
the range 1-5µm following calculated values in a previous study [1], while the 
thickness of the polymer coating on the present sintered pellets, by optical 
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observation, is around 10µm (see Fig. 5.26). The differences in the polymer layer 
thickness is considered to be the reason explaining the fact that the kinetic of 
formation of HA is faster in PDLLA coated scaffolds as compared to PDLLA coated 
pellets after 3 weeks of immersion in SBF, which was assessed by comparing the 
intensity of the XRD peaks.  
 
In addition, the PDLLA coated scaffolds reached a stoichoimetric Ca/P ratio of the 
HA layer formed (Ca/P =1.6-1.7) after 28 days immersion in SBF while the PDLLA 
coated pellets did not reach such stoichoimetric ratio after the same period of 
immersion in SBF. This result could also be due to the highly porous structure and 
high specific area of the coated scaffolds, therefore, faster and more extensive ion 
exchange can occur than in the bulk specimen as has been shown also by previous 
studies [195]. Examining SEM images, the needle-like nanostructure of HA was 
observed after 1 week in SBF for scaffolds coated with PDLLA (see Fig. 5.35).  
 
A new finding was made in this study for the partially sintered PDLLA coated 
scaffolds by XRD analysis (see Fig. 5.37, 5.38, 5.39 and 5.40), showing that HA 
formation is faster in coated samples, in particular at day 7 for both partially and fully 
sintered scaffolds. The explanation for this behaviour could be that PDLLA surfaces 
are hydrolysed by water molecules in SBF, which convert ester linkages into surface 
carboxylic groups which dissociate to provide negatively charged carboxylate anions 
(COO
-
) for binding with calcium ions (Ca
2+
) [146]. The binding of these ions 
stimulates surface nucleation with subsequent HA crystal growth, similar to the 
mechanism proposed by Murphy et al. [196]. Thus the kinetic of HA formation is 
increased at the initial stage of immersion in SBF. However, it is anticipated that for 
long-term immersion in SBF, the kinetic of HA formation on the uncoated scaffolds 
would match that of the coated scaffolds, as indicated by Fig. 5.37, 5.38, 5.39 and 
5.40. This is because the crystalline phase in this material (partially crystallised 
Bioglass
®
) can transform into an amorphous HA phase, as shown in previous reports 
in the literature [53]. 
 
Considering P(3HB), which has a higher Mw of 885,000gmol
-1
 than PDLLA (Mw = 
200,000 gmol
-1
), the kinetic of HA formation on P(3HB) coated scaffolds is lower 
than that on PDLLA coated scaffolds, which is found by comparing the intensity of 
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the XRD peaks at 2θ = 32
o
C on scaffolds made using the same sintering condition 
(1000
o
C, 2 hours). This result could also be explained by the stronger adhesion 
strength between P(3HB) and Bioglass
®
 which could reduce the area of contact of 
SBF with bioactive glass and thus retard the surface reactions. Based on the 
experiment using P(3HB) coated pellets sintered at the same sintering conditions, the 
mechanism for HA formation on the surface of P(3HB) (Fig. 5.55) is similar to that of  
PDLLA coated pellets (Fig. 5.28), as described above. The same mechanism could be 
applied to the bioactive response of P(3HB) coated scaffolds. The delay of HA 
formation on the P(3HB) coated scaffolds was about 2 weeks when compared to the 
PDLLA coated scaffolds by XRD analysis, as expected due to the stronger adhesion 
strength to bioactive glass surface, reducing the contact area of the scaffold surface 
with SBF. However, HA formed on the P(3HB) coated scaffolds can reach a 
stoichoimetric Ca/P (Ca/P=1.6-1.7) after 28 days immersion in SBF, which is similar 
to PDLLA coated samples. This result could be due to the non-homogenous coating 
of the P(3HB) on the scaffolds struts, as shown in Fig 5.44 B, indicating that some 
areas of the scaffold strut surfaces are exposed and in direct contact with SBF, similar 
to results in a previous study [135].  
 
P(3HO) coated scaffolds, where P(3HO) has the lowest rate of degradation as 
compared to PDLLA and P(3HB), are less bioactive than P(3HB) and PDLLA coated 
scaffolds as shown by the lower peaks intensity of Ca and P at SBF immersion time of 
28 days as revealed by SEM-EDS ( see Fig. 5.71). This reduced bioactivity of P(3HO) 
coated scaffolds is documented also by delays in the HA formation, by XRD 
analyses.(see Fig. 5.72)  
 
 
5.4 Conclusions 
 
Results presented in this chapter suggest that PDLLA, P(3HB) and P(3HO) coatings 
on Bioglass
®
 based glass-ceramic scaffolds sintered at a relatively low sintering 
temperature of 1000
o
C for 2 hours increased the mechanical properties (compressive 
strength) of the 3D scaffolds, as compared to the as-sintered (non-coated) scaffolds. 
The coatings, leading to an interpenetrating network microstructure in partially 
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sintered scaffold improved also the scaffold bioactivity (in the case of PDLLA 
coatings). Most importantly, the observation of the fracture surface of PDLLA, 
P(3HB) and P(3HO) coated scaffolds showed that a microscale crack-bridging 
mechanism is active by the polymer fibrils at the crack opening zone. This effect is 
similar to the toughening mechanism in bone, which is based on crack bridging by 
collagen fibrils [179]. The proposed toughening mechanism for the partially sintered 
scaffolds coated with PDLLA, P(3HB) and P(3HO) is thought to be related to the 
glass transition (Tg)  values of the polymers, which will effect the viscosity of the 
solution and also the degree of infiltration into the microcracks and micropores of the 
partially sintered scaffolds. The degree of infiltration of the different polymers into 
the micropores and microcracks is proposed to vary as follows: P(3HO)> PDLLA> 
P(3HB). The results show that 45S5 Bioglass
®
 derived scaffolds coated with PDLLA, 
P(3HB) and P(3HO) maintained their bioactivity when tested in an SBF solution, but 
the onset time of the hydroxyapatite formation process was seen to depend on the type 
of polymer used for the coating. The onset time of the bioreactivity process varies as 
follows: PDLLA>P(3HB)>P(3HO), which could be related to the rate of degradation 
and to the molecular weight of the polymer phase used in each case. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 187 
Chapter Six 
6 Design of bilayered scaffolds: Electrospun 
PDLLA nanofiber coated 45S5 
Bioglass®substrates 
 
6.1 Introduction 
 
As the micro- and nano- architectures of scaffolds have been shown to play a key role 
in cell-biomaterial interaction, the significance of surface science and topographic 
design increases and several techniques based on electric field assisted processing are 
being developed to produce specific structural patterns on biomaterial surfaces [197], 
as well as to fabricate novel nanostructured scaffolds which may have enhanced 
performance in bone regeneration applications. Electric field assisted processing 
consists of several variants, one of which is electrospinning, which has attracted 
considerable attention over the last decade largely due to its applicability in the 
biomedical materials field [198]. The principle of the process, which was patented in 
1934 [199] and is capable of producing ultra-fine fibres, is based on electrically 
charging a suspended droplet of polymer melt or solution. Details of the process and 
its applications in TE have been presented in the literature review (Chapter 2). In 
tissue engineering applications, electrospinning has been used to prepare scaffolds 
directly, as a continuous collection of randomly generated fibres or, alternatively, as 
ordered structures by controlling the deposition pattern [200]. Nanofibrous structures 
manufactured by electrospinning, for example, have a high surface to volume ratio 
exhibiting the potential to provide high surface area for improved cell attachment. 
This design of fibrous structures can be applied to a variety of polymers including 
polyurethane, PLA, PS, polymethylmethacrylate, PLGA, collagen and 
polycaprolactone. In this part of the investigation PDLLA was selected as the polymer 
to introduce fibrous layers in a bilayered scaffold design. 
 
An alternative approach, in particular for bone tissue engineering, is to deposit the 
fibrous nano- or micro-structures onto a substrate material exhibiting intrinsically 
bioactive properties, e.g. formation of biologically active hydroxyapatite crystals in 
contact with physiological fluids [201]. One of such surface reactive materials is 
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bioactive glass [202]. In this case, the approach takes advantage of the rapid rate of 
surface reactions of bioactive glasses, which leads to fast bone bonding without the 
formation of scar tissue as discussed in detailed in the literature review (section 2.6.1).  
 
A novel structure of electrospun PDLLA fibers deposited on 45S5 Bioglass
®
 (sintered 
discs) is introduced in this chapter, which is proposed as the basic material 
combination for the development of bioactive scaffolds. To explore the preliminary 
applications of these structures, surface roughness and in-vitro (acellular) bioactivity 
in simulated body fluid (SBF) were investigated. 
 
In addition, a novel structure of electrospun PDLLA fibers deposited on 3D 45S5 
Bioglass
®
 scaffolds is also introduced in this chapter, which is proposed as the basic 
structure for the development of bilayered scaffolds/constructs for osteochondral 
tissue engineering applications. The suitability of bilayered constructs for 
osteochondral tissue engineering was discussed in the literature review section 
(Section 2.5). To explore the preliminary applications of this bilayered construct, 
morphology, bioactivity in simulated body fluid (SBF) and cell response on the 
bilayered scaffolds were investigated. 
 
6.2 Results 
 
6.2.1 PDLLA fibre deposition on 45S5 Bioglass® sintered pellets 
 
6.2.1.1 Processing 
 
A series of parameters related to different formulations of PDLLA polymer solutions 
and to the electrospinning apparatus were preliminary conducted on glass slides, used 
as substrate, to obtain the optimised conditions for PDLLA nanofibres deposition on 
polished surfaces of 45S5 Bioglass
®
 pellets. The PDLLA solutions for electrospinning 
were prepared by mixing PDLLA granules in dimethylcarbonate (DMC) in 
concentrations of 2.5 and 5.0 wt/v%.  The experimental procedure for the 
electrospinning set-up has been described in Chapter 4 (section 4.9).  A summary of 
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the parameters investigated, including polymer solution concentration, flow rate, 
voltage applied, distance between needle and substrate as well as deposition time are 
tabulated in Tables 6.1, 6.2 and 6.3. 
 
Table 6.1  Electrospinning parameters for deposition of PDLLA fibres on glass 
slide substrate using 2.5 wt% PDLLA solution in DMC. 
PDLLA in DMC 
( 2.5 wt% ) 
Electrospinning parameters Substrate 
1) Flowrate: 10µl/min 
Voltage: 8-10kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass slide 
2) Flowrate: 5µl/min 
Voltage: 8-10kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass slide 
3) Flowrate: 5µl/min 
Voltage: 10-12kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass slide 
4) Flowrate: 2 µl/min 
Voltage: 10-12kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass slide 
 
 
 
Table 6.2  Electrospinning parameters for deposition of PDLLA fibres on glass 
slide substrate using 5wt% PDLLA solution in DMC. 
PDLLA in DMC 
( 5 wt% ) 
Electrospinning parameters Substrate 
5) Flowrate: 10µl/min 
Voltage: 8-10kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass Slide 
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6) Flowrate: 5µl/min 
Voltage: 8-10kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass Slide 
7) Flowrate: 3µl/min 
Voltage: 10-12kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass Slide 
8) Flowrate: 2µl/min 
Voltage: 10-12kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass Slide 
9) Flowrate: 2µl/min 
Voltage: 12-14kV 
Distance: 8 cm 
Deposition time: 1 minute 
Glass Slide 
 
 
 
 
Table 6.3 Optimum conditions for the electrospinning parameters of PDLLA 
fibers on Bioglass
®
pellets using 5wt% PDLLA solution in DMC. 
PDLLA in DMC 
( 5 wt% ) 
Electrospinning parameters Substrate 
10) Flowrate: 5µl/min 
Voltage: 15 kV 
Distance: 15 cm 
Deposition time: 5 and 10 minute 
45S5 Bioglass
®
 
pellet 
 
 
6.2.1.2 Microstructure analysis  
 
From SEM images of electrospun PDLLA nanofibers on glass slides and on polished 
45S5 Bioglass
®
 pellets, as shown in Figure 6.1, 6.2 and 6.3, it becomes clear that the 
morphology of PDLLA nanofibers depends strongly on the parameters chosen for the 
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electrospinning process. For example, a 2.5wt% solution of PDLLA at different flow 
rates of 10µl/min and 5µl/min, respectively (i.e. parameters (1) and (2) (Table 6.1)), 
but working at the same voltage (i.e. 8-10kV) at fixed collection distance (8 cm), led 
to different results. At a lower flow rate (5µl/min), the droplet sizes are smaller 
compared to 10 µl/min flow rate (see Fig. 6.1 (A) and (B)). As the voltage is 
increased (10-12kV) and the flow rate is reduced, the formation of both nanofibers 
and droplets was observed (see Fig. 6.1 (C)). From this observation, it is suggested 
that the emergence of fibers can occur when the flow rate is relatively low (i.e. < 
5µl/min) while the voltage is increased (i.e. > 10-12kV) for the 2.5 wt% PDLLA 
solution.  
 
The same pattern was observed for the 5wt% PDLLA suspension; e.g. the flow rate 
decreased while the voltage increased (i.e. parameter 5,6,7,8 and 9 in Table 6.2). SEM 
images of electrospun PDLLA fibres on 45S5 Bioglass
®
 pellets and on glass slides are 
shown in Fig.6.3 and 6.2, respectively. It is confirmed that the morphology of PDLLA 
fibres depends strongly on the selection of the right combination of parameters for the 
electrospinning process and on the solvents used. There are several explanations as to 
why transitional structures such as beads arise in electrospinning, e.g. polymer 
content, applied voltage and flow rates [203]. As the flow rates were reduced from 10 
µl/min (Figure 6.2(A)) to 3µl/min (Figure 6.2(B)) and 2 µl/min (Figure 6.2(C)) and 
the applied voltage was gradually increased  from  8-10 kV (Figure 6.2(A)) to 10-12 
kV (Figure 6.2(B)(C)) and 12-14kV (Figure 6.2(D)), a higher number of PDLLA 
fibres and fewer beads were formed for the 5%wt/v PDLLA-DMC solution. Fig. 
6.2(D) shows the fibrous structure obtained at the lowest flow rate (2µl/min) and 
highest applied voltage (12-14 kV) investigated using glass slides as substrate.  
 
Using the same solution, uniform PDLLA fibres (Figures 6.3(A) and 6.3(B)) were 
obtained on the Bioglass
®
 substrate at a flow rate of 5µl/min and operating voltage of 
15kV, selecting a collecting distance of 15 cm from the tip of the needle (see Figure 
4.4). The density of the fibre network was seen to increase with deposition time, as 
shown in Figures 6.3(A) and 6.3(B), although the structural integrity of very dense 
mats was compromised with the collection of excess un-evaporated solvent. The 
diameter of the uniform PDLLA fibres is seen to vary between ~100nm and ~0.2µm. 
This result is comparable to other recent studies which have yielded fibres in the same 
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range [204]. However results from another investigation, which used a less volatile 
solvent system (DMF-THF) than the one utilised here (DMC), indicated that fibres 
with diameters as large as 1.5 µm could be produced [205]. The differences in fibre 
size are also related to the concentration of the polymer in the solvent. Polymer 
concentration values of ~5 wt/v% can also result in nano-fibres, as evident from 
literature results [204;206] 
 
 
 
 
Figure 6.1 SEM images of PDLLA deposition on glass slides using a suspension 
of 2.5wt% PDLLA in DMC at different electrospinning parameters A = Flow 
rate (10µl/min), Voltage (8-10kV), B = Flow rate (5µl/min), Voltage (8-10kV) and 
C = Flow rate (2µl/min), Voltage (10-12kV), deposited for 1 minute. (See 
Table.6.1) 
 
 
A) B) 
C) 
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Figure 6.2 SEM images of PDLLA deposition on glass slides using a suspension 
of 5wt% PDLLA in DMC at different electrospinning parameters A = Flow rate 
(10µl/min), Voltage (8-10kV); B = Flow rate (3µl/min), Voltage (10-12kV); C = 
Flow rate (2µl/min), Voltage (10-12kV); D = Flow rate (2µl/min), Voltage (12-
14kV) deposited for 1 minute. (See Table.6.2) 
 
 
  
Figure 6.3 SEM images of PDLLA fibres deposited on 45S5 Bioglass
®
 at 
optimum electrospinning parameters of Flow rate = 5µl/min and Voltage = 
15kV:  (A) Partially aligned fibres (5 minutes deposition time) and (B) Random 
fibres, using a suspension of 5wt% PDLLA in DMC (10 minutes deposition 
time). (See Table 6.3) 
A) B) 
C) D) 
A) B) 
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6.2.1.3 Surface topography measurement using white light 
interferometer 
 
Three measurements were taken by white light interferometry (Zygo
®
) on the surface 
of PDLLA nanofibers deposited for 30 minutes on 45S5 Bioglass
®
 substrates using 
the optimum conditions of electrospinning parameters discussed in the previous 
section. This measurement was carried out to investigate the surface roughness of the 
45S5 Bioglass
®
 substrate coated with nanofibers, as shown in Figure 6.4. The three 
measurements of the surface roughness gave results of rms values of 1.36 ± 0.05µm 
and ra values of 0.72 ± 0.05µm. The results indicate that the surface roughness 
increased due to deposition of PDLLA nanofibers which can be confirmed from the 
3D plot (see Fig. 6.4 B), it can be also observed that there was a fairly homogenous 
distribution of the nanofibers deposited on the 45S5 Bioglass
®
 surface in the area of 
1.45mm x 1.09 mm (see Fig.6.4 A). As indicated by the colour scale, fibres which are 
in the micron size scale were able to be detected by the white light interferometer. 
Fibres which are in nanoscale cannot be detected by using this technique. For 
comparison, the rms value of the polished 45S5 Bioglass
®
 pellets (Fig. 6.5) used as 
substrate was only 0.10 ± 0.05 µm and the ra values was 0.08 ± 0.05µm. From the 3D 
plot, the surface area is seen to be fairly smooth (see Fig. 6.5 B), as compared to the 
PDLLA fibre deposited surface (see Fig. 6.4 B). 
 
 
A) B) 
Figure 6.4  3-D plot and scales in colour of the 45S5 Bioglass
®
 surface coated 
with PDLLA fibers, deposited for 30 minutes obtained by white light 
interferometry (Zygo
®
). 
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A) B) 
Figure 6.5  Scheme showing (A) surface profile and scales in colour and (B) 3D 
representation of the polished 45S5 Bioglass
®
 surface, obtained by white light 
interferometry. 
 
 
6.2.1.4 SBF bioactivity studies. 
 
The assessment of the bioactivity of PDLLA fibre coated 45S5 Bioglass
®
 substrates 
was carried out in SBF (as described in Section 4.10.4). Briefly, disc of 10 mm in 
diameter (sintered Bioglass
®
 pellets) coated with PDLLA fibers (deposited for 10 
minutes) were immersed in 30 ml SBF for up to 28 days. Samples were characterised 
by SEM, EDS and XRD. 
 
A A1 
HA 
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Figure 6.6  SEM images of PDLLA fibres deposited on 45S5 Bioglass
®
 sintered 
discs after immersion in SBF: A, A1)7 days, B, B1) 14 days and C, C1) 28 days at 
different magnifications, showing formation of HA indicated by the needle-like 
nanostructure.  
 
From SEM images, it can be observed that there was formation of HA crystals on the 
disc substrates as well as on PDLLA fibres after 7, 14 and 28 days of immersion in 
SBF, as shown in Figure 6.6. At higher magnification, it was confirmed that 
hydroxyapatite crystals have formed a homogenous coating around the PDLLA fibres, 
as shown in Figure 6.6 A1, B1 and C1. HA crystals and clusters were also formed on 
the 45S5 Bioglass
®
 sintered substrates after immersion in SBF for 7, 14 and 28 days, 
as shown in Figure 6.6 A, B and C. It was observed that the HA layer on the PDLLA 
fibres was thicker than that on the 45S5 Bioglass
®
 substrates due to high volume to 
surface ratio (see Fig. 6.6 C) provided by the fibres. It was also observed that the size 
of the PDLLA fibres increased as the immersion time in SBF increased due to the 
formation of a thicker hydroxyapatite layer, as expected. The SEM image in Fig. 6.7 
shows that the HA can also grew homogenously on PDLLA fibres, which were not in 
direct contact with the 45S5 Bioglass
®
 substrates, as indicated by the arrow. 
 
B B1 
C C1 
HA 
HA 
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Figure 6.7 SEM images showing the homogenous growth of HA on PDLLA 
fibres which are not in direct contact with the 45S5 Bioglass
®
 substrate, as shown 
by the arrow. 
  
XRD spectra obtained on PDLLA fibre coated 45S5 Bioglass
®
 sintered substrates 
after 7, 14 and 28 days immersion in SBF are shown in Figure 6.8. The peak at 2θ = 
32
o
 is the characteristic peak of crystalline hydroxyapatite (HA). The XRD spectrum 
of the material before immersion in SBF is also shown for comparison, where peaks 
corresponding to the Na2Ca2Si3O9 phase are indicated. The presence of Na2Ca2Si3O9 
is typical in the present bioactive glass-ceramics fabricated from Bioglass
®
 by 
sintering at T>900°C [53], as discussed in Chapter 5. The PDLLA fibres are 
completely amorphous and cannot be detected by XRD (see Fig. 6.9). The HA 
formation on the samples is seen to occur after 7 days immersion in SBF, as shown by 
the XRD spectrum in Figure 6.8. There is an increased in the peak height at 2θ = 32
o
 
as the immersion time increased from 7 to 28 days.  
 
The chemical composition of the HA formed on the PDLLA fibres was identified by 
EDS analysis, as shown in Figure 6.10. Calcium and phosphorus as the predominant 
elements identified in the EDS spectrum (in a ratio of approximately 1:50) confirm 
the presence of HA on the surface of PDLLA fibres as well as on the 45S5 Bioglass
®
 
substrate (in a ratio of approximately 1:52) (Figure 6.10). 
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Figure 6.8 XRD spectra showing the peaks corresponding to PDLLA fibre 
coated 45S5 Bioglass
®
 specimens before and after immersion in SBF.  The major 
peaks of Na2Ca2Si3O9 phase and hydroxyapatite (HA) are marked by (∆) and (○), 
respectively. 
 
 
Figure 6.9  XRD spectra of PDLLA films: A) as fabricated and B) after 
immersion in SBF for 2 weeks. The PDLLA film after immersion in SBF shows 
no HA formation on the surface. 
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Figure 6.10 EDS analysis of the surface of a Bioglass
®
 pellet coated with PDLLA 
fibers after 28 days in SBF, showing the presence of P and Ca, indicating the 
presence of a HA layer. 
 
These results indicate that PDLLA fibres can be homogenously mineralised on the 
surface of 45S5 Bioglass
®
 in contact with SBF. These results show thus for the first 
time the introduction of a fibrous HA topography on the polished surface of 45S5 
Bioglass
®
 sintered pellets using electrospun PDLLA fibres as a template. The rough 
fibrous topography should induce better cell attachment and strong bonding to new 
bone, following evidence in the literature [201]. On the contrary, PDLLA fibres (and 
scaffolds) on their own are not bioactive, as demonstrated by XRD analysis (Fig. 6.9) 
and in previous research [207].  
 
Although rough surface topographies, produced for example by sandblasting methods, 
have been shown to significantly improve cell adhesion to biomedical implants [208], 
it is also possible that they can limit cell spreading and may lead to scar formation 
Ca/P=1.5 
Ca/P=1.52 
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[209]. It should be also mentioned that the literature is scarce regarding the detailed 
investigation of cell/surface interactions and cell adhesion on bioactive glass 
substrates with controlled surface topography [209;210]. In one of the few studies 
available, Levy et al. [209] used sandblasting technique to induce surface roughness 
on cast Bioglass
®
 discs to create topographies of Rms ~ 794 nm. They showed that 
surface texture had an effect on cell (MC3T3 cells) spreading, this being lower on 
rough 45S5 Bioglass
®
 surfaces during the initial stages of cell adhesion, however the 
rough surfaces provided numerous sites for cell attachment. In their work, however, 
the surface pattern morphology on the Bioglass
®
 surface was not controlled, as 
opposite to the present investigation where a fibrous surface arrangement can be 
produced with high degree of control by tailoring the diameter and orientation of the 
electrospun PDLLA fibres.  
 
In summary, amorphous PDLLA was electrospun on sintered Bioglass
®
 based glass-
ceramic surfaces forming fibrous structures. Processing conditions of the 
electrospinning method such as flow rate and voltage were the key parameters 
controlling fibre dimensions and morphology. These parameters were optimised to 
reduce the formation of undesired beads. PDLLA fibres deposited on 45S5 Bioglass
®
 
pellets were found to introduce a rough fibrous topography on the polished surface of 
the substrate and this controlled roughness should potentially encourage cell 
attachment. From the SBF studies, it was found that HA can grow on the PDLLA 
fibres after 7 days of immersion in SBF, with uniform HA covering the fibrous 
structure at day 14. This process provides a biologically active fibrous-like calcium 
phosphate patterned surface for the attachment of bone cells and for strong bonding to 
new bone. Recent investigations by Li et al.[211] have utilised a novel jet-based 
patterning technique, template-assisted electrohydrodynamic atomization spraying, to 
control the surface structure as well as dimensions of HA coatings on Ti substrates. A 
range of nano-hydroxyapatite (nHA) line-shaped patterns < 20 µm in width were 
successfully deposited and it was confirmed that the HA patterns were capable of 
regulating human osteoblast cell attachment and orientation. 
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This part of the investigation led also to study the deposition of PDLLA fibrous 
structures on 3D bioactive glass scaffolds. In this case, the novel bilayered scaffolds 
produced are intended for osteochondral tissue engineering, whose basic principles 
were described in Section 2.5 (literature review). The experimental results are 
presented in the next sections. 
 
6.2.2 PDLLA fibre deposition on 45S5 Bioglass® scaffolds 
 
6.2.2.1 Motivation 
 
In this part of the project the research focus was on engineering the surface of 45S5 
Bioglass
®
 scaffolds by coating with PDLLA fibres using electrospinning in order to 
fabricate bilayered constructs suitable for osteochondral tissue engineering. The 
structure of the proposed bilayered scaffolds is schematically shown in Figure 6.11. 
The experimental detail of the electrospinning method has been presented in Chapter 
4 (Section 4.9).  
 
Figure 6.11 Schematic diagram showing A) bilayered structure scaffold covered 
with a thin fibrous mesh of PDLLA fibres obtained by electrospinning and B) the 
applications of the bilayered scaffolds in the osteochondral defect. (Diagram in 
(B) has been adapted from [212]) 
 
Using the optimised electrospinning parameters obtained from the PDLLA fibre 
coatings on the Bioglass
®
 pellets as a substrate (section 6.2.1), the same parameters 
Bone side 
Cartilage surface 
Bioglass
®
- based 
glass ceramic 
scaffold 
PDLLA fibers 
deposited by 
electrospinning 
A) 
B) 
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were used to deposit PDLLA fibers on the 45S5 Bioglass
®
 scaffolds. For the 
preliminary test, a fully sintered scaffold, i.e. sintered at 1100
o
C for 2 hours (section 
6.2.2.2), was chosen as the substrate. For the optimum condition of PDLLA fibre 
deposition, sintered scaffolds (1000
o
C, 2 hours) which had been previously coated 
with 5wt% PDLLA and sintered at 1000
o
C for 2 hours were used as substrates 
considering that these coated scaffolds were developed to mimic the natural bone 
consisting of organic and inorganic phases (section 6.2.2.3). The mechanical 
properties of the scaffolds used were investigated and comprehensively discussed in 
Chapter 5. It was determined that mechanical properties and porosity of the 45S5 
Bioglass
®
 derived glass-ceramic scaffolds are acceptable for bone tissue engineering 
applications, as discussed in Chapter 5. Thus these scaffolds were selected for this 
part of the investigation, e.g. the PDLLA coated bioactive glass-ceramic scaffolds 
would represent the scaffold section forming bone tissue in an osteochondral tissue 
engineering strategy [35] ( see Fig. 6.11) 
 
6.2.2.2 Microstructure analysis of PDLLA fibres on 45S5 Bioglass® 
scaffolds by SEM. 
 
Fig. 6.12 shows SEM images of the PDLLA fibrous deposition on 45S5 Bioglass
®
 
scaffolds. From the microstructure of the PDLLA fibres deposited on 45S5 Bioglass
®
 
scaffolds, it was observed that the fibrous mesh became denser when deposition time 
increased from 10 minutes to 2 hours, as shown in Fig. 6.12 A, B, and C. From the 
SEM images, it can also be seen that the PDLLA fibres were deposited on the struts 
of the Bioglass
®
 scaffolds, as indicated by the red circle in Figure 6.12 (A-C). At 
higher SEM magnification, the increased density of the fibrous mesh on the struts 
with increasing deposition time becomes evident (see Figure 6.12 A1, B1 and C1). 
This observation can suggest that good bonding exists between the two layers, which 
is known to be a requisite to assure good integrity and functionality of the 
osteochondral constructs. Moreover, SEM examination of the 45S5 Bioglass
®
 
scaffolds revealed that pores are highly interconnected and possess a size in the range 
of 50 to 500 microns  (6.12 A)  
 
 203 
 
Figure 6.12 SEM images showing the PDLLA fibrous deposition on 45S5 
Bioglass
®
 scaffolds (uncoated) at different deposition times:  A) 10 mins, B) 30 
mins , C) 2hours, and A1) 10 mins, B1) 30 mins and C1) 2 hours at higher 
magnification of the area’s showed by the circles. 
 
 
Fig. 6.13 shows SEM images of the different orientations of the PDLLA fibers on the 
45S5 Bioglass
®
 scaffolds. Fig. 6.13 B suggests that the PDLLA fibre orientation on 
the struts was random. On the other hand, fibres deposited between strut points are 
A A1 
B B1 
C C1 
100µm     50 µm 
100 µm   50µm 
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seen to be partially aligned (see Fig.6.13 C). This pattern was formed due to the 
structure of the underlying porous 45S5 Bioglass
®
 scaffolds and it was not observed 
in fibre depositions on planar surfaces, described above (section 6.2.1). 
 
 
Figure 6.13 SEM images showing different fibre orientations at different 
positions of the PDLLA fibres on the surface of 45S5 Bioglass
®
 scaffolds 
deposited for 2 hours showed by the cicles. 
 
Fig. 6.14A shows a SEM image of the interface in a PDLLA/45S5 Bioglass
®
 scaffold 
deposited for 2 hours, where it is possible to observe the two distinct porous layers. 
Fig. 6.14 B shows the PDLLA fibrous layer at higher magnification. The estimation 
of the PDLLA fibrous layer thickness was obtained from SEM observation of the 
interface of the bilayered scaffolds (see Fig. 6.14 B). The fibrous layer thickness was 
estimated to be around 150 µm, as can be appreciated in Fig. 6.14 B. Fig. 6.15 shows 
a composite SEM image revealing the typical complete transverse section of the 
bilayered scaffolds. 
A 
B 
C 
20µm 100µm 
  10µm 
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Figure 6.14 SEM images showing the microstructure of a PDLLA/45S5 Bioglass
®
 
bilayered scaffold (coated):  A) interface of the 45S5 Bioglass
®
 scaffold coated 
with PDLLA fibre for 2 hours, B) layer of PDLLA fibres observed at higher 
magnification of the circled area in  A). 
 
 
 
 
Figure 6.15 SEM images showing the cross-section of the PDLLA/45S5 Bioglass
® 
composites bilayered scaffolds. (The PDLLA fibre layer was deposited for 30 
minutes) 
A B 
500µm 100µm 
PDLLA fibres on 
the surface 
PDLLA fibers 
penetrating the  
underlying 45S5 
Bioglass
®
 
scaffolds 
300 µm 
45S5 
Bioglass
®
 
scaffolds 
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6.2.2.3 SBF bioactivity studies  
 
 
The bioactivity assessment of bilayered scaffolds constituted by PDLLA fibres 
deposited on the surface of 45S5 Bioglass
®
 derived glass-ceramic scaffolds, obtained 
at different deposition times of 10 minutes, 30 minutes and 2 hours after immersion in 
SBF for 7, 14 and 28 days, is described in this section. 
 
i) Microstructure and EDS analysis. 
 
Fig. 6.16 shows SEM images of the PDLLA fibres on a 45S5 Bioglass
®
 scaffold 
(coated) deposited for 10 minutes after immersion in SBF for 7, 14 and 28 days. 
There is formation of hydroxyapatite crystals on the PDLLA fibres after 7 days 
immersion in SBF, as shown in Fig. 6.16 A. The PDLLA fibres became coated with 
more HA crystals when immersion time in SBF increased from 14 to 28 days, as can 
be seen in Fig. 6.16 B and 6.16 C, as expected. EDS spectra on PDLLA fibres 
deposited for 10 minutes after immersion in SBF for 14 days (Fig. 6.16 B) show the 
presence of peaks corresponding to Ca and P, confirming calcium phosphate 
formation. Different Ca/P ratios at different locations indicate that the kinetic of HA 
formation was different, which is probably due to the different orientation and 
position of the fibres relative to the scaffolds substrate (see Fig. 6.17). The Au peaks 
are due to the gold coating used for SEM sample preparation. Thus it can be 
concluded that PDLLA fibres deposited for 10 minutes become mineralised after 
immersion in SBF for 7 days and longer periods. This result was obviously expected 
based on the evidence presented above (section 6.2.1), indicating the mineralisation of 
PDLLA fibres on sintered Bioglass
®
 substrates upon immersion in SBF. 
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Figure 6.16 SEM images of PDLLA fibres on 45S5 Bioglass
®
 based scaffolds 
(coated) deposited for 10 mins after immersion in SBF for A) 7, B) 14 and C) 28 
days.  
 
 
 
 
 
 
B) 
C) 
A) 
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Figure 6.17 EDS analysis on PDLLA fibres deposited on 45S5 Bioglass
®
 scaffolds 
(coated) electrospun for 10 minutes and immersed in SBF for 14 days.  The 
spectra correspond to the positions indicated on the SEM image. 
 
Fig. 6.18 (A-C) shows SEM images of PDLLA fibres on 45S5 Bioglass
® 
scaffolds 
(coated) deposited for 30 minutes after immersion in SBF for 7, 14 and 28 days. From 
the SEM images it can be observed that on some PDLLA fibres no HA formation has 
occurred after 7, 14 and 28 days immersion in SBF. Thus it can be concluded that as 
the PDLLA deposition time increases from 10 to 30 minutes the thickness of the 
PDLLA fibrous layer increases (see section above) and therefore, hydroxyapatite 
formation on the PDLLA fibres located on the top layer was reduced as the fibres are 
not in direct contact with the bioactive glass surface. 
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Figure 6.18 SEM images of PDLLA fibres on 45S5 Bioglass
®
 (coated) scaffolds 
deposited for 30 mins after immersion in SBF for A) 7, B) 14 and C) 28 days. 
 
 
Fig. 6.19 shows  SEM images of the PDLLA fibres on a 45S5 Bioglass
® 
scaffold 
(coated with 5 wt% PDLLA) deposited  for 2 hours after immersion in SBF for 7, 14 
and 28 days. From the SEM images, it is seen that there was no HA formation on the 
PDLLA fibers. EDS spectra of the PDLLA fibers deposited for 2 hours and after 
immersion in SBF for 7, 14 and 28 days also confirmed that no HA has formed on the 
PDLLA fibres, showing only the C and O peaks corresponding to PDLLA fibres. 
Thus it can be concluded that PDLLA fibre layers deposited on Bioglass
®
 based 
scaffolds for 2 hours do not mineralise after immersion in SBF for 7, 14 and 28 days. 
This is a very important result for the application of the present bilayered composites 
(Figure 6.11) in osteochondral tissue engineering, since it is required that the cartilage 
side does not mineralise, e.g. where the PDLLA mesh should support the attachment, 
growth and proliferation of chondrocytes only.  
 
A) B) 
C) 
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In summary, SEM observation and EDS analysis have confirmed that formation of 
HA (indicating bioactivity) on PDLLA fibres when immersed in SBF was reduced as 
the PDLLA fibre deposition time increased from 10 minutes to 2 hours, and the 
thickness of the fibrous PDLLA layer increased from 2 micron to 150 micron. 
 
 
  
 
 
Figure 6.19 SEM and EDS results on PDLLA fibres deposited on 45S5 Bioglass
®
 
scaffolds (coated with 5 wt% PDLLA ) deposited for 2 hours after immersion in 
SBF for A) 7, B) 14 and C) 28days and EDS spectra after immersion in SBF for 
A1) 7, B1) 14 and C1) 28days . 
 
 
B 
A 
C 
A1 
B1 
C1 
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ii) Final development of osteochondral scaffolds. 
 
Based on the previous results, it is proposed that the optimal scaffolds for 
osteochondral tissue engineering should have a structure as shown schematically in 
Figure 6.20 
 
 
 
Figure 6.20 Schematic diagram showing the development of the interface of a 
bilayered scaffold A) as fabricated, B) after immersion in SBF for 14 days. 
Interface 
fibrous layer 
partially 
covered with 
HA (induce 
better bonding) 
PDLLA 
fibres 
Bioglass 
Scaffolds 
fully 
coated 
with HA 
B) 
PDLLA 
fibres 
A) 
Bioglass 
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Fig. 6.20 A shows schematically the expected structure of the bilayered scaffolds 
formed by PDLLA fibres deposited for 2 hours on the basic 3D Bioglass
®
 scaffold 
coated with PDLLA. The PDLLA fibrous layer should reach in this case ~150µm in 
thickness. After immersion in SBF for 14 days, PDLLA fibres which are in direct 
contact with the 45S5 Bioglass
®
 scaffold substrate will become mineralised thereby 
increasing the bonding strength at the PDLLA fibre / Bioglass
®
 scaffold interface, as 
indicated Fig. 6.20 B. The mineralisation of the PDLLA fibres will decrease with 
increasing distance from the interface and it will be completely suppressed in the 
outer PDLLA fibre layers. From the EDS analysis reported in the previous section, it 
was confirmed that there is no HA formation on the fibres in the top layer after 
immersion in SBF for up to 28 days. This mechanism is very important to ensure: 1) 
strong bonding of the PDLLA layer to the bioactive glass substrate and 2) smooth 
transition at the interface given by the gradual change of HA layer formation 
dependent on the distance from the Bioglass
®
 scaffold surface. 
 
 
6.2.3 Cell culture assessment of the bilayered osteochondral 
scaffolds 
 
 
This section presents a preliminary assessment of the cell compatibility of PDLLA 
fibre coated bilayered scaffolds for potential osteochondral tissue engineering 
applications. The main aim of this section is to report, for the first time, the cell-
biomaterial interactions on these bilayered scaffolds in terms of chondrocyte 
attachment and spreading, which has been characterised using SEM, and the cell 
proliferation study characterised using the Alamar Blue Assay. The aim was to assess 
the material suitability for osteochondral applications on both 2D 45S5 Bioglass
®
 
sintered pellets and on 3D bilayered Bioglass
®
/PDLLA composite scaffolds surfaces. 
The ADTC5 cell line was chosen in this study due to its proven performance as an 
ideal cell line for development of tissue engineering strategies aimed at cartilage 
generation [213]. 
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6.2.3.1 Cell proliferation on 2D surfaces (pellets). 
 
Cell proliferation was quantitatively measured using the Alamar Blue assay on 
various components such as sintered 45S5 Bioglass
®
 sintered pellets coated with 
PDLLA nanofibers, soda-lime glass slides coated with PDLLA nanofibres and soda-
lime glass slides only. Tissue culture plastic (TCP) was used as a control surface. The 
soda-lime glass slide substrate was used to compare the cell behaviour on a planar, 
bioinert and favourable type of inorganic substrate for cell attachments other than 
TCP. The data are illustrated in Fig 6.21. Statistical analysis using ANOVA graph of 
the mean cell growth plotted against the days for each material gave no indication of 
an interaction between materials and days. In addition, the results of the statistical 
analyses indicated that there were significant differences between TCP and each of 
the individual materials tested (p ≤ 0.05) (refer to appendix table 1), showing that 
proliferation was lower than on TCP. This could be due to high cell affinity towards 
the TCP due to its high surface charge. 
 
SEM observations reveal that cells attached and were able to spread differently on the 
different types of samples. For example, in Fig 6.22 A) the cells on a PDLLA fibre 
coated glass slide tend to spread broadly and in a flat fashion (as shown by the arrow). 
Conversely, the cells attached on a PDLLA fibre coated sintered 45S5 Bioglass
®
 
pellet tend to be more elongated, as shown in Fig 6.22 B). This effect could be due to 
the differences of the substrate surface components. However, there was no 
significant difference between cell proliferations on planar glass slides compared to 
glass slides covered with PDLLA fibres, suggesting that the proliferation on 
nanofibres is activated by the same mechanism from that on planar surfaces of glass 
slides. Some beads appeared to be present on the PDLLA fibres, which could be due 
to non-optimum condition of the electrospinning parameter during the fabrication of 
the fibrous PDLLA layer, as previously discussed in section 6.2.1.1. It should be 
pointed out that if even one of the parameters was less than optimal, irregular beads 
containing fibres could form. 
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Figure 6.21 Cell proliferation data up to 7 days on the different materials 
investigated. (Values are presented by mean ± standard deviation (s.d) where N 
= 6 samples) 
 
 
 
 
 
Figure 6.22 SEM images of the ATDC-5 cell adherence and spreading on PDLLA 
fibres: A) on glass slide and B) on sintered 45S5 Bioglass
®
 pellets (cells are 
indicated by arrows).                               
 
 
A) B) 
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6.2.3.3 Cell proliferation on 3D surfaces (Bilayered scaffolds) 
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Figure 6.23 Cell proliferation data up to 10 days for 45S5 Bioglass
®
/PDLLA 
composites with and without PDLLA fibres deposited on the scaffolds. (Values 
are presented by mean ± standard deviation (s.d) where N = 6 samples). 
 
 
For this part of the investigation, 3D 45S5 Bioglass
®
/PDLLA scaffolds coated with 
PDLLA fibres (bilayered scaffolds) fabricated using the optimum conditions of 
electrospinning were used, as previously discussed in section 6.2.1.1. Scaffolds 
without the fibre deposition were also investigated for comparison purposes. The cells 
were cultured for up to 10 days. Cell proliferation was quantitatively measured using 
the Alamar Blue assay. The data are illustrated in Fig. 6.23. Statistical analyses 
showed that there were clear differences indicating an interaction between the test 
material used and the culture time point (p ≤ 0.001). This is perhaps not surprising 
given the degradable nature of these dynamic materials with time in culture. 
Furthermore, the analysis suggests that the 45S5 Bioglass
®
 scaffolds coated with 
PDLLA fibres supported greater cell growth by day 10 in culture compared with 
control surface (p ≤ 0.05) ( refer to appendix Table 2).  
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At days 1, 7 and 14, selected cell-seeded bilayered scaffolds were fixed and were 
observed by SEM. Fig. 6.24 A) shows that at day 1, several chondrocyte cells 
attached and proliferated on the surface of the PDLLA fibres of the bilayered 
scaffolds. Rounded cells suggest dividing cells during the process of cytokinesis. At 
higher magnification, it can be observed that cells are clearly attached to the fibres 
and formed a three dimensional cell-matrix network, as shown in Fig. 6.24 B). In 
particular at day 7, many cells are clearly attaching and spreading to and amongst the 
fibres and also communicating with one another using shared cytoplasmic filaments 
(cell-cell interaction), as shown in Fig. 6.25 A) such that they could only be 
recognised at high magnification (see Fig. 6.25 B).  In comparison to day 1, the cells 
proliferated and spread into a larger area and formed a three dimensional cell-matrix 
network. The cells also showed guided growth according to the PDLLA fibre 
orientations, giving rise to a three dimensional and multi-cellular network guided by 
the architecture of the fibrous scaffolds, as shown in Fig. 6.25 B). At day 14, the cell 
spreading and proliferation increased as can be seen from the higher density of cells 
(darker phase), as shown in Fig. 6.26. The cells appeared to adhere to the fibres, and 
they seem to have started to migrate through the pores and grow within layers of 
fibres as indicated in Fig. 6.26. These results confirm that the PDLLA fibres deposited 
for 2 h using the optimum condition of the electrospinning parameters are suitable as 
a conducive substrate for chondrocyte cells and the cells were able to attach, 
proliferate and migrate within the 3D network of the fibrous PDLLA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 217 
 
 
(A)  
 
 
 
( B) 
 
Figure 6.24 SEM images showing of the ATDC5-cell adherence and proliferation 
on PDLLA mesh of bilayered scaffolds at different magnifications at day 1: A) 
100 µm, B) 30 µm scale. (Cells are indicated by arrows). 
 
 
100µm 
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(A) 
 
 
(B) 
 
 
Figure 6.25 SEM images showing of the ATDC5-cell proliferation and spreading 
on PDLLA mesh of the bilayered scaffolds at different magnification at day 7: A) 
300µm, B) 60 µm scale. (Cells are indicated by arrows) 
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Figure 6.26 SEM images showing the ADTC5-cells migrate through the pore and 
grew within layers of fibrous network at day 14. 
 
 
 
 
6.3 Discussion 
 
 
 
In this Chapter, we have assessed the potential application of a fibrous PDLLA matrix 
combined with Bioglass
®
 substrates as suitable scaffold for osteochondral TE 
applications. By means of electrospinning, uniform PDLLA fibre meshes were 
produced with fibre diameters in the range between ~100nm and ~0.2µm to form a 
three-dimensional matrix architecture on 2-D sintered 45S5 Bioglass
®
 pellets and on 
3D 45S5 Bioglass
®
 based composite scaffolds. Results showed that the PDLLA 
fibrous matrix deposited on 3D Bioglass
®
 composite scaffolds, as a novel bilayered 
3D composite construct, increased chondrocytes cell attachment and proliferation. 
Increased surface roughness due to electrospun fibres should lead to better cell 
attachment and proliferation of chondrocytes cells [79;214]. White light 
interferometry and SEM images confirmed qualitatively and quantitatively that the 
topography (roughness) of the 2D 45S5 Bioglass
®
 sintered pellets and 3D bilayered 
45S5 Bioglass
®
 composite scaffolds have been altered due to the deposition of 
PDLLA fibres by electrospinning (see Fig. 6.4 and Fig. 6.12). The surface roughness 
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increased more than 13 times in terms of the rms value for 2D Bioglass
®
 sintered 
pellets coated with PDLLA fibres. This result is an agreement with the study by Chen 
et al. [215] who modified the surface of poly(e-caprolactone) membranes via 
electrospinning. Topography (roughness) of the porous bilayered scaffolds could not 
be measured by white light interferometry because the surface was not flat. To 
produce a uniform fibrous layer, we have optimised the fabrication process and fine-
tuning the electrospinning parameters, such as polymer viscosity, voltage, flow rate 
and electric field, as previously discussed in section 6.2.1.1. It should be pointed out 
that if even one of these parameters was less than optimal, irregular, bead-containing 
fibres could form, suggesting their coordinated requirement during the electrospinning 
process. One of the difficulties in the processing technique was to monitor the 
formation of fibres on the sintered pellets and scaffolds due to the opaque colour of 
the substrate, thus fibres were also deposited on glass slides to determine the optimal 
fibre formation and morphology. It was also observed that the fibre formation stability 
did not last for long period of time (less than 5 minutes) due to the instability of the jet 
formation at the needle tip. Therefore, deposition of PDLLA fibres needs to be done 
intermittently after 5 minutes. This process also allows enough time for solvent to be 
evaporated for the next PDLLA layer deposition. Nevertheless, the optimum 
electrospinning parameters were obtained using flow rate = 5µl/min, voltage = 15kV, 
5wt% PDLLA concentration, distance of application of the electric field = 15 cm and 
2 hours deposition time. Optimal fibre fabrication parameters are specific for a 
particular poly(α-hydroxy ester) [216].  
 
A scaffold intended to be used in TE needs to have surface resemblance of the ECM 
found in the human body (literature review, section 2.4) and the incorporation of  a  
fibrous layer aims at mimicking, to some extent, the natural matrix for the 
osteochondral TE applications. The fabrication of fibrous layers by electropsinning 
for cartilage TE applications has been extensively investigated, as previously 
described in the literature review (section 2.10.2). Results in this chapter show that the 
deposition of a PDLLA fibrous layer on the surface of 3D Bioglass
®
 composite 
scaffolds by electrospinning could be controlled reaching 150 µm in thickness which 
is sufficient to prevent HA mineralization from occurring. This effect is significant for 
the application of the bilayered constructs for osteochondral TE applications, which 
should not show mineralisation on the cartilage side. This is an agreement with 
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previous study by Reis et al. [217]. The risk of possible delamination between both 
the polymeric and composite constituents, respectively, was avoided since the 
bilayered constructs showed an integrated continuous interface assessed by SEM 
images and SBF in vitro assessment, as discussed in sections 6.2.2.2 and 6.2.2.3. It is 
hypothesized that the residue solvent could enhance the adhesion of PDLLA fibres to 
the PDLLA coated 45S5 Bioglass
®
 scaffold substrate, forming a strong bond, 
according to previous results reported by Chen et al.[215]. The quantification of the 
interfacial adhesion strength has not been covered in the thesis and needs dedicated 
further investigation in the future. Nevertheless the bilayered scaffolds developed here 
were qualitatively robust and of adequate structural integrity for their handling for 
material characterisation and for cell culture studies. The micro features of 
biodegradable polymer scaffolds, in addition to the chemical composition and 
polymer molecular structure, are the primary determinants of the degradation profile 
of a 3D tissue-engineering scaffolds [214], although macro features such as the 
morphology and architecture of the scaffold (e.g. porosity) are also important factors. 
Apart from the materials aspects, the environment (biochemistry) in which the 
material is placed is vitally important. In relation to our scaffolds, ultra-fine 
electrospun fibres would be more susceptible to hydrolysis compared with larger 
fibres when used in vitro and in vivo. The results showed that PDLLA fibers can 
maintain their structural stability in SBF and in cell culture media for up to 14 days, 
as shown by the SEM images in Figure 6.19 and Figure 6.26, respectively. 
 
Moreover PDLLA fibre roughness is hypothesized to act as anchorage for cells, to 
enhance cellular adhesion and spreading. A wide variety of cells, including 
chondrocytes, are able to detect changes in the surface topography and approaches to 
topographical control of cells have been reviewed by Wilkinson et al.[218]. 
Nevertheless, the present results showed that cells proliferated better on 3D 45S5 
Bioglass
®
 composite scaffolds compared to 2D sintered Bioglass
®
 pellets deposited 
with PDLLA fibrous layers (see Fig. 6.21 and Fig. 6.23), respectively, which indicates 
that roughness might be a secondary factor in the control of cell behaviour when 
compared to the influence of ion release from the materials during their degradation in 
vitro. In addition, these results also show that chondrocyte cells proliferated better on 
3D-scaffolds coated with PDLLA fibres compared to 3D-scaffolds without fibres, as 
indicated by the data in Fig. 6.23. Thus, it is hypothesized that in the present 
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composite scaffolds PDLLA fibre roughness is relevant in controlling cell behaviour 
when the ion release from the materials (e.g. material chemistry) during degradation is 
fixed. In this case the larger surface area achieved by nanofibrous modification 
provides more binding sites for the cells to attach and proliferate. The enhanced 
roughness and fibrous topology also contribute to stronger cell-cell interaction. It was 
reported that fibrous features with high surface area to volume ratio are able to absorb 
serum and ECM proteins for better cell adhesion.  Woo et al. have reported that 
fibronectin and vitronectin preferentially absorbed to a nanofibrous scaffolds at the 
rate of 2-4 times higher than solid walled scaffolds [219]. Thus the present bilayered 
scaffolds exhibit both advantages by having the basic 3D bioactive porous Bioglass
®
 
based scaffold for releasing the relevant ions for bone regeneration and the PDLLA 
nanofibres for increased protein absorption leading to improved chondrocyte cell 
adhesion. The smaller pore size of the PDLLA fibrous layer compared to the larger 
pore size of the 3D Bioglass
® 
based composite scaffolds (see Fig. 6.14) could also 
improved chondrocytes cell attachment. Indeed, investigations have shown that cells 
cultured in a 3D scaffold with large pore size (30 times the cell diameter, which is of 
the range 10-15µm) are more likely to behave as in a monolayer culture condition, 
which is known to promote dedifferentiation of chondrocytes [220]. On the other 
hand, too small a pore sizes may impair homogenous cell distribution within the 
scaffolds as well as access to nutrients [221]. To maintain the initial shape of the 
scaffold surface and the number of attached chondrocytes, adequate mechanical 
strength and highly cellular adhesivity are requirements for scaffolds in cartilage 
tissue engineering. Based on the current initial data, for cartilage tissue engineering, 
we may reasonable conclude that our novel bilayered construct based on PDLLA 
fibres on 3D 45S5 Bioglass
®
 porous composite substrates can be potentially an ideal 
biomaterial to create a 3D scaffold with adequate strength (Chapter 5), high cellular 
adhesivity and excellent support for chondrogenesis for osteochondral tissue 
engineering applications (Chapter 6). 
 
The other consideration is that chondrocytes exhibit a profound change in their 
phenotype after isolation from the ECM. They show the development of a fibroblastic 
morphology and a switch in production from type II collagen to type I collagen. To 
maintain the chondrocyte phenotype through the process of cartilage regeneration, 
scaffolds must have the potential to support chondrogenesis while maintaining the 
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chondrocyte phenotype. These aspects were not yet covered and will be considered 
for future studies. Another limitation of this study is that the results were derived from 
an in vitro experimental model. Therefore, the biocompatibility of the current 
bilayered scaffolds in living joints is still unclear and remains an important task for 
future investigations.  
 
Although there are limitations as mentioned above, the initial data derived from this 
study suggest great potential for the future of bilayered PDLLA fibre coated 45S5 
Bioglass
®
 composite scaffolds for osteochondral defect applications. 
 
 
6.4 Conclusions. 
 
The present bilayered PDLLA fibre coated 45S5 Bioglass
®
 composite scaffolds have 
been shown to have excellent chondrocyte cell-support ability. Cells infiltrate and 
migrate effectively into the porous network structure of the PDLLA fibre layer. 
Bilayered scaffolds showed better cell proliferation than 3D Bioglass
®
 scaffolds 
without PDLLA fibre coating, while cell proliferated better on the PDLLA fibrous 
matrix deposited on 3D Bioglass
® 
scaffolds than on 2D Bioglass
®
 sintered pellets. An 
increase in surface roughness due to deposition of PDLLA fibres by electrospinning 
improved cell attachment and proliferation. However, compared to the ion release 
effect from the Bioglass
®
 based scaffold, surface roughness can be a secondary factor 
in the control of cell proliferation. The PDLLA fibre stability was seen to be 
maintained up to 14 days in culture solution, probably due to the attachment of cells 
and extracellular matrix produced by the cells, but this hypothesis needs further 
investigation. 
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Chapter Seven 
 
7 Conclusions and Further Work 
7.1 General remarks 
 
 
In the framework of this research project, the fabrication and characterisation of novel 
3D porous bioactive composite scaffolds based on 45S5 Bioglass
® 
and biodegradable 
polymers intended for bone and osteochondral tissue engineering have been 
investigated. The experiments were designed to achieve the several objectives of this 
project, including: 1) optimisation of the Bioglass
®
 based scaffold processing 
technology and their microstructure, 2) coating of the basic scaffold with suitable 
polymer layers, 3) coating of Bioglass
®
 substrates with nanofibers by electrospinning 
to form bilayered scaffolds for osteochondral tissue engineering and 4) in vitro trial of 
the bilayered scaffolds via cell culture.  
 
The results of this research project have demonstrated that a better combination of 
mechanical and biological properties can be achieved with a composite using PDLLA, 
P(3HB) or P(3HO) polymer phases in combination with 45S5 Bioglass
®
 derived 
glass-ceramic scaffolds for tissue engineering applications. Coated 45S5 Bioglass
® 
pellets fabricated under the same conditions as the scaffolds proved the bioactivity 
and biodegradability of the material. The initial in vitro trials via chondrocyte cell 
culture, have suggested that bilayered 45S5 Bioglass
®
/PDLLA nanofibrous composite 
scaffolds constitute a suitable matrix for osteochondral tissue engineering, but it is 
also clear that to achieve clinical applications further work is needed in terms of both 
basic biomaterial engineering and in-vivo testing. This Chapter will summarize the 
key areas investigated during the course of this research, namely: optimisation of 
Bioglass
® 
scaffold microstructure by developing composites, PDLLA nanofibers 
coating to form bilayered scaffolds and in vitro testing of the bilayered constructs. 
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7.2 Optimisation of scaffolds microstructure by developing 
composites 
 
1. Highly porous, bioactive and biodegradable 45S5 Bioglass®-based scaffolds 
for bone engineering have been successfully synthesised using the replication 
technique in particular series 1000 (different sintering time; same sintering 
temperature) and series 900-1100 (different sintering temperature; same 
sintering time). The uncoated 45S5 Bioglass
®
– based scaffolds sintered under 
the optimum conditions of 1000
o
C for 2 hours have a similar macroporous 
structure to spongy bone: 1) they are highly porous (~ 80%-90%), 2) they have 
completely interconnected open porosity, 3) they have appropriate pore size to 
deliver nutrients, remove waste and to vascularise (300-500 micron) and 4) 
they can be functionalised with ALP enzymes. 
2. A significant progress in the optimisation of the scaffold microstructure is the 
possibility to use a cost-effective binder as opposed to PDLLA, as investigated 
in this work, and 10wt% PVA was selected as optimum condition. 
3. PDLLA polymer coating has significantly increased the mechanical strength 
(compressive strength) of 45S5 Bioglass
®
 based glass-ceramic scaffolds by 
effective infiltration of the polymer phase into the macro and micro-cracks of 
the scaffold struts when compared with the as-sintered (non-coated) scaffolds. 
The mean compressive values of samples after coating with PDLLA became 
three times higher than that of the sintered scaffolds at the optimum sintering 
condition of 1000
o
C for 2 hours. The mean compressive strength values of 
samples after and before coating with PDLLA are 0.34 ± 0.08MPa and 0.11 ± 
0.03MPa respectively. 
4. The bioactivity of the PDLLA coated scaffolds was maintained in SBF and 
this was proven by characterising PDLLA coated pellets sintered at the same 
conditions of the scaffolds and applying a wide range of techniques (SEM, 
EDX, and XRD). 
5. P(3HB) and P(3HO) polymers have been also used to coat Bioglass® scaffolds 
and they significantly increased the mechanical strength (compressive 
strength) of the coated 45S5 Bioglass
®
 scaffolds for series 1000 (different 
sintering time; same sintering temperature). The strong relationship between 
strut microstructure and scaffold mechanical strength was confirmed. The 
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mean compressive strength values of P(3HB) and P(3HO) coated scaffolds 
were 0.31 ± 0.09MPa and 0.29 ± 0.05MPa, respectively. The mean 
compressive strength values were three times greater after polymer coating 
confirming the suitability of the present approach. 
6. P(3HB) coatings infiltrated to a lesser extent the microcracks of the scaffold 
struts compared to PDLLA and P(3HO), due to the highly crystalline structure 
of P(3HB). P(3HO) efficiently infiltrated the microcracks and macrocracks of 
the scaffold struts due to lowest Tg value of this polymer. The degree of 
infiltration of the coating varied as follows: P(3HO)>P(DLLA)>P(3HB). 
7. The bioactivity of P(3HB) and P(3HO) coated scaffolds was maintained and 
this was proved by assessing P(3HB) and P(3HO) coated sintered pellets upon 
immersion in SBF. The onset time for the HA formation is as follows: 
PDLLA>P(3HB)>P(3HO). 
8. The significant finding in relation to the optimisation of the scaffold 
microstructure is the formation of polymer fibrils bridging the cracks, in the 
struts, which seems to induce a similar toughening mechanism to the one 
acting in bone, based on crack bridging by collagen fibrils. 
 
7.3 PDLLA nanofiber coatings on the 45S5 Bioglass® pellets 
and scaffolds: bilayered scaffold development 
 
1. PDLLA nanofibers of diameter ranging from 100 nm to 0.2µm were deposited 
on 45S5 Bioglass
®
 substrates at optimum electrospinning parameters of flow 
rate = 5µl/min and voltage = 15kV, deposited at 15 cm distance from the 
substrate using a suspension of 5wt% PDLLA in DMC. 
2. The surface roughness of the 45S5 Bioglass® flat substrates increased by the 
PDLLA nanofiber deposition, which was verified by white light 
interferometry. 
3. HA grew homogenously on the PDLLA nanofibers deposited on 45S5 
Bioglass
® 
sintered substrates after immersion in SBF for 7 days and longer 
time periods. 
4. For osteochondral applications, PDLLA nanofibers were deposited on 3D 
45S5 Bioglass
®
 scaffolds and the deposition time was varied to form bilayered 
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constructs. The density of the PDLLA fibrous layer increased with increasing 
deposition time. The thickness of the PDLLA fibrous layer reached 100-
150µm on the 3D scaffolds after deposition for 2 hours using the optimum 
condition of electrospinning. 
5. From the SBF immersion study, it was confirmed that PDLLA fibres 
deposited for 10 minutes were mineralised after 7 days and for longer 
immersion periods, while fibres deposited for 2 hours did not become 
mineralised after immersion in SBF for 7 days and longer. This is a very 
important result for the application of the present bilayered composites in 
osteochondral tissue engineering, since it is required that the cartilage side 
does not mineralise, e.g. where the PDLLA mesh should support the 
attachment, growth and proliferation of chondrocytes only.  
6. Initial in vitro studies of the bilayered scaffolds via cell culture techniques 
using chondrocyte cells (ATDC5) suggested that the bilayered scaffolds have 
an excellent cell-supporting ability. Cells can proliferate and migrate into the 
3D porous fibrous network structure of the PDLLA layer. Compared to the 
effect of ion release, surface roughness is a secondary factor in controlling the 
cell proliferation based on comparison of cell proliferation on 2D 45S5 
Bioglass
®
 sintered pellets and on 3D 45S5 Bioglass
®
-based scaffolds coated 
with PDLLA fibres. 
 
 
7.4 Suggested Further Work 
 
Based on the results presented and discussed in the framework of the present project, 
a number of investigations remain to be carried out for the full assessment of the 
scaffolds suitability for tissue engineering of bone and cartilage. 
 
7.4.1 Composite scaffolds 
       
1. The biodegradability of the Bioglass®-based scaffolds can be tailored 
according to the application requirement, depending on the bone anatomic 
position. On the other hand, the bioreactivity of the scaffolds is influenced by 
several factors, such as strut crystallinity and density, overall porosity of the 
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foam, surface chemical modification and the presence of biopolymer coatings. 
In the case of coated scaffolds, the intrinsic degradability properties of the 
polymer coatings, their thickness and homogeneity will also affect the general 
biodegradability of the construct. Therefore, it is essential to build a database 
on the bioreactivity of the scaffolds dependence of these individual factors, for 
supporting the potential suitability of the scaffolds for clinical applications.  
This will provide a broader scope than the limited approach investigated in 
this study. 
 
2. Kinetic studies of Bioglass® powder sintering remain to be carried out. There 
is very limited viscosity data available for Bioglass
®
 powder at relevant 
temperatures and variables such as heating rate, sintering temperature, holding 
time, particle size and green body density need to be investigated in detail. 
The interaction of densification (by viscous flow) and crystallisation should be 
investigated quantitatively at different heating rates, providing a broader scope 
than the limited variables investigated in this study. These sintering kinetic 
studies will be relevant to tailor the sintering schedule required to fabricate 
Bioglass
®
 based glass-ceramic scaffolds with improved structural integrity. 
 
3. The mechanical properties of coated scaffolds sintered at a relatively lower 
temperature of 1000
o
C should be further investigated, for example by the 
impact test and three point bending test for a complete mechanical assessment 
of the scaffolds, since the polymer infiltration may have different effects under 
different loading modes. Moreover the time-dependant variation of 
mechanical properties, e.g. compression strength, of scaffolds immersed in 
relevant environments, e.g. SBF, remains to be investigated. 
 
 
4. To further increase the mechanical property of the partially sintered scaffolds, 
improved infiltration techniques and different concentrations of polymers 
should be further investigated. The goal should be to develop fully 
interpenetrating polymer/Bioglass
®
 microstructure of the struts for enhanced 
scaffold toughness. In this regard, it will be necessary to measure the viscosity 
of PDLLA and P(3HB) solutions under different conditions, including, 
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possibly, the development of vacuum infiltration method to ensure that the 
polymer penetrates fully the open cracks (or pores) in the struts leading to a 
truly interpenetrating strut microstructure. 
 
5. The interfacial properties of the polymer /Bioglass® scaffolds (both PDLLA 
and P(3HB) coated scaffolds) need thorough investigations with a range of 
appropriate characterisation techniques. Currently, the interfacial properties 
have only been investigated qualitatively on sintered Bioglass
®
 discs coated 
with PDLLA. Quantitative investigations need to be carried out and the link 
between interfacial strength and effective mechanical properties, in particular 
intrinsic strut properties, must be established. 
 
6. The fracture mechanics of the composite scaffolds needs to be investigated in 
detail using the results presented in this study as starting information. The 
fracture characteristics of the composite depend not only on the relative 
volume fraction of the Bioglass
®
 and the polymer phases, but also on the 
microstructural arrangement of these phases and their relative size and 
orientation. Obviously the interfaces play a key role in determining the 
mechanical properties (see point (5) above). 
 
7. Stronger composite scaffolds might be achievable by increasing the 
organic/inorganic interfacial bonding by using surface functionalised phases of 
either the Bioglass
®
 scaffolds or the polymer phases. The inclusion of 
nanoparticles into the biopolymer matrix with the dual objective of improving 
the mechanical properties as well as of incorporating nanotopograhical 
features that mimic the nanostructure of natural bone can be considered. 
 
8. It is essential to increase the number of samples used for mechanical property 
characterisation in order to reduce the standard deviation and to arrive to 
quantitative and statistically meaningful conclusions regarding the correlation 
between process parameters and compressive strength data. 
 
9. Different dimensions of composite scaffolds should be considered in future 
investigations of the mechanical properties and bioactivity reaction 
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characterisation. Different dimensions of the scaffolds, relevant for a range of 
applications in tissue engineering, will influence the overall properties of the 
composite scaffolds and thus the effect of scaffold dimension remains to be 
investigated. 
 
10.  It is essential to carry out a comprehensive biocompatibility test of the 
composite scaffolds coated with natural biodegradable polymer synthesised 
from bacteria fermentations, in this case the P(3HB) and P(3HO) coated 45S5 
Bioglass
®
 scaffolds. These studies should directly clarify the possible effect of 
bacteria derived polymers on biocompatibility. 
 
11. In order to reduce P(3HB) polymer brittleness, and thus the lack of toughening 
effect on the composite scaffolds,  future experiments could combine P(3HB) 
with the more elastomeric polymer (P(3HO)) to form a hydrid polymer type 
for the coatings of the Bioglass
®
 scaffolds. These new scaffolds should be 
compared in their structural integrity and compression strength with PDLLA 
coated scaffolds. 
 
12. To improve the biological function of the scaffolds, an obvious future 
development, exploiting our technology of scaffold coating with 
biodegradable polymers, will be the incorporation of growth factors and other 
bioactive molecules in the polymer phase, which should include bone growth 
factors and angiogenesis growth factors. In addition, multifunctional scaffolds 
with a drug delivery capability could be also developed using as platform the 
polymer coated Bioglass® based glass-ceramic scaffolds developed here.   
 
 
7.4.2 Bilayered scaffolds 
 
1.  Alternative combinations of Bioglass® scaffolds and biopolymers should 
be considered for osteochondral tissue engineering applications, in 
particular the use of P(3HO) is promising based on the high flexibility of 
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this polymer, which should impart increased fracture toughness to the bone 
side of the scaffold.  
 
2. The fundamental experimental aspects of the electrospinning technique 
applied to the development of PDLLA fibres needs a thorough 
investigation in order to develop a reliable method to fabricate robust and 
homogenous nanofibrous mats on scaffolds that exhibit the optimal 
properties for cartilage regeneration. 
 
3. The thickness of the PDLLA fibrous layer should be increased to ~1 mm 
taking special consideration not to greatly reduce the pore size and 
porosity of the fibrous matrix. The thickness of the natural cartilage layer 
is around 1 mm thickness, thus further improvement of the electrospinning 
method is required. 
 
4.  A higher molecular weight PDLLA for the electrospinning technique can 
be considered in order to improve the polymer biodegradation stability and 
the mechanical properties of the PDLLA fibres. 
 
5. To facilitate viability, attachment and phenotypic maintenance of the 
chondrocytes cells, PDLLA fibres mesh can be treated with NaOH to 
increase the surface hydrophilicity. Other possible surface 
functionalisation methods for PDLLA fibrous substrates should be 
considered. 
 
6. The interfacial properties of the bilayered constructs developed in the 
present project needs more detailed investigations. Currently, only SEM 
observation was used for characterisation of the interfacial properties. In 
future work a complete mechanical property characterisation will be 
required, with emphasis on testing the shear strength at the interface. The 
possible degradation of bilayered scaffolds in a relevant environment, e.g. 
SBF, needs to be investigated to assess the possible synergetic effect of the 
degradation products of the bioactive glass-ceramic scaffold on the 
PDLLA fibre degradation, e.g. effect of possible local change of pH. 
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7. The mechanical properties of the bilayered scaffolds during cell culture 
need to be evaluated and investigated in detail. It is hypothesised that the 
mechanical properties of scaffolds will increase with increasing cell 
culture time. Therefore, a long term cell culture investigation is 
recommended. 
 
8. The material chemistry property of the bilayered scaffolds during the cell 
culture studies needs to be evaluated and investigated in detail. The 
bioreactivity of the scaffolds is influenced by several factors, such as 
crystallinity, densification of the struts, porosity and surface coating, as 
discussed in the present work. Therefore, it is essential to build a database 
of relevant material property variation during cell culture studies. 
 
9. A long term cell culture investigation of the bilayered scaffolds is essential 
to assess in a comprehensive manner the response of chondrocyte cells 
(ATDC 5) in contact with the bilayered scaffolds and to better understand 
the implications for osteochondral tissue engineering. 
 
10. Mechanical forces play a central role in the physiology of a wide variety of 
tissues. Cells and tissues react to external mechanical stimuli that can 
include gravitational and hydrostatic pressures, shear stresses caused by 
fluid flow, acoustic waves and contractile forces exerted from one cell to 
another. Therefore, a bioreactor based characterisation of the materials 
developed here would be the obvious next step in their further 
development to optimise the scaffolds performance for osteochondral 
tissue engineering. 
 
11. Further investigations in vitro and in vivo are required to assess the 
phenotype of the chondrocyte cells (ATDC 5) in contact with the bilayered 
scaffolds to better understand the implication for osteochondral tissue 
engineering. The results of further in-vitro studies and, specially, in vivo 
assessments, will enable to realistically consider the bilayered constructs 
for future osteochondral tissue engineering strategies.  
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12. From the point of view of the material development, in order to improve 
the biological function of the bilayered scaffolds, growth factors such as 
TGF-ß family (TGF-ßs), insulin-like growth factor (e.g., IGF-1) and bone 
morphogenetic proteins (BMPs) or drugs can be grafted to the PDLLA 
fibre mesh or they can be mixed together to produce nanofiber meshes 
loaded with relevant biomolecules by electrospinning. 
 
13. Recently, the possibility of producing encapsulated cells in fibres and 
meshes by electrospinning has been explored. There is also a possibility to 
apply this approach to the development of the bilayered scaffolds 
investigated in this project. 
 
14.  A major goal in osteochondral tissue engineering is to be able to promote 
tissue synthesis derived from progenitor cells, preferentially from a single 
cell source, that will be differentiated in the construct to chondrocytes and 
osteoblasts. This will require the incorporation of cell adhesion molecules 
and specific growth factors in different region of the construct for tissue 
engineering chondrogenesis and osteogenesis. Our scaffolds can be the 
matrices of choice to test different cell culture based methods in the field 
of osteochondral regeneration. 
 
15. Further investigation of the effect of sterilisation on the bilayered scaffolds 
required systematic study. 
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APPENDIXES 
Table 1. Individual Components (2D sintered pellets) Summary Data – 
MULTIPLE COMPARISONS 
 
Response: Cell Growth (Bonferroni) 
Material vs. 
Material 
Mean 
difference 
Std. error Sig. 95% CI 
Lower 
95% CI 
Upper 
1 2 14.5850 3.2545 0.000 5.7200 23.4700 
 3 14.8278 3.2545 0.000 5.9528 23.7028 
 4 13.2844 3.2545 0.001 4.4094 22.1594 
2 3 0.2328 3.2545 1.000 -8.6422 9.1078 
 4 -1.3106 3.2545 1.000 -10.1856 7.5044 
3 4 -1.5433 3.2545 1.000 -10.4183 7.3317 
Based on observed means 
The mean difference is significant at the 0.05 level 
 
 
 
Table 2. Bioglass ± PDLLA fibres (3D scaffold) Summary Data – 
MULTIPLE COMPARISONS 
 
Response: Cell Growth (Bonferroni) 
Material vs. 
Material 
Mean 
difference 
Std. error Sig. 95% CI 
Lower 
95% CI 
Upper 
1 2 -25.7933 9.3038 0.043 -50.8552 -0.7315 
 3 37.0250 9.3038 0.004 11.9631 62.0869 
2 3 62.8183 9.3038 0.000 37.7565 87.8802 
Based on observed means 
The mean difference is significant at the 0.05 level 
 
 
 
 
 
 
